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The extensive scientific interest in cellular and biomolecular processes is due in large part to the 
importance of such processes deep inside living organisms, in the context of both health and disease. 
However, most methods for imaging cellular processes such as gene expression have relied on 
fluorescent proteins and other optical reporters that, while providing a direct optical readout of the 
biomolecular environment in cells readily exposed to light, have greatly limited performance in large 
animals due to the poor penetration of visible light beyond 1 mm of biological tissue. In contrast, 
ultrasound is widely used to noninvasively image tissue deep inside living organisms but has rarely 
been used to investigate cellular function due a lack of acoustic reporters whose production and 
properties are coupled to biomolecular events. Recently, the first acoustic reporter genes (ARGs) 
were developed for ultrasound imaging of a unique class of air-filled protein nanostructures known 
as gas vesicles, or GVs, which scatter sound waves when expressed in bacterial and mammalian 
cells. ARGs allow gene expression to be visualized with ultrasound similar to how green fluorescent 
protein (GFP) allowed gene expression to be visualized with light. However, ARGs will have limited 
utility in practical applications involving living organisms without ultrasound imaging methods 
providing the specificity to reliably distinguish GVs from surrounding tissue and the sensitivity to 
detect GVs at low concentrations. 
In this thesis, we present two novel ultrasound imaging methods that exploit the unique nonlinear 
physical properties of gas vesicles to enhance image quality in situations that pose challenges for 
conventional imaging methods. In Chapter 1, we provide a brief background and introduction to 
methods for enhancement of ultrasound imaging of biological structure and function through contrast 
agents. In Chapter 2, we address the problem of distinguishing GVs from tissue with cross-
Amplitude Modulation (xAM), an ultrasound pulse sequence that uses X-waves to isolate the signal 
generated by reversible buckling of the GV shell while cancelling scattering and artifacts from tissue. 
In Chapter 3, we present an application of xAM to imaging of dynamic biomolecular processes. We 
show that, when GVs are engineered such that buckling is induced by enzyme activity, xAM can 
visualize enzymatic processes deep inside living animals. In Chapter 4, we address the problem of 
detecting very low concentrations of ARG-expressing cells with Burst Ultrasound Reconstructed 
with Signal Templates (BURST), an imaging method that exploits the strong, transient signals 
 vi 
generated during sudden GV collapse under acoustic pressure by unmixing the temporal 
dynamics of such signals from background scattering. BURST imaging improves cellular sensitivity 
by more than 1000-fold and, in dilute cell suspensions, enables the detection of gene expression in 
individual bacteria and mammalian cells. In Chapter 5, we present an application of an early 
formulation of BURST to imaging gene expression in mammalian cells. We use this imaging method 
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C h a p t e r  1  
METHODS FOR CONTRAST-ENHANCED ULTRASOUND IMAGING OF 
BIOLOGICAL STRUCTURE AND FUNCTION 
 
1.1 Introduction  
 
In this chapter, I provide an overview of the field of contrast-enhanced ultrasound, emphasizing the pulse 
sequences and image processing algorithms that exploit the unique properties of ultrasound contrast agents. I 
first provide a brief background on the principles of ultrasound imaging, including the relevant physical 
properties of sound waves, common pulse sequences used to generate echoes from the sample, and the data 
processing pipeline by which the echoes are used to reconstruct an image. Next, I introduce microbubbles, the 
most widely-used synthetic ultrasound contrast agent. I then describe how novel pulse sequences and 
algorithms designed to exploit the unique physical properties of these contrast agents have enhanced the 
capabilities of contrast-enhanced ultrasound. Finally, I introduce gas vesicles as the first genetically encodable 
ultrasound contrast agents, compare their properties with those of synthetic ultrasound contrast agents, discuss 
existing methods for imaging them, and present some remaining challenges for ultrasound imaging with gas 
vesicles. Throughout, I compare the development of microbubbles and gas vesicles in ultrasound imaging to 
the development of synthetic dyes and fluorescent proteins used in optical imaging to place these technologies 
in the broader context of imaging of biomolecular and cellular function. 
  
1.2 Principles of Biomedical Ultrasound Imaging  
 
Ultrasound has been widely used as a portable and low-cost imaging technique in the medical field since the 
1960s and is currently the most prescribed diagnostic modality1. However, while diagnostic medical 
ultrasound is generally considered a mature technology in some applications, recent advances in 
computational processing power and contrast agents have ushered in a large number of novel research 
directions2. Here, I provide a brief overview of acoustic waves in biological tissue and biomedical ultrasound 
imaging on programmable systems in sufficient detail to confer a conceptual understanding. 
 





Ultrasound is a form of energy manifested as a compressive wave consisting of periodic regions of 
compression and rarefaction, or peaks of high and low pressure, in a medium such as air or water (of course, 
this is also a description of audible sound: ultrasound is distinguished by having a frequency above the upper 
audible range in humans of roughly 20 kHz). The basic principle that makes ultrasound imaging possible is 
the reflection or scattering of acoustic waves at boundaries of media with different material properties. 
Specifically, the density and compressibility of a medium determine its acoustic impedance3, a property 
analogous to the index of refraction in optics. The greater the mismatch in acoustic impedance between two 
media, the greater the fraction of energy of an ultrasound wave that will be reflected when it encounters that 
boundary. The acoustic impedances of different types of soft biological tissue are relatively similar, resulting 
in a small fraction of an acoustic wave’s energy being backscattered at each interface4. For example, at a 
boundary between muscle and fat tissue, on the order of 1% of the acoustic energy is backscattered. This 
allows ultrasound to remain coherent and pass through multiple layers of tissue while sending backscattered 
echoes back toward the ultrasound probe, providing the information necessary to reconstruct an image. When 
a boundary consists of a particle on the order of ten times smaller than the wavelength of ultrasound 
propagating through it (such as a fiber, cell, or organelle), an omnidirectional scattering event occurs instead 
of a directional reflection5. Most soft biological tissues include many such scatterers, creating a pattern known 
as speckle between tissue interfaces4 whose intensity is mostly independent of the orientation of the transducer 
with respect to the tissue.  
Finally, an important acoustic property is nonlinearity. In a perfectly linear medium with linear 
scatterers, an acoustic wave and its backscattered echoes will have the same frequency components as the 
transmitted wave. However, in nonlinear media and scatterers, for instance those whose speed of sound and 
attenuation change in response to the amplitude of an acoustic wave, the shape of the acoustic wave becomes 
distorted6–8, creating new frequency components in the frequency spectrum of both the backscattered and 
propagating waves. As a rough rule of thumb, nonlinearity occurs when the properties of a medium or a 
scatterer change in response to the properties of an acoustic wave. In reality, all media, including water and 
biological tissue, have some degree of nonlinearity. However, the strongest commonly-encountered sources 
of nonlinearity are ultrasound contrast agents, discussed in the next section. While the effects of nonlinearity 
can be undesirable9, we will see later how they represent some of the most interesting opportunities for 
improving ultrasound imaging with novel pulse sequences and algorithms. 
 
1.2.2 Data processing pipeline 
A typical programmable ultrasound system consists of a probe connected to a scanner system communicating 
with a host computer. The probe contains a linear array of piezoelectric transducer elements (often 128 or 256 





for low-level signal processing operations such as amplification, analog-to-digital conversion, and filtering. 
In most clinical equipment, the scanner system also performs the higher-level image reconstruction and 
processing operations using dedicated digital signal processing chips to minimize latency for real-time 
imaging. The conventional sequence for these operations includes beamforming, envelope detection, 
interpolation, and dynamic range compression (often by conversion to dB scale). Beamforming is the process 
by which the times of flight of the received echoes and the positions of the receiving probe elements are used 
to compute the origin in the imaging plane of every echo. In recent decades, popular platforms for preclinical 
ultrasound research began implementing these higher-level processing functions in software on the host 
computer11, allowing users to access raw data and implement custom reconstruction algorithms. These 
systems, along with advances in computing power, have accelerated research on novel pulse sequences and 
image reconstruction algorithms12 due to their programmability, versatility, and general lack of proprietary 
processing steps. The following discussion on pulse sequences assumes such a programmable ultrasound 
system connected to a linear array probe. 
 
1.2.3 Pulse sequences 
A pulse sequence is, at a basic level, a pattern of voltage values applied to each probe element as a function 
of time and element position. A pulse sequence usually consists of several transmits, each of which represents 
a pattern of transmit waveforms applied to one or more of the probe elements. 
  Each transmit waveform is a function of pressure over time that is typically parameterized 
by frequency, number of cycles, amplitude, and phase. Frequency is an important property of the acoustic 
wave itself that determines its wavelength (𝜆 = 𝑐/𝑓, where 𝑐 is the speed of sound in the medium and 𝑓 is 
the frequency of the ultrasound wave), which determines a lower limit for the resolution of conventional 
imaging and ranges from 500 µm in clinical imaging to 50 µm in microscanning of small animals13. Because 
attenuation increases with frequency as mentioned above, there is an inherent trade-off between resolution 
and penetration depth. If the transmit waveform contains more than one cycle, the axial (depth-wise) 
resolution will be reduced in proportion to the number of cycles, though signal-to-noise ratio of the imaging 
(SNR) increases with number of cycles. The amplitude of a transmit waveform, determined primarily by the 
voltage applied to the probe, also affects the SNR, as well as the strength of nonlinear distortion. Moreover, 
as described in the next section, even small differences in amplitude can result in qualitatively different 
acoustic phenomena when imaging with contrast agents. The phase of a transmit waveform does not typically 
affect the image on its own because phase information in the received echoes is usually lost during envelope 
detection, but it can be useful for techniques such as phase inversion14 where RF echoes from transmits with 
opposite phases are combined to highlight nonlinear signal. Most commonly, a single set of waveform 





  During a transmit event, a set of delays is applied to all active probe elements as they transmit 
the specified waveform, after which the probe elements all wait to receive echoes generated in the region to 
be imaged before initiating any other transmit events in the pulse sequence. The (usually contiguous) set of 
active elements is called the aperture and the set of delays applied to these elements is called the delay law. 
Together, the aperture and delay law determine the shape of the ultrasound beam, which is formed by 
constructive interference of the quasi-spherical waves generated by each element after the programmed delay.  
  Most pulse sequences utilize some variation of one of two types of ultrasound beam: focused 
(or parabolic) beams, and plane waves. Conventional brightness-mode (B-mode) images rely on focused 
beams, which involve a parabolic delay law that ensures the acoustic waves transmitted by each active element 
arrive simultaneously at a target focal depth at the center of the aperture. For a given aperture size and 
waveform amplitude, focused beams maximize the peak acoustic pressure experienced at the target location. 
During a beamforming process known as delay and sum, delays are applied to echoes received by all the 
active elements to account for different travel times from the aperture bisector. The delayed echoes are then 
summed together to generate a 1-dimensional signal known as a ray line. In pulse sequences relying on 
focused beams, a 2-dimensional image is generated by successively shifting the aperture by a single element 
prior to each transmit until the maximum number of ray lines is acquired. For instance, a focused beam pulse 
sequence with a 64-element aperture implemented on a 128-element array will generate an image from 128 −
64 + 1 = 	65 ray lines. In this example, an image with up to the full 128 ray lines could be formed by 
continuing to transmit with progressively truncated apertures at the edges of the array, but this would result 
in lower, nonuniform contrast in the rightmost and leftmost 32 ray lines. 
  Plane waves, formed using a flat or linear delay law, allow images encompassing the probe’s 
maximum lateral field of view to be reconstructed from the echoes of as few as one transmit, allowing for 
ultrafast imaging with frame rates improved by two orders of magnitude relative to focused beams (7,700 Hz 
compared to 59 Hz for a 10-cm-deep image with a 128-element probe)15. Plane wave image reconstruction is 
accomplished through a process called synthetic aperture beamforming, in which delay-and-sum 
beamforming is successively applied to the RF recordings of subsets of the probe elements in a convolution-
like process. Consequently, the computational intensity of reconstruction in plane wave imaging increases in 
proportion to the higher frame rate, which made recent improvements in computer hardware crucial for the 
advance of ultrafast imaging. While images acquired with single plane waves have low contrast compared to 
those acquired with focused beams, images from a small number of plane waves tilted at different angles can 
be combined to improve contrast while maintaining ultrafast framerates16. Ultrafast plane wave imaging has 
been the basis for several recent advances in ultrasound, including functional doppler imaging of blood flow 





the blood flow velocity in the brain vasculature over time with high SNR17,18. Ultrafast imaging has also 
enabled advances when combined with contrast agents, as described below. 
  
1.3 Synthetic Contrast Agents 
 
While the relative homogeneity of acoustic impedance across soft biological tissues provides conventional 
ultrasound with its signature advantage of large penetration depth, it also results in relatively low contrast. 
This causes an inability to distinguish tissue features with scattering properties similar to those of their 
surroundings, such as tumors, or those with small size and low scattering levels relative to their surroundings, 
such as small blood vessels3.  
  In the field of microscopy, similar limitations, resulting from the small difference in optical 
properties between spatially co-localized tissues, cells, and organelles, were addressed with synthetic dyes 
that allowed distinct chemical and structural properties to be coupled to large changes in optical properties. 
For example, the Golgi stain allowed visualization of the axons and dendrites of individual neurons, which 
are small and whose weak levels of absorbance and scattering of visible light are similar to those of other 
neurons and glial cells. The stain accomplishes this by producing a large increase in absorbance confined to 
the cytoplasm of the target neuron19. 
  In both ultrasound and microscopy, then, there is often an overlap between the imaging 
target’s properties of interest and its hidden properties, namely those that are not detectable or distinguishable 
by the respective imaging modality. In this way, for a given biomedical imaging modality, we can view a 
good contrast agent as a substance or particle with one or more physical properties that are 1) detectable by 
the imaging modality, 2) distinguishable from the target’s background signal, and 3) dependent on one or 
more of the imaging target’s hidden properties of interest. In addition, the contrast agent should be robust in 
the sense that its presence should not change the target’s properties of interest to an extent that is confounding 
of the results of experiments or, for in vivo imaging, harmful to the subject. Of course, the utility of a contrast 
agent depends on other factors such as cost and ease of use, but a simplified framework of detectability, 
distinguishability, dependence, and robustness is a helpful way to conceptualize the differences among 




To address the limitations of ultrasound imaging mentioned above, researchers and clinicians have for several 





agent known as microbubbles20–22. The Golgi stain had a spatial distribution of absorbance that was detectable 
by visible light, distinguishable from neural tissue, and dependent on the structure of neurons. Similarly, 
microbubbles have a spatial distribution of scattering that is detectable by ultrasound, distinguishable from 
most types of soft tissue, and dependent on the structure of blood vessels in the vascular system. In addition, 
the safety and robustness of microbubbles in clinical imaging has been long-established20,23. 
  The size and composition of microbubbles represent two characteristics that are virtually 
essential for any ultrasound contrast agent. Ultrasound contrast agents are designed to be no larger than red 
blood cells3, allowing them to pass through the smallest capillaries and scatter omnidirectionally even for the 
higher range of frequencies used in ultrasound imaging. Second, ultrasound contrast agents are almost always 
gas-filled inclusions. Because gas is dramatically more compressible and less dense than biological tissue, an 
inclusion filled with gas maximizes the acoustic impedance mismatch and thus also the amount of scattering 
for a scatterer of a given radius.  
 
1.3.2 Imaging methods for microbubbles 
 
While microbubbles were initially developed to exploit the linear acoustic properties mentioned above for use 
with existing imaging methods3, novel imaging methods continue to be developed that exploit these properties 
in new ways. The high linear scattering of microbubbles allows ultrafast plane wave imaging to maintain good 
contrast at high frame rates24, and their small size results in signals with high spatiotemporal frequency that 
can be unmixed from tissue background signal25. Together, these properties have enabled super-resolution 
methods that track the motion of individual microbubbles to produce images of the brain or tumors at the 
organ scale with resolutions of less than 10 µm16,26. 
  In addition to the linear acoustic properties, the size and composition of microbubbles also 
endows them with interesting nonlinear properties that became some of their most useful features as novel 
pulse sequences were developed to exploit them14,27,28. The sub-wavelength size of microbubbles allows them 
to be fully exposed to each cycle of compression and rarefaction in an acoustic wave, while their highly-
compressible gaseous composition allows their size to fluctuate in response to these rapid pressure changes. 
These changes in the radius of the scatterers in response to incident acoustic waves generate nonlinearity in 
the form of harmonic frequencies29. 
  Because biological tissue has weak nonlinearity, nonlinear contrast agents present an 
opportunity to improve imaging specificity by separating contrast agent signal from the tissue background. 
The method of pulse inversion does this by successively sending two transmits in which the phase of the 
waveforms are shifted by one half-cycle relative to each other14. The coherent sum of the echoes from these 





by the contrast agent. Another method is amplitude modulation, in which echoes from two low-pressure 
transmits are coherently subtracted from the echoes of a high-pressure transmit whose beam is the sum of the 
first two30,31. This cancels the linear signals and preserves nonlinear signal present in both the fundamental 
and second harmonic frequencies. 
 
 
1.3.3 Current limitations of microbubbles 
 
Despite their many capabilities and remaining opportunities for improvement, there are a number of 
limitations intrinsic to all forms of synthetic microbubbles. The imaging methods for microbubbles we have 
discussed have all functioned to expand their detectability and distinguishability across spatial and temporal 
dimensions and across imaging contexts. However, none of these have expanded the dependence of 
microbubbles to biological phenomena other than blood flow and vascular structure.  
  While microbubbles have been functionalized to bind to specific molecular targets in the 
blood stream20,22,27, their microscale size and limited stability after injection create significant challenges for 
their use in molecular imaging of targets outside the bloodstream and of dynamic cellular processes. Enabling 
robust noninvasive imaging of biological processes at the cellular and biomolecular levels will require an 
ultrasound contrast agent whose physical properties are intrinsically dependent on such processes. 
 
1.4 Genetically Encodable Contrast Agents 
 
To provide context and tentative outlook for biomolecular ultrasound imaging, we return to our analogy with 
optical microscopy. In 1994, the gene encoding green fluorescent protein (GFP) was expressed in E. coli and 
C. elegans and shown to generate fluorescence in these non-native organism for the first time32,33, allowing a 
plethora of questions in the burgeoning field of molecular biology to be answered with the well-established 
tools of optical microscopy. As a fluorescent protein whose gene could be readily expressed in non-native 
prokaryotic and eukaryotic cells, GFP created a robust dependence between detectable and distinguishable 
optical signal and the processes that define the central dogma of molecular biology. Moreover, because GFP 
is built with the same well-characterized molecular machinery and building blocks common to all forms of 
life, the goals of creating dependence between optical signals and other biomolecular processes, such as Ca2+ 
signaling34, without exogenous agents were transformed from open scientific problems to engineering 
challenges. While GFP and an increasing number of engineered variants demonstrated the exciting potential 
of this class of tools with conventional microscopy techniques, innovations in optical imaging such as 





unique physical properties of these proteins. This resulted in the ever-increasing resolution, scope, information 
content, and robustness of fluorescent protein imaging technologies that made them the mainstays of scientific 
and industrial biotechnology they are today. 
  However, as fluorescent protein imaging has matured, so has recognition of its limitations. 
Because the physical nature of visible light limits ballistic penetration past approximately 1 mm of biological 
tissue39, it appears clear that biomolecular and cellular processes occurring deep inside the body are unlikely 
ever to be noninvasively imaged in situ using optical methods. This is an important problem because most of 
the cellular and biomolecular processes investigable by optical methods are interesting because of their roles 
deep inside the bodies of living animals. 
 
1.4.1 Gas vesicles and acoustic reporter genes 
 
In 2014, gas vesicles, a unique class of gas-filled protein nanostructures that scatter acoustic waves, were 
presented as the first biomolecular ultrasound contrast agents40. The native function of gas vesicles is to 
regulate buoyancy in photosynthetic microbes for optimal access to light41,42. In a process that remains to be 
fully understood, chaperones and other assembly factor proteins nucleate and assemble the hollow gas vesicle 
shell out of repeating subunits of a protein called GvpA, an amphiphilic protein whose hydrophobic residues 
face the inside of the shell and prevent the condensation of water while leaving the shell selectively permeable 
to gas. A second protein, GvpC, acts as an outer scaffold that increases the structural integrity of the shell. 
This structure allows water vapor and gas dissolved in the surrounding media to equilibrate with the gas in 
the gas vesicle on a microsecond timescale, leaving no pressure differential across the shell at equilibrium and 
providing long-term stability in contrast to microbubbles, which typically dissolve in under 6 minutes20. In 
recent years, the gene cluster encoding gas vesicles and the auxiliary proteins has been engineered to develop 
the first acoustic reporter genes for imaging gene expression of gut bacteria in mammalian hosts43. In this 
way, gas vesicles have shown the potential to do for ultrasound what GFP and its derivatives have done for 
optical imaging.  
  
1.4.2 Imaging methods for gas vesicles 
 
As sub-wavelength, gas-filled inclusions, gas vesicles share many of the advantageous linear acoustic 
properties of microbubbles. As with microbubbles, the size and composition of gas vesicles also create 
interesting nonlinear properties. However, the encasement in a gas-permeable protein shell and the consequent 
lack of surface tension give gas vesicles unique nonlinear properties distinct from those of microbubbles. The 





which are genetically determined and can be modulated by the biomolecular environment40,44–47. Irreversible 
collapse of the gas vesicle shell occurs when it is exposed to positive acoustic pressures above a genetically 
determined threshold, liberating the gas inside as nanobubbles48 and erasing any ultrasound contrast. 
Reversible buckling of the gas vesicle shell occurs at acoustic pressures above a genetically determined 
buckling threshold (but below the collapse threshold) at ultrasound frequencies above 1 MHz47, where the 
time between ultrasound cycles is short enough that the internal pressure of the gas vesicle is maintained 
despite the free gas exchange across the shell, which occurs on the order of 10-5 seconds41.  
  Unlike the nonlinear behavior of microbubbles, which occurs even at low acoustic pressures7, 
the nonlinear phenomena of buckling and collapse in gas vesicles occur at sharply-defined acoustic pressure 
thresholds due to the rigid structure of the gas vesicle shell. For gas vesicle collapse, this property allows for 
multiplexed imaging of gas vesicle variants with different collapse profiles44. This method works by applying 
successively higher acoustic pressures to collapse one gas vesicle variant population at a time, followed by 
linear unmixing to isolate the total signal due to each variant for every image pixel. For gas vesicle buckling, 
the sharp threshold property allows signal from different engineered gas vesicle variants to be distinguished 
on the basis of nonlinear harmonic generation44,47, including with the use of the amplitude modulation method 
discussed above in the context of microbubbles. 
 
1.4.3 Limitations of gas vesicle imaging methods 
Despite the demonstrated potential of gas vesicles and acoustic reporter genes, a number of challenges remain 
that limit their practical utility. First, while amplitude modulation imaging of harmonic gas vesicles improves 
contrast relative to tissue, use of this technique to image targets in vivo showed the presence of strong 
nonlinear propagation artifacts in tissue downstream of gas vesicle inclusions47. Because the spatial 
distribution of gas vesicles will not be known a priori, such artifacts compromise the specificity of this 
technique. Second, while B-mode ultrasound imaging was shown to detect engineered bacteria expressing gas 
vesicles inside the mouse colon at 109 cells/ml, endogenous targets of interest such as immune cells and certain 
gut microbes are present at concentrations orders of magnitude smaller49,50. 
  As was the case with GFP and optical imaging methods, the full realization of the potential 
of acoustic reporter genes requires ultrasound imaging methods that exploit the unique physical properties of 
gas vesicles to address these outstanding limitations and augment advances in the engineering of these 
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C h a p t e r  2  
NONLINEAR X-WAVE ULTRASOUND IMAGING OF ACOUSTIC 
BIOMOLECULES 
This chapter is in large part a reformatted version of the manuscript entitled “Nonlinear X-Wave Ultrasound 
Imaging of Acoustic Biomolecules” published by Maresca, D., Sawyer, D. P., Renaud, G., Lee-Gosselin, 
A. & Shapiro, M. G. in Physical Review X. Under the supervision of Mikhail Shapiro, my contributions to 
this work were to conceive, design, and conduct the experiments, design and optimize the ultrasound pulse 
sequence and reconstruction algorithm, analyzed the data, and write the manuscript alongside David 
Maresca. Thanks to Guillaume Renaud for performing the ultrasound simulations and to Audrey Lee-
Gosselin for assistance with the animal experiments. 
 
2.1 Abstract 
The basic physics of sound waves enables ultrasound to visualize biological tissues with high spatial and 
temporal resolution. Recently, this capability was enhanced with the development of acoustic biomolecules – 
proteins with physical properties enabling them to scatter sound. The expression of these unique air-filled 
proteins, known as gas vesicles (GVs), in cells allows ultrasound to image cellular functions such as gene 
expression in vivo, providing ultrasound with its analog of optical fluorescent proteins. Acoustical methods 
for the in vivo detection of GVs are now required to maximize the impact of this technology in biology and 
medicine. We previously engineered GVs exhibiting a nonlinear scattering behavior in response to acoustic 
pressures above 300 kPa, and showed that amplitude-modulated (AM) ultrasound pulse sequences that both 
excite the linear and nonlinear GV scattering regimes were highly effective at distinguishing GVs from linear 
scatterers like soft biological tissues. Unfortunately, the in vivo specificity of AM ultrasound imaging is 
systematically compromised by the nonlinearity added by the GVs to propagating waves, resulting in strong 
image artifacts from linear scatterers downstream of GV inclusions. To address this issue, we present an 
imaging paradigm, cross-amplitude modulation (xAM), which relies on cross-propagating plane-wave 
transmissions of finite aperture X-waves to achieve quasi artifact-free in vivo imaging of GVs. The xAM 
method derives from counter-propagating wave interaction theory which predicts that, in media exhibiting 
quadratic elastic nonlinearity like biological tissue, the nonlinear interaction of counter-propagating acoustic 
waves is inefficient.  By transmitting cross-propagating plane-waves, we minimize cumulative nonlinear 





at the two plane-waves’ intersection. We show in both simulations and experiments that residual xAM 
nonlinearity due to wave propagation decreases as the plane-wave cross-propagation angle increases. We 
demonstrate in tissue-mimicking phantoms that imaging artifacts distal to GV inclusions decrease as the 
plane-wave cross-propagation angle opens, nearing complete extinction at angles above 16.5 degrees. Finally, 
we demonstrate that xAM enables highly specific in vivo imaging of GVs located in the gastrointestinal tract, 
a target of prime interest for future cellular imaging. These results advance the physical facet of the emerging 
field of biomolecular ultrasound, and are also relevant to synthetic ultrasound contrast agents. 
2.2 Introduction 
Green fluorescent protein (GFP) and its analogs serve as irreplaceable tools allowing biologists to visualize 
gene expression and other cellular processes using optical microscopes1. However, the microstructure of 
biological tissues restricts a photon’s transport mean free path to about 1 mm2, limiting in vivo optical imaging 
applications. In contrast, the physics of ultrasonic waves allow them to propagate centimeters deep into 
biological tissues without losing their coherence, and enable tissue scanning at the organ scale. Very recently, 
the first acoustic biomolecules for ultrasound, analogous to GFP for optics, were developed3 based on a unique 
class of air-filled protein nanostructures called gas vesicles, or GVs4, making it possible to use ultrasound to 
visualize the function of cells deep inside tissues. 
To maximize the impact of acoustic biomolecules in biology and medicine, physical methods are needed to 
discriminate GV scattering from tissue scattering, analogous to previous developments in the imaging of 
synthetic microbubble contrast agents5–11. GVs are air-filled nanocompartments with dimensions on the order 
of 200 nm, enclosed by a rigid 2 nm-thick protein shell12,13. In 2014, it was reported that GVs could be imaged 
with ultrasound4, and it was recently shown that gene clusters encoding GVs could be expressed 
heterologously in engineered cells and serve as acoustic reporter genes3. While most natural GVs behave as 
linear ultrasound scatters, Lakshmanan et al.14 engineered harmonic GV variants (hGVs) that buckle and 
scatter higher harmonics at acoustic pressures above 320 kPa, corresponding to a mechanical index of 0.08, 
well below the FDA safety requirement of 1.915. Amplitude modulation (AM) ultrasound pulse sequences 
emerged as logical candidates to exploit dissimilar hGV responses below and above buckling and enabled 
nonlinear imaging of hGVs in vitro, in ovo, and in vivo15. In AM, backscattered echoes of two half-amplitude 
transmissions are digitally subtracted from echoes of a third, full-amplitude transmission. The full-amplitude 
transmission creates pressures above the hGV buckling threshold, triggering hGV harmonic scattering, while 
the half-amplitude transmissions create pressures below hGV buckling and trigger hGV linear scattering. This 
scattering response difference in hGV echoes persists after the subtraction, while linear echoes from 





AM imaging of hGVs was systematically compromised by nonlinear wave propagation artifacts that lead to 
the misclassification of biological tissue as hGVs15. 
  In a highly nonlinear medium such as buckling hGVs or resonant microbubbles (nonlinearity parameter B/A 
two orders of magnitude higher than tissue)16, ultrasonic waves experience amplitude-dependent attenuation 
and amplitude-dependent speed of sound17,18. In consequence, the high amplitude pulse of the AM sequence 
gets distorted in proportions that to not scale linearly with the low amplitude pulse of the sequence. Ultrasonic 
waves carry that distortion as they travel forward in the medium. We hypothesized that this phenomenon, 
reported in microbubble inclusions19, is also the cause of nonlinear artifacts distal to GV inclusions. 
It is established that in a medium exhibiting quadratic elastic nonlinearity, the interaction of two ultrasonic 
waves propagating in the same direction exhibits a cumulative nonlinear interaction20. With a conventional 
AM pulse sequence, images are reconstructed line-by-line along the wave propagation direction. The high 
amplitude pulse of the sequence can be seen as the sum of two pulses of half amplitude that co-propagate and 
are subject to cumulative nonlinear interaction effects. It is less well known that the nonlinear interaction of 
ultrasonic waves propagating in opposite directions is inefficient21. In a pioneering proof-of-concept, Renaud 
et al.22 showed that a pair of subwavelength elements of an ultrasound transducer array could be used to 
transmit circular wave pulses that are quasi counter-propagative in the near field of the array, allowing them 
to minimize nonlinear distortion, while generating a 2-fold higher amplitude at the moment of their 
intersection. Here we show that propagation nonlinearity (Fig. 2.1a) can be efficiently minimized with a non-
collinear plane-wave transmission paradigm, which we call cross amplitude modulation, or xAM, while 
allowing depth-invariant, nonlinear imaging of acoustic biomolecules (Fig. 2.1b). We demonstrate in 
simulations and experiments that plane-wave cross-propagation prevents cumulative distortion of the AM 
wave code, suppresses nonlinear propagation artifacts distal to highly nonlinear hGV inclusions, and enables 
highly specific in vivo nonlinear ultrasound imaging of hGVs in mice.
 
Figure 2.1 | Nonlinear acoustic phenomena. Sketch of the two nonlinear phenomena that take place while imaging a 
biological medium containing acoustic biomolecules. (a) Propagation history of a single plane wave: nonlinear frequency 
components accumulate with depth as the wave propagates through tissue before being attenuated. This phenomenon, 





inclusions. (b) Nonlinear scattering behavior of GVs insonified above their buckling pressure, enabling their detection 
with an amplitude modulation (AM) code.
2.3 Nonlinear Interaction of Cross-Propagating Plane Waves 
2.3.1 The cross amplitude modulation sequence (xAM) 
Cross amplitude modulation is a biomolecular ultrasound imaging paradigm that aims at minimizing wave 
propagation-related harmonics23 using propagation symmetry considerations, while capturing local acoustic 
biomolecules’ harmonics to ensure their specific in vivo detection. Considering an N-element aperture of a 
linear array of ultrasonic transducers, the xAM sequence consists in (1) using the elements 1 to N/2 to transmit 
a tilted plane-wave at an angle θ with respect to the array (Fig. 2.2a),  (2) using the elements N/2+1 to N to 
transmit a symmetric plane-wave at an angle θ with the array (Fig. 2.2b), and (3) transmitting the previous 
two plane-waves simultaneously (Fig. 2.2 c). The two cross-propagating waves depicted in Fig. 2.2c interact 
along the virtual bisector that separates the two half-apertures. Particles of the insonified medium that are 
located along the bisector experience the same wave amplitude for steps (1) and (2), and a doubled wave-
amplitude for step (3) as seen in Fig. 2.1d. This axisymmetric pulse sequence creates an AM code along the 
bisector that separates the two N/2 sub-apertures. 
Our working hypothesis was that cumulative nonlinear plane-wave interaction arsing during wave 
propagation decreases as the cross-propagation angle θ increases.  We therefore started by determining 
whether minimal AM code distortion could be achieved with xAM in a weakly nonlinear 
homogeneous/isotropic medium. To do so, we first evaluated xAM signal cancellation during plane-wave 
propagation in water using two-dimensional time-domain numerical simulations (see Methods)24. Keeping 
the experimental realization of the xAM sequence in mind, we assessed the directivity of individual elements 
of our transducer array25 and set the maximal angle θ to 21° based on the array -3 dB directivity bandwidth 
(see Methods, Fig. 2.7). The simulation result displayed in Fig. 2.2d shows that, for a xAM sequence of angle 
θ = 18° at a depth of 3.6 mm, the residual peak wave amplitude is reduced by four orders of magnitude to 
0.02% of the cross-propagating plane-waves peak amplitude (0.13 kPa compared to 747 kPa, respectively). 
As a comparison, a high-end commercial scanner provides an AM residual of the order of 0.5%. 
Cross-propagating plane-waves, or X-waves, intersect with each other along a finite geometric distance which 
defines the depth of field 𝑍0 of the xAM sequence, 
                                                                                   	𝑍0 =
1
2






where A is the full aperture used for the X-wave transmission. For an angle θ = 18° and an aperture A = 6.5 
mm, 𝑍0 equals 10 mm, which would for example enable scanning of a full mouse brain. Note that beyond 𝑍0, 
images could be reconstructed further down thanks to the diffraction of the wavefronts edges using spherical 
delay laws analogous to Renaud et al. [22].  
 
Figure 2.2 | xAM simulation. Simulation of the xAM sequence for θ = 18° in a homogeneous/isotropic water medium. 
(a) Half-aperture plane-wave transmission at an 18° angle with respect to the transducer array. (b) Axisymmetric half-
aperture plane-wave transmission at an 18° angle with the other half of the array. (c) Cross-propagating plane-waves 
transmission at an 18° angle using both half-apertures. (d) Simulated waveforms at the bisector intersection for z = 3.6 
mm. The cross-propagating plane-waves peak positive pressure was 747 kPa (blue curve), while the residue peak positive 
pressure (green curve) was 0.13 kPa, or 0.02% of the cross-propagating plane-waves peak positive pressure. 
We further assessed the significance of nonlinear effects accumulating during plane-wave propagation as a 
function of θ (Figs. 3a- 3b). At low θ angles, which correspond to quasi co-propagation, residual AM 
nonlinearity clearly accumulated with depth (see Fig. 2.3a, θ = 0° and 5°). In particular, for plane-waves 
propagating in water with a peak amplitude of 400 kPa and at an angle θ = 0° (collinear propagation case), 
the residual AM peak amplitude reached 13.5 kPa at a distance z = 8 mm (Fig. 2.3a). As θ increased, the 
residual AM nonlinearity was significantly reduced, reaching a non-cumulative 0.3 kPa peak pressure at an 
angle θ = 20° (Fig. 2.3a). Fig. 2.3b reports the peak amplitude of the AM residue as a function of θ at the 
distances z = 4 mm and z = 6 mm from the array. Data reported in Figs 2.3a and 2.3b were obtained using a 
constant transmit peak pressure at 4 mm equal to 400 kPa. The simulations show that the amplitude of the 
xAM residue drops rapidly as θ increases, and converges below a threshold of 0.2 kPa for θ > 15°. These 
results support our hypothesis that nonlinear plane-wave interaction becomes less efficient as θ increases, and 
predict that in a weakly nonlinear homogeneous/isotropic medium as water (attenuation equal to 0.002 
dB/MHz2 cm), one can expect an AM code showing minimal wave distortion due to propagation at cross-





While a complete analytical treatment of this phenomenon has not been developed, some intuition can be 
obtained from the work of Hamilton et al.26,27, who reported that the noncollinear nonlinear interaction of two 
plane wave fields results in an asynchronous interaction that generates a sum frequency wave whose amplitude 
oscillates with a spatial period of 2𝜋 2𝑘(1 − cos 𝜃)⁄ , k being the wave vector of the plane waves. As the 
angle between the two waves increases, the phase mismatch increases, the spatial period of the nonlinear 
pressure field decreases, and the nonlinear interaction becomes less efficient. The same phenomenon is 
observed in our simulations: as the angle increases, the spatial period of oscillation and the amplitude of the 
nonlinear pressure field decrease (see Fig 2.3a, 10, 15 and 20 degree lines). The nonlinear pressure field is 
also expected to increase or decrease with the nonlinearity of the medium, as characterized by its shock length. 
With these considerations supporting the plausibility of our simulation results, we proceeded to implement 
the xAM concept experimentally. A full analytical treatment of this problem will be described in future work. 
 
Figure 2.3 | Simulation of nonlinearity vs. angle. Simulation of nonlinear plane-wave interaction as a function of the 
cross-propagation angle θ. (a) Peak positive pressure of the xAM residual as a function of depth for five cross-propagation 
angles. (b) Peak positive pressure of the xAM residual as a function of θ at depths z equals 4 mm and 6 mm. 
2.3.2 Experimental reduction of residual xAM nonlinearity as a function of θ 
To assess experimentally the ability of higher-θ xAM pulses to minimize nonlinearity, we implemented the 
xAM imaging sequence and beamforming on a programmable ultrasound system with a 128-element linear 
array (see Methods) and measured the peak residual AM signal of a subwavelength linear scatterer immersed 
in water. This configuration enabled the assessment of the nonlinearity captured by the AM sequence that is 
solely due to wave propagation in a typical quasi-incompressible medium (water serves as a first-
approximation model for sound wave propagation in soft biological tissues). A 10 µm diameter nickel wire 





was imaged using xAM at θ values ranging from 1.5° to 21° (Fig. 2.4a). We measured the AM residual for 
each angle as the peak value of the beamformed radio-frequency (RF) data. The data show the same trend 
predicted by the simulations, with residual nonlinearity decreasing sharply with wider angles (Fig. 2.4b). To 
compare these results with a conventional AM imaging sequence, we implemented a standard parabolic 
amplitude modulation (pAM) code, in which half-amplitude transmissions were achieved by silencing the 
even or odd transmitting elements of the array and imaging lines were reconstructed along the wave 
propagation direction15. As of θ = 3°, xAM significantly outperformed pAM in reducing the residual AM 
signal (Fig. 2.4b). We measured the axial and lateral resolution of xAM using the full-width half-maximum 
(FWHM) of the point-spread function (PSF) along the respective directions. The mean axial resolution was 
117 µm ± 16 µm, and the mean lateral resolution is 381 µm ± 42 µm, with values remaining constant across 
angles. The axial resolution of pAM was 103 µm and the lateral resolution was 250 µm. 
 
Figure 2.4 | xAM residual signal. xAM images of the cross section of a subwavelength nickel wire as a function of the 
cross-propagation angle θ. (a) Images reconstructed from the three component transmissions of the pAM code and xAM 
code at angles ranging from 1.5° to 21°. The wire was positioned at a depth of 4 mm. Each image depth ranges from 3.0 
mm to 4.5 mm and width from -1.5 mm to 1.5 mm. Scale bar: 1 mm. (b) Peak AM residual signal as a function of the 
xAM sequence angle θ. xAM signals are labelled in orange, the pAM signal is labelled with a gray square symbol. Values 
in dB represent the peak value of the residual signal relative to the peak value of the noise. 
2.4 Cross Amplitude Modulation Imaging of Acoustic Biomolecules 
2.4.1 Angle-dependent xAM reduction of nonlinear propagation artifacts distal to GV inclusions 
The xAM sequence was developed to detect hGVs with high specificity. The peak positive pressure of the 
single tilted plane-waves excites the hGVs in the linear scattering regime, while the doubled X-wave 
intersection amplitude excites the hGVs in the nonlinear scattering regime. By summing the echoes from the 





solely retrieve non-zero differential GV signals while the echoes of surrounding linear scatterers cancel. To 
evaluate the effectiveness of xAM in reducing the nonlinear propagation artifact, we embedded a 2-mm wide 
cylindrical inclusion of hGVs in agar (at a concentration of 256 pM; see Section 2.6 for GV preparation) in a 
tissue-mimicking phantom consisting of agar and 3 µm aluminum oxide particles (a model linear scatterer). 
A second inclusion filled with a scatterer-free PBS/agar mixture was positioned 1 mm below the GVs (see 
schematic, Fig 2.5a). We imaged the phantom using the same sequence parameters used for the subwavelength 
scatterer measurements, with the top of the hGV inclusion positioned at 4 mm (Fig. 2.5], since X-waves 
provide extended depths of fields compared to parabolic beams28. 
With parabolic and low-θ xAM pulses, we observed significant nonlinear propagation artifact distal to hGV 
inclusions (Fig. 2.5a and 2.5b), confirming the high nonlinearity of hGV-filled media. The pAM and xAM 
images where quantified in terms of contrast-to-tissue ratios (CTR), contrast-to-artifact ratios (CAR), and 
artifact-to-tissue ratios (ATR) (Fig. 2.5b-d). For pAM and low θ angles, the artifact intensity was on par or 
above the hGV inclusion intensity (e.g. for θ = 1.5°, CAR = -1.6 dB at z = 4 mm), highlighting the specificity 
issue posed by collinear AM imaging. For angles above 15°, xAM produces images with a clear reduction in 
artifact signal while maintaining full contrast in the hGV inclusion. We also observed that, as in the simulation 
and subwavelength scatter results, the artifact reduction is a non-monotonic function of θ, with a local jump 
in xAM artifact at 10.5° (Fig. 2.5c). Overall, these results suggested that xAM provides the highest specificity 
for hGV signals at angles larger than 15º. 
 
Figure 2.5 | In vitro pAM and xAM. In vitro pAM and xAM images of an hGV inclusion in a tissue-mimicking phantom. 
(a) Left, schematic of the phantom configuration: linearly scattering tissue-mimicking medium in gray, hGV inclusion 
in blue, anechoic agar-filled inclusion in black, and ROIs for contrast (C), tissue (T) and artifact (A) quantification. Right, 





to 9 mm are concatenated. Scale bar: 1 mm. White dotted line: 𝑍0 at θ = 21°. (b) Contrast-to-tissue ratio (CTR) as a 
function of θ. (c) Artifact-to-tissue ratio (ATR) as a function of θ. (d) Contrast-to-artifact ratio (CAR) as a function of θ. 
N = 6. Error bars: SEM. 
 
2.4.2 In vivo xAM ultrasound imaging of acoustic biomolecules 
Finally, to test the xAM imaging method in vivo, we injected into the gastrointestinal tract of a mouse a 
patterned agar-GV mixture that consisted of a core of wild-type linearly scattering GVs (wtGVs) surrounded 
by a circular layer of hGVs. We imaged the mouse abdomen using xAM at θ = 19.5°, which yielded the 
highest contrast-to-artifact ratio in the phantom experiments, and compared the results to imaging with pAM 
with the focus adjusted to 4 mm and an aperture of 20 elements (f-number = 2.0) to align the depth-of-field 
with that of the xAM sequence. The parabolic B-mode (pBMode) image, i.e. the conventional anatomical 
ultrasound image, was sharper than the cross-propagating B-mode (xBMode) image, which is expected, as X-
waves generate higher side lobes that reduce image contrast29. Only the top of the hGV inclusion was visible 
in the pAM image due to the narrow depth-of-field of parabolic beams (Fig. 2.6c). The pAM image also 
contained a large artifact below the inclusion (CTR = 2.8 dB, CAR = -2.6 dB), parts of which blended with 
the hGV signal, displaying a potentially misleading distribution of the contrast agent. In contrast, the annular 
hGV inclusion is almost entirely visible in the xAM image, with little-to-no artifact in the vicinity, and inner 
and outer contours more clearly delineated (Fig. 2.6e). The xAM CTR was 9.0 dB and the xAM CAR was 






Figure 2.6 | In vivo pAM and xAM. In vivo pAM and xAM imaging of acoustic biomolecules. (a) Schematic of the 
experiment. A concentric mixture of nonlinearly scattering hGVs and linearly scattering wtGVs was injected in a mouse 
gastrointestinal (GI) tract and imaged with pAM and xAM. (b) pBMode image, focus = 4 mm, f-number = 2.0. (c) pAM 
image, arrows point at the artifact (A). (d) xBMode, θ = 19.5° (e) xAM image. pAM and xAM dynamic ranges are 
displayed relative to their respective BMode ranges. All images depth ranged from z = 2 mm to 𝑍0 = 9.2 mm. (f) 
Comparison of xAM and pAM in terms of mean contrast-to-tissue ratios (CTR) and contrast-to-artifact ratios (CAR). N 
= 3. ROIs for CTR and CAR measurements are reported in Fig. 2.8, Methods. 
 
2.5 Discussion 
Taken together, our results suggest that the xAM ultrasound pulse sequence, based on one X-wave and two 
tilted plane-wave transmissions, achieves highly specific nonlinear imaging of acoustic biomolecules through 
wave-amplitude modulation. Two non-collinear plane waves interact to generate a two-fold amplitude 
modulation at their intersection with minimal nonlinear distortion for angles θ above 15°. This allows retrieval 
of non-zero differential hGV signals, while the echoes of surrounding linear scatterers cancel and propagation 
artifacts are reduced to the noise floor level (-10 dB at 18°). With a 6.4 mm aperture, this technique offers a 
depth-of-field suitable for small-animal imaging (10 mm at 18°). The xAM sequence proved to be robust 
enough to suppress in vivo artifacts present in pAM while distinguishing engineered nonlinear hGVs from 
linearly scattering wild type GV variants in the gastrointestinal tract of a mouse. While this manuscript is 
focused on introducing and thoroughly characterizing the xAM pulse sequence for use with non-linear 
contrast agents, with purified GVs as the model agent, these results are relevant to parallel work being done 
to apply GVs as functionalized contrast agents and as reporter genes expressed inside cells3,13,30. The xAM 
imaging method introduced here thus paves the way for in vivo biomolecular ultrasound studies of molecular 
and cellular processes based on visualization of acoustic biomolecules13. Interestingly, theory and simulations 
predict that the peak of the cross-propagating plane-waves travels at a supersonic velocity, increasing as θ 
opens (see Supplementary Material, Fig. 2.9), an effect that may be linked to the decreasing nonlinear 
interaction of the planar wavefronts. Coherent compounding of xAM data acquired at four different angles θ 
(see Supplementary Material, Fig. 2.10) was also shown to be a way to increase CTR and CAR further. 
Potential limitations of this method include its reduced depth of field as the cross-propagating angle increases. 
The method appears therefore to be well suited for ultrasound biomicroscopy, small animal experiments and 
superficial examinations in humans. xAM image depth can be extended beyond the intersection distance of 
the X-wave by using spherical delay laws reported by Renaud et al.22, but the quality of nonlinear artifact 
reduction will decline with depth. Another potential limitation of the method is that it relies on propagation 
symmetry in a homogeneous/isotropic medium to generate an amplitude-modulated code, and will therefore 





adaptive wavefront-shaping techniques developed in optics and acoustics31,32. In the near future, xAM could 
be implemented at ultrafast frame rates33 by relying on 2D arrays of transducers34 to improve the sensitivity 
or the temporal resolution of xAM further. Finally, while this study focused on the use of xAM to image 
nonlinear acoustic biomolecules, we expect this technology to propagate across as a general solution to the 
long-standing problem of distal nonlinear propagation artifacts in the field of synthetic microbubble-based 
ultrasound contrast agents. 
2.6 Methods 
2.6.1 k-Wave simulations 
We investigated the influence of the transmit angle θ on the nonlinear interaction between two non-collinear 
plane waves emitted by two apertures using two-dimensional time-domain numerical simulations (k-Wave 
version 1.2,24). The transmit angle was varied from 1 to 21 degrees (Fig. 2.3). Transmit delays are calculated 
to generate a plane-waves with the proper angle θ. We simulated wave propagation in a 
homogeneous/isotropic medium (water) with a configuration corresponding to the setup reported 
experimentally in Fig. 2.4. Speed of sound in water was set to 1480 m/s, the attenuation to 0.002 dB/MHz2 
cm), and the nonlinear parameter B/A to 5. The size of the domain was 6.4 mm x 8 mm; it is discretized with 
a step size of 10 µm. Perfectly matched layers are used to absorb the waves at the edges of the domain. The 
source broadcasts a short pulse with a center frequency of 15 MHz. The acoustic pressure generated by the 
source is varied so that the peak acoustic pressure generated at 4 mm depth by a single aperture equals 400 
kPa for all tested angles. For a given transmit angle, three simulations are required: 1) transmission with the 
right aperture only, 2) transmission with the left aperture only and 3) transmission with both apertures. The 
pressure field is recorded along the segment bisector (between the two transmit apertures). For a given transmit 
angle, the amplitude modulation scheme is applied to the recorded signals, then the result is band-pass filtered 
to reproduce the effect of the limited frequency bandwidth of the transducer with a 100% relative frequency 
bandwidth (the cutoff frequencies of the filter are 7.5 MHz and 22.5 MHz). 
2.6.2 Engineering of harmonic acoustic protein nanostructures 
Anabaena GVs were cultured and transferred to sterile separating funnels and the buoyant cells were allowed 
to float to the top and separate from the spent media over a 48h period. GVs were harvested by hypertonic 
lysis. Purification was done by repeated centrifugally assisted floatation followed by resuspension. Wild type 





rounds of centrifugally assisted floatation followed by removal of the subnatant layer to ensure complete 
removal of native GvpC. For detailed information, see Lakshmanan et al.30. 
 
2.6.3 Tissue-mimicking phantom 3D design & preparation 
Tissue-mimicking phantoms for imaging were prepared by melting 1% (w/v) agarose gel in PBS and with 
0.2% (w/v) AlO3. We used a custom 3D-printed mold to create a 2-by-2 grid of cylindrical wells with 2 mm 
diameter and 1 mm spacing between the outer radii in the bulk material. GVs were incubated at 42 °C for 1 
minute and then mixed in a 1:1 ratio with molten agarose (at 42 °C) for a final GV concentration corresponding 
to 2.25 OD500nm and immediately loaded into the phantom. Wells not containing GVs were filled with plain 
1% agar. The AlO3 concentration was chosen to match the scattering echogenicity of the GV well as measured 
by the contrast-to-noise ratio of the respective regions in a B-mode ultrasound image. The phantoms used for 
the angle ramp images contained stripped Ana GVs in the upper-left well. The phantom used for the voltage 
ramp images contained wild type Ana GVs in the upper-left well and stripped Ana GVs in the upper-right 
well. All phantoms were imaged on top of an acoustic absorber material while immersed in PBS. Based on 
the elevation f-number of the probe, the elevation resolution (i.e. the thickness of the imaging plane) is 512 
µm. The molarity of Ana GVs for a given OD value is 114 pM/OD30. Using these values and the dimensions 
of the hGV inclusion, we estimate that 2.47×105 GVs contribute to each image, or roughly 200 GVs for each 
pixel. 
 
2.6.4 Ultrasound acquisition sequence 
We used a Verasonics Vantage ultrasound system with a L22-14v probe (Verasonics Inc., Redmond, WA, 
USA) to implement the xAM and pAM imaging sequences. The probe is a linear array of 128 elements with 
a 0.10 mm pitch, an 8 mm elevation focus, a 1.5 mm elevation aperture, and a center frequency of 18.5 MHz 
with 67% -6 dB bandwidth. We applied a single-cycle transmit waveform at 15.625 MHz to each active array 
element to ensure our fundamental frequency divided four times with the 62.5 MHz sampling rate of the 
system. To provide a reasonable tradeoff between lateral field of view and axial depth of field, we used an 
aperture of 65 elements for the xAM sequence (with the center element silenced to allow for a symmetric AM 
code). This allowed for 64 ray lines per xAM image. The focus of the parabola used in the pAM sequence 
was set to 8 mm to match the probe’s elevation focus. We used an aperture of 38 elements for the pAM 





control for variation in pressure across different beam profiles, we selected probe voltages for each xAM angle 
and for pAM that generated to a CTR of 10 dB in the hGV inclusion of the phantoms. The voltage table is 
provided in Section 2.7 Supplementary Material. 
We collected raw RF data from our acquisitions and implemented a custom real-time image reconstruction 
pipeline, including a beamforming algorithm suited to the unique requirements of xAM. To reduce noise 
during live imaging while saving system memory, we applied a first-order infinite impulse response (IIR) 
filter to successive frames of RF data, according to the following difference equation  
𝑦[𝑛] = 𝛼𝑦[𝑛 − 1] + (1 − 𝛼)𝑥[𝑛], (1 − 𝐴1) 
where 𝑛 is the frame index, 𝛼 is the persistence coefficient, 𝑥 is the unfiltered RF data, and 𝑦 is the output of 
the filter. All RF data reported was acquired with 𝛼 = 0.9 except for the in vivo pAM image, which was 
acquired with 𝛼 = 0.7 to avoid blurring due to motion. 
2.6.5 xAM beamforming 
The novel cross-propagation paradigm necessitated adjustments to conventional beamforming for image 
reconstruction, as a particularity of this method is that xAM image lines are not formed along the propagation 
direction of the ultrasonic waves, but along the line along which the two cross-propagating plane-waves 
intersect. The linear array transmission configuration and directivity25 can be modeled as in Fig. 2.7. 
 
Figure 2.7 | Linear array aperture geometry and directivity. (a) Ultrasound imaging linear array configuration. θ is 
the cross-propagation angle, p the pitch of the linear transducer array, x1 the first element of the active aperture (blue 
elements), xb the element along the aperture, and xn an arbitrary element along the array. dtx is the distance from the planar 
wavefront to a point along the bisector, and drx is the return distance to the array. Silent elements are labelled in orange. 
(b) Directivity of an individual element of the linear transducer array (p = 0.1 mm, f = 15.6 MHz). The red dotted line 






The distance from either angled wavefront to the point (𝑥K, 𝑧) and the return trip distance of the echo received 
by array element 𝑥M are, respectively, 
𝑑O0(𝜃, 𝑥K, 𝑧) = (𝑥K − 𝑥P)𝑝 sin 𝜃 + 𝑧 cos 𝜃 , (1 − 𝐴2) 
𝑑T0(𝑥K, 𝑥M, 𝑧) = U(𝑥M − 𝑥K)2𝑝2 + 𝑧2. (1 − 𝐴3) 
Hence, the two-way travel time to element 𝑥M is  
𝜏X T⁄ →Z[ =
1
𝑐




U(𝑥M − 𝑥K)2𝑝2 + 𝑧2, (1 − 𝐴4)
 
whereas the observed arrival time of this echo on the bisector element is  
𝜏X T⁄ →Z\ =
1
𝑐
[(𝑥K − 𝑥P)𝑝 sin 𝜃 + 𝑧 cos 𝜃 + 𝑧]. (1 − A5) 
We can then derive the depth of the echo signal from its arrival time on the bisector as 
𝑧 = 	
𝑐𝜏X T⁄ →Z\ − (𝑥K − 𝑥P)𝑝 sin𝜃
cos 𝜃 + 1
, (1 − 𝐴6) 
and, finally, obtain the time delay to apply to the received signal for dynamic focusing:  




_U(𝑥M − 𝑥K)2𝑝2 + 𝑧2 − 𝑧` (1 − A7)
 
These beamforming equations are valid in the region over which the waves are cross-propagating. The depth 
of field (equation (1)) to which this region extends is given by (𝑥M − 𝑥K) cot 𝜃. 
 






The in vivo experiment was performed on a C57BL/6J male mouse (Jackson Laboratory) under a protocol 
approved by the Institutional Animal Care and Use Committee of the California Institute of Technology. No 
randomization or blinding were necessary in this study. Ultrasound imaging was performed as follows: the 
mouse was anaesthetized with 2–3% isoflurane, depilated over the imaged region, and imaged using an L22-
14v transducer with the pulse sequence described above. For imaging of GVs in the gastrointestinal tract, the 
mouse was placed in a supine position, with the ultrasound transducer positioned on the lower abdomen, 
transverse to the colon. Prior to imaging, wild type and stripped Ana GVs were mixed in a 1:1 ratio with 42 °C 
4% agarose–PBS for a final GV OD500nm equal to 2.25. An 8-gauge needle was filled with the mixture of 
agarose and stripped Ana GVs. Before it solidified, a 14-gauge needle was placed inside the 8-gauge needle 
to form a hollow lumen within the gel. After the agarose–GV mixture solidified at room temperature for 
10 min, the 14-gauge needle was removed. The hollow lumen was then filled with the agarose mixture 
containing the wild type Ana GVs. After it solidified, the complete cylindrical agarose gel was injected into 
the colon of the mouse with a PBS back-filled syringe. Additional PBS was then injected into the colon to 
remove air bubbles in the vicinity of the gel. 
 
Figure 2.8 | In vivo regions of interest. Tissue (T), Contrast (C) and Artifact (A) regions of interest used for the ratios 
displayed in Fig. 2.6. 
 
2.7 Supplementary Material 
2.7.1 Supersonic cross-propagating plane-waves intersection 
Interestingly, as both plane-waves cross-propagate, local coordinates of each wave-front interact with their 
axisymmetric counterpart, but contrary to co-propagating plane waves, it is a transient interaction. The plane-
waves intersection velocity 𝑐0 is given by, 





where 𝑐a is the speed of sound in the propagation medium. It can readily be seen from (2) that the plane-
waves intersection velocity 𝑐0 is supersonic for θ > 0 as reported by Lu and Greenleaf28, and seen in Fig. 2.9. 
The third transmission event of the xAM sequence (Fig. 2.2c) corresponds to a finite aperture forward 
propagating X-wave solution of the homogeneous/isotropic wave equation with the form 𝑓(𝑥, 𝑧 − 𝑐0𝑡), 
where 𝑓 represents a scalar function (e.g. the acoustic pressure pulse) of space and time28, although in our case 




Figure 2.9 | X-wave intersection velocity. Analytical and simulated cross-propagating plane-waves intersection velocity 
as a function of θ. 
2.7.2 Coherent compounding 
We tested the effect of coherent compounding35 of the RF data from multiple xAM acquisitions with different 
angles. Due to the difference in interaction velocity for different angles, the RF data from individual 
acquisitions was first aligned to the peak of the average autocorrelation function of the individual beamformed 
ray lines composing the images. The best results were achieved by compounding of four adjacent angles. This 






Figure 2.10 | Coherently compounded xAM. Comparison of coherently compounded and to single-acquisition xAM 
images the in vitro data at 4 mm. (a) A set of xAM images from the experiment depicted in Fig. 2.5. (b) The same images 
with coherent compounding applied to successive sets of four acquisitions. (c) Contrast-to-tissue ratio of single-
acquisition xAM compared with coherently compounded data as a function of angle. (d) Artifact-to-tissue ratio. (e) 
Contrast-to-artifact ratio. n = 6. Error bars not shown for ease of comparison. 
 
2.7.3 Voltage-pressure table 
The phantom images reported in Fig. 2.5 were acquired using the following voltage table that ensured a 10 
dB CTR across images and therefore enable for the comparison of the artifact intensity across cross-
propagation angles. 





θ (°) pAM 1.5 3.0 4.5 6.0 7.5 9.0 10.5 12.0 13.5 15.0 16.5 18.0 19.5 21.0 
V4 
mm 
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C h a p t e r  3  
ACOUSTIC BIOSENSORS FOR ULTRASOUND IMAGING OF ENZYME 
ACTIVITY 
This chapter is in large part a reformatted version of the manuscript entitled “Acoustic Biosensors for 
Ultrasound Imaging of Enzyme Activity” published by Lakshmanan, A., Jin, Z., Nety, S., Sawyer, D. P., 
Lee-Gosselin, A., Malounda, D., Swift, M., Maresca, D. and Shapiro, M. G. in Nature Chemical Biology. 
Under the supervision of Mikhail Shapiro, my contributions to the work was to help optimize the xAM 
pulse sequence for the experimental setups and engineered GVs used, as well as to provide guidance on its 
use during experiments. 
 Working as a collaborator on this project taught me valuable lessons about what it takes for a novel 
tool to be impactful: namely the practicalities of learning, optimizing, and extending the tool. After 
developing xAM, I had to ensure that those leading the biosensors project, particularly Zhiyang, not only 
knew how to use xAM, but understood the scripts well enough to modify and extend them. This is important 
because, while the utility of a method over other tools may be enough to drive adoption despite a difficult 
learning curve, it may not be enough to facilitate further optimizations, extensions, and innovations that 
require an in-depth understanding of how the method works. In this sense, making the xAM code well-
documented and the results reproducible ended up being just as important as the custom graphical user 
interface I implemented to allow easy plug-and-play use of xAM in live imaging experiments. 
However, another point I recognized was that secondary engineering considerations can have just 
as large an impact on the utility of a method as its fundamental capabilities. Because we implemented the 
xAM reconstruction in MATLAB rather than a compiled language like C/C++, the frame rate was quite 
low at only 1-3 frames per second, which made dealing with tissue motion during in vivo imaging 
experiments challenging. This gave me an appreciation for how engineering challenges can be just as 
important as research challenges in determining the utility and impact of a novel method. 
 
3.1 Abstract 
Visualizing biomolecular and cellular processes inside intact living organisms is a major goal of chemical 
biology. However, existing molecular biosensors, based primarily on fluorescent emission, have limited 
utility in this context due to the scattering of light by tissue. In contrast, ultrasound can easily image deep 
tissue with high spatiotemporal resolution, but lacks the biosensors needed to connect its contrast to the 






genetically encodable acoustic biosensors – molecules that 'light up' in ultrasound imaging in response to 
protease activity. These biosensors are based on a unique class of air-filled protein nanostructures called 
gas vesicles, which we engineered to produce non-linear ultrasound signals in response to the activity of 
three different protease enzymes. We demonstrate the ability of these biosensors to be imaged in vitro, 
inside engineered probiotic bacteria, and in vivo in the mouse gastrointestinal tract. 
 
3.2 Introduction 
Virtually every biological process in living organisms involves dynamic changes in the concentration or 
activity of specific molecules. Visualizing these changes within the context of intact living tissues is critical 
to expanding our understanding of biological function and developing next-generation medicines. A large 
repertoire of genetically encoded fluorescent sensors has been developed to image specific molecular and 
cellular events1-4. However, deploying such biosensors in living organisms is challenging due to the limited 
penetration of light in tissue5. In contrast, non-invasive techniques such as ultrasound are capable of 
imaging deep tissues with high spatial and temporal resolution (below 100 µm and 1 ms, respectively)6. 
However, ultrasound currently lacks the sensors needed to observe dynamic molecular activity. 
Here, we introduce molecular biosensors for ultrasound based on gas vesicles (GVs), a unique class 
of air-filled protein nanostructures that were recently established as genetically encodable imaging agents 
for ultrasound7,8. GVs evolved in certain aquatic microbes as a means to regulate cellular buoyancy for 
optimal photosynthetic illumination9. GV nanostructures comprise a 2 nm-thick protein shell enclosing an 
air-filled compartment, with genetically determined widths between 45-250 nm and lengths of several 
hundred nm9,10. The low density and high compressibility of GVs relative to surrounding aqueous media 
allows these proteins to scatter sound waves and thereby produce ultrasound contrast when injected into 
the body or expressed heterologously in engineered cells7,8,11,12.  
We hypothesized that we could engineer GV-based biosensors that dynamically change their 
ultrasound contrast in response to the activity of specific biomolecules. This possibility arises from the 
recent discovery that GVs’ acoustic properties can be modified at the level of their constituent proteins12. 
In particular, the scaffolding protein GvpC, which sits on the GV surface (Fig. 3.1a) and provides structural 
reinforcement13, can be modified at the level of its amino acid sequence to change GV mechanics. For 
example, shortening or removing GvpC makes GVs less rigid, allowing them to buckle more easily under 
acoustic pressure12,14. This reversible buckling produces nonlinear ultrasound contrast, which appropriate 
ultrasound pulse sequences readily distinguish from the linear signals produced by non-buckling GVs and 
background tissue14,15. 
 As an initial target for acoustic biosensor development, we chose proteases – an important class of 






biology16-22. While these enzymes were the targets of some of the first fluorescent biosensors23,24, and 
continue to be a major focus of sensor engineering25, no acoustic biosensors of protease activity have been 
developed. We postulated that by engineering variants of GvpC incorporating amino acid sequences that 
are recognized and acted upon by specific proteases, we could generate GVs whose nonlinear ultrasound 
contrast becomes activated by protease activity. As representative targets, we selected the constitutively 
active tobacco etch virus (TEV) endopeptidase, the calcium-dependent mammalian protease calpain, and 
the processive bacterial protease ClpXP. We set out to test the ability of acoustic biosensors engineered to 
respond to each of these enzymes to reveal their activity under ultrasound, and to demonstrate biosensor 
imaging in vitro, in living engineered cells, and in vivo in the mouse gastrointestinal (GI) tract. 
 
Figure 3.1: Acoustic biosensor of TEV endopeptidase. (a) Top: schematic of a gas vesicle (GV), including the 
primary shell protein GvpA (gray) and the reinforcing protein GvpC (blue). Bottom: schematic of GvpC structure, 
comprising five 33-amino acid repeats flanked by N-and C-terminal regions. (b) Schematic of GVSTEV. (c) Normalized 
OD500nm of GVSTEV as a function of hydrostatic pressure, after incubation with active TEV or heat-inactivated TEV 
(dTEV). The legend lists the midpoint collapse pressure for each condition (±95% confidence interval), determined 
from fitting a Boltzmann sigmoid function (N = 3 biological replicates for GVSTEV + TEV and 4 for GVSTEV  + dTEV). 
(d) Coomassie-stained SDS-PAGE gel of OD500nm-matched samples of GVSTEV incubated with dTEV or active TEV 






repeated 3 times with similar results. (e) Representative TEM images of GVSTEV after incubation with dTEV or active 
TEV protease (N=3 biological replicates for GVSTEV + TEV and 2 for GVSTEV  + dTEV; at least 100 GV particles 
were imaged for each condition). (f) DLS measurements of the average hydrodynamic diameter of GVSTEV and GVWT 
samples after protease incubation (N = 3 biological replicates for GVSTEV and 4 for GVWT; individual dots represent 
each N, and thick horizontal line indicates the mean). (g) Representative ultrasound images of agarose phantoms 
containing GVSTEV incubated with TEV or dTEV protease at OD500nm 2.2. The linear (B-mode) image was acquired 
at 132 kPa and the nonlinear (x-AM) image was acquired at 438 kPa. (h) Average ratio of x-AM to B-mode ultrasound 
signal as a function of applied acoustic pressure for GVSTEV, after incubation with TEV or dTEV protease. N=3 
biological replicates, with each N consisting of 2-3 technical replicates for g and h. For ultrasound images in g, CNR 
stands for contrast-to-noise-ratio, and color bars represent relative ultrasound signal intensity on the dB scale. Solid 
curves represent the mean in c and h. Error bars in c, f and h indicate SEM and were calculated from independent 
biological replicates. Scale bars in e represent 100 nm. Scale bars in g represent 1 mm. Individual data points for 
panels c and h shown as scatter plots in Extended Data Figure 3.1. 
 
3.3 Results 
3.3.1 Engineering an acoustic sensor of TEV endopeptidase 
We selected the TEV endopeptidase as our first sensing target because of its well-characterized recognition 
sequence and widespread use in biochemistry and synthetic biology26,27. To sense TEV activity, we 
engineered a GvpC variant containing the TEV recognition motif ENLYFQ’G (Fig. 3.1b), hypothesizing 
that the cleavage of GvpC into two smaller segments would cause the GV shell to become less stiff, thereby 
allowing it to undergo buckling and produce enhanced nonlinear ultrasound contrast. We implemented this 
design in vitro using GVs from Anabaena flos-aque (Ana), whose native GvpC can be removed after GV 
isolation, and replaced with new versions expressed heterologously in Escherichia coli12,28. Ana GvpC 
comprises five repeats of a predicted alpha-helical polypeptide (Fig. 3.1a), and we tested insertions of the 
TEV recognition sequence, with and without flexible linkers of different lengths, at several locations within 
this protein. After incubating the engineered GVs with active TEV protease or a heat-inactivated “dead” 
control (dTEV), we measured their hydrostatic collapse using pressurized absorbance spectroscopy. This 
technique measures the optical density of GVs (which scatter 500 nm light when intact) under increasing 
hydrostatic pressure, providing a quick assessment of GV shell mechanics: GVs that collapse at lower 
pressures also produce more nonlinear contrast7,8,12,28. Using this approach, we identified an engineered GV 
variant that showed ~ 70 kPa reduction in its collapse pressure midpoint upon incubation with the active 
TEV protease (Fig. 3.1c and Extended Data Fig. 3.1), and selected it for further characterization. This GV 
sensor for TEV, hereafter referred to as GVSTEV, has the TEV cleavage site on the second repeat of GvpC, 







Extended Data Figure 3.1 | Engineering an acoustic sensor of TEV endopeptidase activity. (a) Coomassie-stained 
SDS-PAGE gel of OD500nm-matched samples of GVWT incubated with dTEV and TEV protease, before and after 
buoyancy purification (labeled pre b.p. and post b.p., respectively). N = 3 biological replicates. (b) Scatter plots 
showing normalized OD500nm of GVSTEV as a function of hydrostatic pressure. (N = 3 biological replicates for GVSTEV 
+ TEV and N =4 for GVSTEV + dTEV.) (c) Scatter plots showing the ratio of nonlinear (x-AM) to linear (B-mode) 
ultrasound signal as a function of applied acoustic pressure for all the replicate samples used in the x-AM voltage 
ramp imaging experiments for GVSTEV. N = 3 biological replicates and total number of replicates is 8. (d) Scatter 
plots showing normalized OD500nm of GVWT as a function of hydrostatic pressure. (N = 3 biological replicates for 
GVWT +dTEV and N =4 for GVWT + TEV.) (e) Representative ultrasound images of agarose phantoms containing 
GVWT incubated with TEV or dTEV protease at OD500nm 2.2. The B-mode image was acquired at 132kPa and the x-
AM image at 569 kPa. Similar images acquired for N=3 biological replicates, with each N consisting of 3 technical 
replicates. CNR stands for contrast-to-noise-ratio, and color bars represent relative ultrasound signal intensity on the 
dB scale. Scale bars represent 1 mm (f) Scatter plots showing the ratio of nonlinear (x-AM) to linear (B-mode) 
ultrasound signal as a function of applied acoustic pressure for all the replicate samples used in the x-AM voltage 
ramp imaging experiments for GVWT. N=3 biological replicates, with each N consisting of 3 technical replicates. Solid 
curve represents the mean of all the replicates. 
TEV cleavage of the GvpC on GVSTEV is expected to produce N- and C-terminal fragments with 
molecular weights of approximately 9 and 14 kDa, respectively. Indeed, gel electrophoresis of GVSTEV 
after exposure to active TEV resulted in the appearance of the two cleaved GvpC fragments and a significant 
reduction in the intact GvpC band intensity (Fig. 3.1d). In addition, removal from solution of unbound 
fragments via buoyancy purification of the GVs resulted in a reduced band intensity for the N-terminal 
cleavage fragment, indicating its partial dissociation after cleavage (Fig. 3.1d). No significant changes in 






(TEM) images showed intact GVs with similar appearance under both conditions, confirming that protease 
cleavage did not affect the structure of the underlying GV shell (Fig. 3.1e). Dynamic light scattering (DLS) 
showed no significant difference in the hydrodynamic diameter of the engineered GVs after incubation with 
dTEV and active TEV protease, confirming that the GVs remain dispersed in solution (Fig. 3.1f).  
After confirming the desired mechanical and biochemical properties of GVSTEV, we imaged it by 
ultrasound. Nonlinear imaging was performed in hydrogel samples containing the biosensor, using a 
recently developed cross-amplitude modulation (x-AM) pulse sequence15. x-AM uses pairs of cross-
propagating plane waves to elicit highly specific nonlinear scattering from buckling GVs at the wave 
intersection, while subtracting the linear signal generated by transmitting each wave on its own15. Linear 
images were acquired using a conventional B-mode sequence. As hypothesized, exposing the GVSTEV 
samples to TEV protease produced a strong nonlinear acoustic response, with a maximal contrast-to-noise 
ratio (CNR) enhancement of ~ 7 dB at an applied acoustic pressure of 438 kPa (Fig. 3.1g). Substantially 
less nonlinear contrast was observed in controls exposed to dTEV, while, as expected, both samples 
produced similar linear scattering. Consistent with the pressure-dependent mechanics of the GV shell, the 
differential nonlinear acoustic response of GVSTEV became evident at pressures above 295 kPa, and kept 
increasing until 556 kPa, at which point the GVs began to collapse (Fig. 3.1h and Extended Data Fig. 
3.1). As an additional control, we found that GVs with the wild-type GvpC sequence (GVWT) showed no 
difference in their hydrostatic collapse pressure or nonlinear acoustic contrast in response to TEV protease 
(Extended Data Fig. 3.1), and no wild-type GvpC cleavage was seen upon gel electrophoresis (Extended 
Data Fig. 3.1). These results established GVSTEV as an acoustic biosensor of the TEV protease enzyme, and 
additionally provided an experimental template to develop additional sensors. 
 
3.3.2 Engineering an acoustic sensor of calpain 
After validating our basic acoustic biosensor design using the model TEV protease, we examined its 
generalizability to other endopeptidases. As our second target, we selected the calcium-dependent cysteine 
protease calpain, a mammalian enzyme with critical roles in a wide range of cell types 29-31. The two most 
abundant isoforms of this protease, known as µ-calpain and m-calpain, are expressed in many tissues and 
involved in processes ranging from neuronal synaptic plasticity to cellular senescence29,30. We designed an 
acoustic biosensor of µ-calpain by inserting the α-spectrin-derived recognition sequence 
QQEVY’GMMPRD32 into Ana GvpC (Fig. 3.2a). We screened several versions of GvpC incorporating 
this cleavage sequence, flanked by GSG or GSGSG linkers, at different positions within the second helical 
repeat. Pressurized absorbance spectroscopy performed in buffers with and without calpain and Ca2+ 
allowed us to identify a GV sensor for calpain (GVScalp), showing an approximately 50 kPa decrease in 






Data Fig. 3.2). Electrophoretic analysis confirmed cleavage and partial dissociation of the cleaved 
fragments from the GV surface (Extended Data Fig. 3.2), while TEM showed no change in GV 
morphology (Extended Data Fig. 3.2).  
 
Figure 3.2 | Acoustic biosensor of calcium-activated calpain protease. (a) Schematic illustration GVScalp. (b) 
Hydrostatic collapse curves of GVScalp after incubations in the presence or absence of calpain and calcium. The legend 
lists the midpoint collapse pressure for each condition (±95% confidence interval) determined from fitting a 
Boltzmann sigmoid function N = 5 biological replicates for +Calp/+Ca2+, 6 for -Calp/+Ca2+ and +Calp/-Ca2+, and 7 
for -Calp/-Ca2+. (c, e, g) Representative ultrasound images of agarose phantoms containing GVScalp incubated with 
and without calpain and/or calcium at OD500nm 2.2. The B-mode images were taken at 132 kPa for c, e and g, and the 
x-AM images were taken at 438 kPa for c, e and at 425 kPa for g. CNR stands for contrast-to-noise-ratio, and color 
bars represent relative ultrasound signal intensity on the dB scale. Scale bars represent 1 mm. (d, f, h) Average ratio 
of x-AM to B-mode ultrasound signal as a function of applied acoustic pressure for GVScalp after incubation in the 
presence or absence of calpain and/or calcium. N=3 biological replicates, with each N consisting of 2 technical 
replicates for c-h. Solid curves represent the mean and error bars indicate SEM. Statistics were performed on 
independent biological replicates for b, d, f and h.(i) Calcium-response curve for GVScalp in the presence of µ-calpain, 
showing the ratio of x-AM to B-mode ultrasound signal at 425 kPa as a function of calcium concentration. The mean 
values are fitted to a Hill equation with a coefficient of 1, giving a half-maximum response concentration (EC50) of 
140 µm (N = 3 biological replicates, individual dots represent the mean values with the solid blue line showing the 










Extended Data Figure 3.2 | Engineering an acoustic sensor of calpain activity. (a) Individual scatter plots for Fig. 
3.2(b). N = 5 biological replicates for +Calp/+Ca2+, 6 for -Calp/+Ca2+ and +Calp/-Ca2+, 7 for -Calp/-Ca2+. (b) 
Coomassie-stained SDS-PAGE gel of OD500nm-matched samples of GVScalp incubated in the presence (+) or absence 
(-) of calpain (first +/-) and calcium (second +/-), before and after buoyancy purification (labeled pre b.p. and post b.p. 
respectively). N = 3 biological replicates. (c) Representative TEM images of GVScalp after incubations in the presence 
or absence of calpain and/or calcium. Scale bars represent 100 nm. At least 20 GV particles were imaged for each 
condition. (d) DLS measurements showing the average hydrodynamic diameter of GVScalp and GVWT samples after 
calpain/calcium incubations (N = 2 biological replicates for GVScalp +/-, +/+, GVWT +/+ and 3 for other conditions, 
individual dots represent each N and horizontal line indicates the mean). Error bars indicate SEM when N = 3. (e, f, 
g) Individual scatter plots for Fig. 3.2(d, f, h). N = 3 biological replicates with each N consisting of 2 technical 
replicates (total number of replicates is 18 for +/+ and 6 for each of the remaining conditions). Solid line represents 
the mean of all the replicates for (a, e-g). (h) Scatter plots for Fig. 3.2i; N = 3 biological replicates, individual dots 
represent each N and solid blue line showing the fitted curve (a Hill equation with a coefficient of 1, with a half-
maximum response concentration (EC50) of 140 µm). 
 
Ultrasound imaging of GVScalp revealed a robust nonlinear acoustic response when both calpain 
and calcium were present (Fig. 3.2, c, e, g), but not in negative controls lacking either or both of these 
analytes. A slight clustering tendency of GVScalp nanostructures, which was attenuated by incubation with 
activated calpain (Extended Data Fig. 3.2), resulted in a slightly higher B-mode signal for the negative 
controls. However, this did not significantly affect the maximal nonlinear sensor contrast of GVScalp of 
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of 320 kPa (Fig. 3.2, d, f, h and Extended Data Fig. 3.2). Using this biosensor, ultrasound imaging could 
be used to visualize the dynamic response of calpain to Ca2+, with a half-maximal response concentration 
of 140 µM (Fig. 3.2i and Extended Data Fig. 3.2). Additional control experiments performed on GVs 
with wild-type GvpC showed no proteolytic cleavage, change in GV collapse pressure or ultrasound 
response, after incubation with calcium-activated calpain (Extended Data Fig. 3.3). These results show 
that acoustic biosensor designs based on GvpC cleavage can be generalized to a mammalian protease and 
used to sense the dynamics of a conditionally active enzyme. 
 
Extended Data Figure 3.3 | Characterization of GVWT sample with calpain protease. (a, b, c) Representative 
ultrasound images of agarose phantoms containing GVWT incubated in the presence (+) or absence (-) of calpain (first 
+/-) and calcium (second +/-), at OD500nm 2.2. The B-mode images were taken at 132 kPa for a, b and c and the x-AM 
images corresponding to the maximum difference in non-linear contrast between the +/+ sample and the negative 
controls were taken at 438 kPa for a and b and at 425 kPa for c. CNR stands for contrast-to-noise-ratio and color bars 
represent ultrasound signal intensity in the dB scale. Scale bars represent 1 mm. N = 2 biological replicates for a, b 
and c. (d, e, f) Scatter plots showing the ratio of x-AM to B-mode ultrasound signal as a function of increasing acoustic 
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pressure for GVWT after incubation in the presence or absence of calpain and/or calcium (N = 2 biological replicates). 
(g) Hydrostatic collapse curves of GVWT after incubations in the presence (+) or absence (-) of calpain and/or calcium. 
The legend lists the midpoint collapse pressure for each condition (±95% confidence interval) determined from fitting 
a Boltzmann sigmoid function (N = 5 biological replicates for -/+ and N = 6 for other conditions) (h) Coomassie-
stained SDS-PAGE gel of OD500nm-matched samples of GVWT incubated in the presence (+) or absence (-) of 
calpain/calcium, before and after buoyancy purification (labeled pre b.p. and post b.p., respectively, N=1). Individual 
dots in d, e, f and g represent each N and solid line represents the mean of all the replicates. 
 
3.3.3 Building an acoustic sensor of the protease ClpXP 
In addition to endopeptidases, another important class of enzymes involved in cellular protein signaling and 
homeostasis is processive proteases, which unfold and degrade full proteins starting from their termini33. 
To determine whether GV-based biosensors could be developed for this class of enzymes, we selected 
ClpXP, a processive proteolytic complex from E. coli comprising the unfoldase ClpX and the peptidase 
ClpP34. ClpX recognizes and unfolds protein substrates containing specific terminal peptide sequences 
called degrons. The unfolded proteins are then fed into ClpP, which degrades them into small peptide 
fragments34. We hypothesized that the addition of a degron to the C-terminus of GvpC would enable ClpXP 
to recognize and degrade this protein, while leaving the underlying GvpA shell intact, resulting in GVs with 







Figure 3.3: Acoustic biosensor of ClpXP protease. (a) Schematic of GVSClpXP. (b) Coomassie-stained SDS-PAGE 
gel of OD500nm-matched GVSClpXP samples, incubated in a reconstituted cell-free transcription-translation (TX-TL) 
system containing a protease inhibitor cocktail or ClpXP (N= 3 biological replicates). Additional bands in these gels 
arise from components of the TX-TL system (Extended Data Figure 3.4) (c) Representative TEM images of 
GVSClpXP after incubations in the presence of a protease inhibitor or ClpXP. Scale bars represent 100 nm. A minimum 
of 100 GV particles were imaged for the +ClpXP condition and 50 particles for the +inhibitor control. (d) Normalized 
optical density (OD500nm) measurements of GVSClpXP as a function of hydrostatic pressure after protease incubation 
(N=5 biological replicates). (e) Representative ultrasound images of agarose phantoms containing GVSClpXP incubated 
with the inhibitor cocktail or active ClpXP at OD500nm 2.2. (f) Average x-AM/B-mode ratio as a function of applied 
acoustic pressure for GVSClpXP, after incubation with the protease inhibitor or active ClpXP. (g) Hydrostatic collapse 
pressure measurements for engineered Ana GVs with WT-GvpC (GVWT) after protease incubation (N=5 biological 
replicates). For collapse pressure data in d and g, the legend lists the midpoint collapse pressure for each condition 
(±95% confidence interval), determined from fitting a Boltzmann sigmoid function.  (h) Representative ultrasound 
images of agarose phantoms containing GVWT incubated with the inhibitor cocktail or active ClpXP at OD500nm 2.2. 
Scale bars in e and h represent 1mm. CNR stands for contrast-to-noise-ratio, and color bars represent relative 
ultrasound signal intensity on the dB scale. The B-mode images were acquired at 132 kPa and the x-AM images were 
acquired at 477 kPa. (i) Average ratio of x-AM to B-mode acoustic signal as a function of applied acoustic pressure 
for GVWT after incubation with the inhibitor cocktail or ClpXP protease. For e, f, h and i, N=3 biological replicates, 
with each N having 3 technical replicates. For d, f, g and i, solid curves represent the mean and error bars indicate 
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SEM, which were calculated from independent biological replicates. Individual scatter plots for d, f, g and i are shown 
in Extended Data Figure 3.4. 
 
To test this hypothesis, we appended the ssrA degron, AANDENYALAA, via a short SG linker, to 
the C-terminus of Ana GvpC, resulting in a sensor that we named GVSClpXP (Fig. 3.3a). We tested the 
performance of this biosensor in vitro using a reconstituted cell-free transcription-translation system 
comprising E. coli extract, purified ClpX, and a ClpP-expressing plasmid. Gel electrophoresis performed 
after incubating GVSClpXP with this cell-free extract showed significant degradation of the engineered GvpC, 
compared to a negative control condition in which the extract was pre-treated with a protease inhibitor (Fig. 
3.3b).  TEM images showed intact GVs under both conditions, confirming that GvpC degradation left the 
underlying GV shell uncompromised (Fig. 3.3c). Pressurized absorbance spectroscopy indicated a 
substantial weakening of the GV shell upon ClpXP exposure, with the hydrostatic collapse midpoint 
shifting by nearly 250 kPa (Fig. 3.3d and Extended Data Fig. 3.4). Ultrasound imaging revealed a 17dB 
enhancement in the nonlinear contrast produced by GVSClpXP at an acoustic pressure of 477 kPa, in response 
to ClpXP activity (Fig. 3.3, e-f and Extended Data Fig. 3.4). Control GVs containing wild type GvpC 
showed no sensitivity to ClpXP (Fig. 3.3, g-i and Extended Data Fig. 3.4). These results establish the 
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Extended Data Figure 3.4 | Engineering an acoustic sensor of ClpXP proteolytic activity. (a, b) Scatter plots for 
Figure. 3(d, g). N = 5 biological replicates. (c) Coomassie-stained SDS-PAGE gel of OD500nm-matched GVWT samples 
incubated in a reconstituted cell-free transcription-translation (TX-TL) system containing a protease inhibitor cocktail 
or ClpXP. N = 3 biological replicates. (d) Coomassie-stained SDS-PAGE gel of 30x diluted content of TX-TL system 
containing ClpXP. N = 2 biological replicates(e) DLS measurements showing the average hydrodynamic diameter of 
GVSClpXP and GVWT samples, after incubations with protease inhibitor or ClpXP (N = 2 biological replicates, 
individual dots represent each N and horizontal line indicates the mean). (f, g) Scatter plots showing the ratio of x-
AM to B-mode acoustic signal as a function of applied acoustic pressure for all the replicate samples used in the x-
AM voltage ramp experiments for GVSClpXP (f) and GVWT (g). N = 3 biological replicates, with each N consisting of 
3 technical replicates. Individual dots represent each N and solid line represents the mean of all the replicates for a, b, 
f and g. 
 
3.3.4 Constructing intracellular acoustic sensor genes 
After demonstrating the performance of acoustic biosensors in vitro, we endeavored to show that they could 
respond to enzymatic activity inside living cells. As the cellular host, we chose E. coli Nissle 1917. This 
probiotic strain of E. coli has the capacity to colonize the mammalian gastrointestinal tract, and is widely 
used as a chassis for the development of microbial therapeutics35-37, making it a valuable platform for 
intracellular biosensors.  Recently, an engineered operon comprising GV-encoding genes from Anabaena 
flos-aquae and Bacillus megaterium was expressed in Nissle cells as acoustic reporter genes (ARGs), 
allowing gene expression to be imaged with linear B-mode ultrasound8. To develop an intracellular acoustic 
sensor gene targeting ClpXP (ASGClpXP), we swapped the wild type gvpC in the ARG gene cluster (ARGWT) 
with the modified gvpC from GVSClpXP (dGvpC) (Fig. 3.4a). For a first test of this intracellular biosensor, 
we transformed it into wild-type (WT) Nissle cells, which natively express ClpXP protease, hypothesizing 
that it would show a reduced intracellular collapse pressure and enhanced nonlinear contrast compared to 
ARGWT. Indeed, pressurized absorbance spectroscopy on intact cells expressing ASGClpXP revealed a 
reduction in the hydrostatic collapse pressure midpoint of ~ 160 kPa relative to cells expressing ARGWT 
(Extended Data Fig. 3.5). In ultrasound imaging, live cells expressing ASGClpXP showed an enhancement 
in nonlinear contrast of approximately 13 dB (Extended Data Fig. 3.5), while linear B-mode signal was 
similar. The nonlinear response of ASGClpXP expressing cells was strongest beyond an acoustic pressure of 







Figure 3.4: Monitoring intracellular protease activity and circuit-driven gene expression in engineered cells. 
(a) Schematic of E. coli Nissle cells expressing the acoustic sensor gene construct for ClpXP. In some cases, the Nissle 
cells are genomically modified to lack the clpX and clpP genes (DclpXP), and co-transformed with a plasmid encoding 
L-arabinose (L-ara) driven ClpXP. (b) Normalized pressure-sensitive optical density at 600 nm of DclpXP Nissle cells 
expressing ASGClpXP with or without L-ara induction of ClpXP protease expression. The legend lists the midpoint 
collapse pressure for each cell type (±95% confidence interval) determined from fitting a Boltzmann sigmoid function 
(N = 3 biological replicates). (c) Representative ultrasound images of DclpXP Nissle cells expressing ASGClpXP with 
or without L-ara induction of ClpXP protease at OD600nm 1.5. (d) Average x-AM/B-mode ratio as a function of applied 
acoustic pressure for DclpXP Nissle cells expressing ASGClpXP with or without L-ara induction of ClpXP expression 
at OD600nm 1.5. N=3 biological replicates, with each N having 3 technical replicates for c and d. (e) Schematic of pT5-
LacO driven ASGClpXP and pTet-TetO driven WT gvpC gene circuits co-transformed into Nissle cells for dynamic 
switching of non-linear acoustic signals from the intracellular GV sensors in response to circuit-driven gene 
expression. (f) Representative ultrasound images of Nissle cells (OD600nm 1) expressing ASGClpXP, with or without aTc 
induction to drive expression of WT GvpC. (g) Average x-AM/B-mode ratio as a function of applied acoustic pressure 
for Nissle cells expressing ASGClpXP, with or without aTc induction. N=5 biological replicates for f and g. CNR stands 
for contrast-to-noise-ratio, and color bars represent relative ultrasound signal intensity in the dB scale. The B-mode 
images were acquired at 309 kPa for (c) and 132 kPa for (f). The x-AM images were acquired at 1.61 MPa for (c), and 
1.34 MPa for (f). Scale bars in c and f represent 1 mm.For b, d and g, solid curves represent the mean and error bars 
indicate SEM. Statistics were performed on data from independent biological replicates. Individual scatter plots for 
b,d and g are shown in Extended Data Figure 3.5. 
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Next, to examine the ability of ASGClpXP to respond to intracellular enzymatic activity in a dynamic 
manner, we generated a ClpXP-deficient strain of Nissle cells (DclpXP) through genomic knock-out of the 
genes encoding ClpX and ClpP, and created a plasmid containing these two genes under the control of an 
arabinose-inducible promoter (Fig. 3.4a). This allowed us to externally control the activity of the ClpXP 
enzyme. DclpXP Nissle cells were co-transformed with an inducible clpX-clpP (clpXP) plasmid and 
ASGClpXP. ClpXP production in these cells after induction with L-arabinose resulted in an approximately 
160 kPa reduction in the hydrostatic collapse pressure midpoint (Fig. 3.4b and Extended Data Fig. 3.5). 
Under ultrasound imaging, cells with induced ClpXP activity showed substantially stronger nonlinear 
contrast (+6.7 dB)  compared to cells uninduced for this protease (Fig. 3.4c), while showing a similar B-
mode signal. This enhancement in nonlinear signal was detectable with acoustic pressures above 950 kPa 
(Fig. 3.4d and Extended Data Fig. 3.5). These experiments demonstrate the ability of ASGClpXP to function 
as an intracellular acoustic sensor to monitor variable enzyme activity.  
 
Extended Data Figure 3.5 | Constructing intracellular acoustic sensor genes for dynamic monitoring of protease 
activity and circuit-driven gene expression. (a) Normalized pressure-sensitive optical density at 600 nm of WT 
Nissle cells expressing either ARGWT or ASGClpXP. The legend lists the midpoint collapse pressure for each cell type 
(±95% confidence interval) determined from fitting a Boltzmann sigmoid function (N = 5 biological replicates and 8 
total replicates for ASGClpXP; N = 3 biological replicates for ARGWT and 6 total replicates). (b) Representative 
ultrasound images of WT Nissle cells expressing either ARGWT or ASGClpXP at OD600nm 1.5 (N = 4 biological replicates 
and the number of total replicates is 10). (c) Scatter plots showing x-AM/B-mode ratio as a function of applied acoustic 
pressure for WT Nissle cells expressing either ARGWT or ASGClpXP at OD600nm 1.5 (N = 4 biological replicates and the 
number of total replicates is 10). (d) Scatter plots for Figure 3.4b, N = 3 biological replicates. (e, f) Scatter plots 
showing the ratio of x-AM to B-mode acoustic signal as a function of acoustic pressure for all the replicate samples 
used in the x-AM voltage ramp experiments for DclpXP Nissle cells expressing ASGClpXP and araBAD driven clpXP, 
with or without L-arabinose induction (e) and WT Nissle cells expressing ASGClpXP and pTet-TetO driven WT gvpC, 
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= 5 biological replicates for (f). Individual dots represent each N and solid line represents the mean of all the replicates 
for a, c, d, e and f. 
A major application of dynamic sensors in cells is to monitor the activity of natural or synthetic 
gene circuits38-40. To test if our acoustic sensors could be used to track the output of a synthetic gene circuit 
in cells, we co-transformed WT Nissle cells with ASGClpXP, and a separate wild-type gvpC gene controlled 
by anhydrotetracycline (aTc) (Fig. 3.4e). Our hypothesis was that induction of this gene circuit only with 
IPTG would result in the production of GVs with ClpXP-degradable GvpC, resulting in nonlinear contrast, 
whereas the additional input of aTc would result in the co-production of non-degradable wild-type GvpC, 
which would take the place of any degraded engineered GvpC on the biosensor shell and lead to reduced 
nonlinear scattering (Fig. 3.4e). Indeed, when we induced cells with just IPTG we observed strong nonlinear 
contrast. However, when aTc was added to the cultures after IPTG induction, this contrast was reduced by 
approximately 10 dB (Fig. 3.4f-g and Extended Data Fig. 3.5). These results, together with our findings 
in DclpXP cells with inducible ClpXP, show that acoustic biosensors can be used to visualize the output of 
synthetic gene circuits. 
 
3.3.5 Ultrasound imaging of intracellular ClpXP activity in vivo 
Finally, after establishing the basic principles of acoustic biosensor engineering in vitro and demonstrating 
their performance in living cells, we assessed the ability of our sensor constructs to produce ultrasound 
contrast within a biologically relevant anatomical location in vivo. In particular, approaches to imaging 
microbes in the mammalian GI tract8,41-43 are needed to support the study of their increasingly appreciated 
roles in health and disease44,45 and the development of engineered probiotic agents46,47. The GI tract is also 
an excellent target for ultrasound imaging due to its relatively deep location inside the animal, and the use 
of ultrasound in clinical diagnosis and animal models of GI pathology, with appropriate measures taken to 
minimize potential interference from air bubbles and solid matter48,49.  
 
Extended Data Figure 3.6 | Schematic illustrating the in vivo ultrasound imaging experiment. Cells in cylindrical 
hydrogel with the indicated cross-sectional arrangements were injected into the GI tract of mice and imaged with 
ultrasound. 
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To demonstrate the ability of acoustic biosensors to produce nonlinear ultrasound contrast within 
the in vivo context of the mouse GI tract, we first co-injected WT Nissle cells expressing ASGClpXP and 
ARGWT into the mouse colon (schematic shown in Extended Data Fig. 3.6), distributing one cell population 
along the lumen wall and the other in the lumen center. In these proof-of-concept experiments, the cells are 
introduced into the colon in a rectally-injected agarose hydrogel to enable precise positioning and control 
over composition. Using nonlinear ultrasound imaging, we could clearly visualize the unique contrast 
generated by the protease-sensitive ASGs as a bright ring of contrast lining the colon periphery (Fig. 3.5a). 
When the spatial arrangement was reversed, the bright nonlinear contrast was concentrated in the middle 
of the lumen (Extended Data Fig. 3.7). A comparison of ultrasound images acquired before and after 
acoustic collapse of the GVs, using a high-pressure pulse from the transducer, confirmed that the bright 
ring of nonlinear contrast was emanating from ASGClpXP -expressing cells (Fig. 3.5a), and this result was 
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Figure 3.5: Ultrasound imaging of bacteria expressing acoustic sensor genes in the gastrointestinal tract of 
mice. (a) Transverse ultrasound image of a mouse whose colon contains WT Nissle cells expressing ARGWT at the 
center of the lumen and the same strain expressing ASGClpXP at the periphery of the lumen. These imaging experiments 
were independently repeated 9 times with similar results. (b) B-mode and xAM contrast-to-noise ratio (CNR) in vivo, 
for WT Nissle cells expressing ARGWT or ASGClpXP. N = 9 mice. P = 7.8E-5 for x-AM signal from cells expressing 
ASGClpXP versus the ARGWT control and P = 0.2890 for B-mode signal. (c) Transverse ultrasound image of a mouse 
whose colon contains DclpXP Nissle cells expressing ASGClpXP with L-ara induction of ClpXP protease expression at 
the center and without L-ara induction at the periphery of the lumen. These imaging experiments were independently 
repeated 7 times with similar results. Cells were injected in agarose gel at a final concentration of 1.5E9 cells ml-1 for 
a and c. Nonlinear (x-AM) images of the colon, acquired at 1.27 MPa for (a) and 1.56 MPa for (c) before and after 
acoustic collapse (hot color map), are superimposed on linear (B-mode) anatomical images (bone colormap). Color 
bars represent relative ultrasound signal intensity on the dB scale. Scale bars represent 2 mm for a and c. (d) B-mode 
and xAM CNR in vivo, for DclpXP Nissle cells expressing ASGClpXP with or without L-ara induction of ClpXP 
expression. N = 7 mice. P = 1.8E-5 for x-AM signal from cells expressing ASGClpXP with ClpXP protease expression 
induced versus non- induced and P = 0.8293 for B-mode signal. Individual dots represent each N, and the thick 
horizontal line indicates the mean. Error bars indicate SEM. P-values were calculated using a two-tailed paired t-test. 
 
To demonstrate in vivo imaging of enzyme activity, we introduced DclpXP Nissle cells expressing 
ASGClpXP into the mouse colon, with and without transcriptionally activating intracellular ClpXP (schematic 
shown in Extended Data Fig. 3.6) . As above, the cells were contained in an agarose hydrogel. Cells 
induced to express this enzyme showed enhanced nonlinear contrast compared to cells not expressing 
ClpXP (Fig. 3.5c). Acoustic collapse confirmed the acoustic biosensors as the primary source of nonlinear 
signal (Fig. 3.5c). This performance was consistent across 7 mice and 2 spatial arrangements of the cells 
(Fig. 3.5d). These results demonstrate the ability of acoustic biosensors to visualize enzyme activity within 






Extended Data Figure 3.7 | Ultrasound imaging of bacteria expressing acoustic sensor genes in the 
gastrointestinal tract of mice. (a) Schematic illustrating two orientations of the wild type (WT) E. coli Nissle cells 
expressing ARGWT or ASGClpXP introduced into the mouse colon as a hydrogel. (b, c) Representative transverse 
ultrasound images of the colon for two mice used in the in vivo imaging experiments, with orientation #1 (b) and 
with orientation #2. (c). Cells are injected at a final concentration of 1.5E9 cells ml-1. B-mode signal is displayed 
using the bone colormap and x-AM signal is shown using the hot colormap. Color bars represent B-mode and x-AM 
ultrasound signal intensity in the dB scale. Scale bars represent 2 mm. (d, e) B-mode and xAM contrast-to-noise 
ratio (CNR) in vivo, for WT Nissle cells expressing ARGWT or ASGClpXP in orientation #1 (d) and orientation #2. (e). 
N = 5 mice for orientation #1 (b, d) and N = 4 mice for orientation #2 (c, e). Error bars indicate SEM. P = 0.0014 for 
x-AM signal from cells expressing ASGClpXP versus the ARGWT control in orientation #1, and P = 0.0016 for that in 
orientation #2. P = 0.0570 for B-mode signal in orientation #1 and P = 0.3445 in orientation #2. P-values were 
calculated using a two-tailed paired t-test. Individual dots represent each N and horizontal line indicates the mean. 
 
Besides molecular sensing, one additional benefit of the nonlinear contrast generated by ASGClpXP 
-expressing cells is to make the cells easier to detect relative to background tissue compared to linear B-
mode imaging. Indeed, the nonlinear contrast of WT Nissle cells expressing ASGClpXP had a significantly 
higher contrast-to-tissue ratio than either the nonlinear contrast of ARGWT-expressing cells, or the B-mode 
contrast of either of these two species (Extended Data Fig. 3.8). 
a
































































































 Extended Data Figure 3.8 | ASGClpXP -expressing cells showed 
higher contrast to tissue with nonlinear imaging. B-mode and xAM 
contrast-to-tissue ratio (CTR) in vivo, for WT Nissle cells expressing 
ARGWT or ASGClpXP in both orientations. P = 7.8E-5 for the CTR from 
xAM imaging of cells expressing ASGClpXP versus CTR from xAM 
imaging of cells expressing ARGWT. P = 1.4E-6 for the CTR from 
xAM imaging of cells expressing ASGClpXP versus CTR from B-mode 
imaging of cells expressing ASGClpXP and P = 4.9E-7 for the CTR from 
xAM imaging of cells expressing ASGClpXP versus CTR from B-mode 
imaging of cells expressing ARGWT. Individual dots represent each N, 
and the thick horizontal line indicates the mean. Error bars indicate 
SEM. N = 9 mice. P-values were calculated using a two-tailed paired 
t-test for each comparison independently. Individual dots represent each N and horizontal line indicates the mean. 
 
3.4 Discussion 
Our results establish a paradigm for visualizing protease activity non-invasively with ultrasound imaging. 
This paradigm is enabled by the dependence of the buckling mechanics of GVs on the reinforcing protein 
GvpC, and the ability to turn this protein into a protease substrate by incorporating specific internal or 
terminal peptide sequences. Similar to the earliest work on fluorescent biosensors23,24, this initial study has 
focused on proteases due to the importance of this class of enzymes in biology, their relatively compact 
recognition motifs, and the large impact of their activity on protein structure. Based on our success in 
sensing the function of three distinct proteases, we anticipate that the basic design strategy presented here 
should be applicable to many enzymes of this type. 
Our study lends itself to numerous future investigations to extend the applications of acoustic 
protease sensors beyond the proof-of-concept demonstrations shown here. While our experiments in E. coli 
and within the mouse GI tract establish the critical ability of such biosensors to produce ultrasound contrast 
in relevant biological settings, additional application-centric optimizations would enable the use of these 
constructs to address specific problems in basic and synthetic biology. For example, purified acoustic 
biosensors could be designed to sense extracellular proteases, which play homeostatic and disease-causing 
roles in tissues ranging from extracellular matrix remodeling and blood clot formation to inter-cellular 
signaling. Meanwhile, the expression of acoustic biosensor genes in cells could be used to monitor natural 
cellular enzyme activity or serve as the output of synthetic signaling pathways. Intracellular use in bacteria 
could be particularly relevant in studying microbes in the mammalian GI tract, provided the successful 
adaptation of acoustic sensor genes to the relevant host species and ensuring successful delivery via oral 
gavage, colonization and metabolic viability. For potential applications in mammalian cells, acoustic 
protease sensor designs must be integrated into recently developed genetic programs enabling the 
expression of GVs in mammalian cells50. Successful use of acoustic sensors in this context will require 






































In parallel, significant scope exists for further optimizing and generalizing the design of acoustic 
biosensors. While all three of our sensors produced detectable nonlinear contrast in response to protease 
activity, the changes exhibited by GVSClpXP were significantly larger than for the other two constructs. This 
is not surprising for an enzyme that processively degrades GvpC, and whose recognition motif can be 
incorporated outside the main GV-binding region of GvpC. Endopeptidase sensors could be optimized to 
reach similar performance by incorporating more than one cleavage site within the GvpC sequence and 
tuning the linkers connecting these sites to the rest of the protein. As with other protease biosensors, the 
irreversibility of proteolysis means that for repeated or continuous sensing, it is necessary for new sensor 
molecules to be synthesized or delivered. For genetically encoded biosensors, this occurs through gene 
expression, potentially posing a metabolic burden to the cell. For GVs, this burden could be reduced by re-
expressing only the engineered GvpC rather than the full GV, since this protein can be added onto the shell 
of existing GVs, as demonstrated in this study and previous work12. Going beyond proteolytic sensors, we 
anticipate that our biosensor design strategy could be modified to enable allosteric conformational changes 
in GvpC, rather than its cleavage, to alter ultrasound contrast, thereby creating acoustic biosensors that 
respond reversibly to non-cleaving enzymes, ions or other signals of interest. 
In addition to optimizing the biosensor constructs, it is also possible to improve the ultrasound 
techniques used for their visualization. In this study, we monitored the activation of our biosensors using a 
nonlinear x-AM pulse sequence, quantifying the resulting contrast relative to linear B-mode scattering. This 
ratiometric signal is advantageous for quantification in scenarios where the sensor concentration may vary. 
However, the dependence of the x-AM response on applied acoustic pressure introduces a variable that may 
differ across the ultrasonic field of view, and strategies involving dynamic pressure adjustment may be 
needed to obtain the optimal signal from each point in the imaged plane.  In addition, normalization to B-
mode signal in complex in vivo contexts may require methods to separate the linear scattering contributions 
of acoustic sensors from those of background tissue. With these improvements, acoustic biosensors promise 
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3.5.1 Design and cloning of genetic constructs 
All gene sequences were codon optimized for E.Coli expression and inserted into their plasmid backbones 
via Gibson Assembly or KLD Mutagenesis using enzymes from New England Biolabs and custom primers 
from Integrated DNA Technologies. The protease recognition sequences for TEV protease and µ-calpain, 
flanked by flexible linkers, were introduced by substitution-insertion into the second repeat of the wild-
type Ana gvpC gene sequence in a pET28a expression vector (Novagen) driven by a T7 promoter and lac 
operator. The ssrA degradation tag for the ClpXP bacterial proteasome was appended to the C-terminus of 
Ana gvpC using a short flexible linker. The acoustic sensor gene for intracellular protease sensing of ClpXP 
was constructed by modifying of the acoustic reporter gene cluster ARG18, by addition of the ssrA 
degradation tag to the C-terminal of gvpC using a linker sequence. For expression in E.coli Nissle 1917 
cells, the pET28a T7 promoter was replaced by the T5 promoter. For inducible expression of clpX and clpP, 
the genes encoding those two proteins were cloned from the E. coli Nissle 1917 genome into a modified 
pTARA backbone under a PBAD promoter and araBAD operon. For dynamic regulation of intracellular 
sensing, the wild-type GvpC sequence was cloned into a modified pTARA backbone under a pTet promoter 
and tetracycline operator. The complete list and source of plasmids used in this study is given in 
Supplementary Table 1. Plasmid constructs were cloned using NEB Turbo E. Coli (New England Biolabs) 
and sequence-validated. 
 
3.5.2 Construction of clpX – clpP – strain of E.coli Nissle 1917 (DclpXP) 
The knockout of clpX and clpP in E.coli Nissle (ECN) was accomplished by Lambda Red recombineering 
using previously published methods51. A FRT-flanked cat gene was recombined into ECN genome to 
replace the clpX and clpP genes, and the integrated cat gene was then removed by the FLP recombinase 
from pE-FLP52 to yield the DclpXP strain. More information on the recombineering plasmids used in this 
study and their source is provided in Supplementary Table 1.  
 
3.5.3 GV expression, purification and quantification 
For in vitro assays, GVs were harvested and purified from confluent Ana cultures using previously 
published protocols12,28. Briefly, Ana cells were grown in Gorham’s media supplemented with BG-11 
solution (Sigma) and 10 mM sodium bicarbonate at 25°C, 1% CO2 and 100 rpm shaking, under a 14h light 
and 10h dark cycle. Confluent cultures were transferred to sterile separating funnels and left undisturbed 
for 2-3 days to allow buoyant Ana cells expressing GVs to float to the top and for their subnatant to be 
drained. Hypertonic lysis with 10% Solulyse (Genlantis) and 500 mM sorbitol was used to release and 






with removal of the subnatant and resuspension in phosphate buffered saline (PBS, Corning) after each 
round.  
For expression of acoustic reporter/sensor genes (ARG/ASG) in bacteria, wild-type E. Coli Nissle 
1917 cells (Ardeypharm GmbH) were made electrocompetent and transformed with the genetic constructs. 
After electroporation, cells were rescued in SOC media supplemented with 2% glucose for 1h at 37°C. 
Transformed cells were grown for 12-16 hours at 37°C in 5 mL of LB medium supplemented with 50 
µg/mL kanamycin and 2% glucose. Large-scale cultures for expression were prepared by a 1:100 dilution 
of the starter culture in LB medium containing 50 µg/mL kanamycin and 0.2% glucose. Cells were grown 
at 37°C to an OD600nm of 0.2-0.3, then induced with 3µM Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
and allowed to grow for 22 hrs at 30°C.  Buoyant E.Coli Nissle cells expressing GVs were isolated from 
the rest of the culture by centrifugally assisted floatation in 50 mL conical tubes at 300g for 3-4 hrs, with a 
liquid column height less than 10 cm to prevent GV collapse by hydrostatic pressure.  
The concentration of Ana GVs was determined by measurement of their optical density (OD) at 
500 nm (OD500) using a Nanodrop spectrophotometer (Thermo Fisher Scientific), using the resuspension 
buffer or collapsed GVs as the blank. As established in previous work28,  the concentration of GVs at OD500 
= 1 is approximately 114 pM and the gas fraction is 0.0417%. The OD of buoyant cells expressing GVs 
were quantified at 600 nm using the Nanodrop. 
 
3.5.4 Bacterial expression and purification of GvpC variants 
For expression of Ana GvpC variants, plasmids were transformed into chemically competent BL21(DE3) 
cells (Invitrogen) and grown overnight for 14-16 h at 37°C in 5 mL starter cultures in LB medium with 50 
µg/mL kanamycin. Starter cultures were diluted 1:250 in Terrific Broth (Sigma) and allowed to grow at 
37°C (250 rpm shaking) to reach an OD600nm of 0.4-0.7. Protein expression was induced by addition of 1 
mM IPTG, and the cultures were transferred to 30°C. Cells were harvested by centrifugation at 5500g after 
6-8 hours. For the GvpC-ssrA variant, expression was carried out at 25°C for 8 hours to reduce the effect 
of protease degradation and obtain sufficient protein yield. 
GvpC was purified from inclusion bodies by lysing the cells at room temperature using Solulyse 
(Genlantis), supplemented with lysozyme (400 µg/mL) and DNase I (10 µg/mL). Inclusion body pellets 
were isolated by centrifugation at 27,000g for 15 mins and then resuspended in a solubilization buffer 
comprising 20 mM Tris-HCl buffer with 500 mM NaCl and 6 M urea (pH: 8.0), before incubation with Ni-
NTA resin (Qiagen) for 2 h at 4°C. The wash and elution buffers were of the same composition as the 






protein was assayed using the Bradford Reagent (Sigma). Purified GvpC variants were verified to be >95% 
pure by SDS-PAGE analysis. 
 
3.5.5 Preparation of gas vesicles for in vitro protease assays 
Engineered GVs having protease-sensitive or wild-type GvpC were prepared using urea stripping and GvpC 
re-addition12,28. Briefly, Ana GVs were stripped of their native outer layer of GvpC by treatment with 6M 
urea solution buffered with 100 mM Tris- HCl (pH:8-8.5). Two rounds of centrifugally assisted floatation 
with removal of the subnatant liquid after each round were performed to ensure complete removal of native 
GvpC. Recombinant Ana GvpC variants purified from inclusion bodies were then added to the stripped 
Ana GVs in 6 M urea a 2-3x molar excess concentration determined after accounting for 1:25 binding ratio 
of GvpC: GvpA. For a twofold stoichiometric excess of GvpC relative to binding sites on an average Ana 
GV, the quantity of recombinant GvpC (in nmol) to be added to stripped GVs was calculated according to 
the formula:  2 * OD * 198 nM * volume of GVs (in liters). The mixture of stripped GVs (OD500nm = 1-2) 
and recombinant GvpC in 6 M urea buffer was loaded into dialysis pouches made of regenerated cellulose 
membrane with a 6-8 kDa M.W. cutoff (Spectrum Labs). The GvpC was allowed to slowly refold onto the 
surface of the stripped GVs by dialysis in 4 L PBS for at least 12 h at 4 °C. Dialyzed GV samples were 
subjected to two or more rounds of centrifugally assisted floatation at 300 g for 3-4 h to remove any excess 
unbound GvpC. Engineered GVs were resuspended in PBS after subnatant removal and quantified using 
pressure-sensitive OD measurements at 500 nm using a Nanodrop. 
 
3.5.6 Pressurized absorbance spectroscopy  
Purified, engineered Ana GVs were diluted in experimental buffers to an OD500nm ~ 0.2-0.4, and 400 µL of 
the diluted sample was loaded into a flow-through quartz cuvette with a pathlength of 1 cm (Hellma 
Analytics). Buoyant E.Coli Nissle cells expressing GVs were diluted to an OD600nm of ~ 1 in PBS for 
measurements.  A 1.5 MPa nitrogen gas source was used to apply hydrostatic pressure in the cuvette through 
a single valve pressure controller (PC series, Alicat Scientific), while a microspectrometer (STS-VIS, 
Ocean Optics) measured the OD of the sample at 500 nm (for Ana GVs) or 600 nm (for Nissle cells). The 
hydrostatic pressure was increased from 0 to 1 MPa in 20 kPa increments with a 7 second equilibration 
period at each pressure before OD measurement. Each set of measurements was normalized by scaling to 
the Min-Max measurement value, and the data was fitted using the Boltzmann sigmoid function 𝑓(𝑃) =
1 + 𝑒(ghgi)/∆ghP, with the midpoint of normalized OD change (Pl) and the 95% confidence intervals, 








3.5.7 TEM sample preparation and imaging 
Freshly diluted samples of engineered Ana GVs (OD500nm ~ 0.3) in 10 mM HEPES buffer containing 150 
mM NaCl (pH 8) were used for TEM. 2 µL of the sample was added to Formvar/carbon 200 mesh grids 
(Ted Pella) that were rendered hydrophilic by glow discharging (Emitek K100X). 2% uranyl acetate was 
added for negative staining. Images were acquired using the FEI Tecnai T12 LaB6 120kV TEM equipped 
with a Gatan Ultrascan 2k X 2k CCD and ‘Leginon’ automated data collection software suite. 
 
3.5.8 Dynamic light scattering (DLS) measurements 
Engineered Ana GVs were diluted to an OD500nm ~ 0.2 in experimental buffers.  150-200 µL of the sample 
was loaded into a disposable cuvette (Eppendorf UVette®) and the particle size was measured using the 
ZetaPALS particle sizing software (Brookhaven instruments) with an angle of 90 ° and refractive index of 
1.33. 
 
3.5.9 Denaturing polyacrylamide gel electrophoresis (SDS-PAGE) 
GV samples were OD500nm matched and mixed 1:1 with 2x Laemmli buffer (Bio-Rad), containing SDS and 
2-mercaptoethanol. The samples were then boiled at 95°C for 5 minutes and loaded into a pre-made 
polyacrylamide gel (Bio-Rad) immersed in 1x Tris-Glycine-SDS Buffer. 10 uL of Precision Plus ProteinTM 
Dual Color Standards (Bio-Rad) was loaded as the ladder. Electrophoresis was performed at 120V for 55 
minutes, after which the gel was washed in DI water for 15 minutes to remove excess SDS and commassie-
stained for 1 hour in a rocker-shaker using the SimplyBlue SafeStain (Invitrogen). The gel was allowed to 
de-stain overnight in DI water before imaging using a Bio-Rad ChemiDocTM imaging system. 
 
3.5.10 In vitro protease assays 
For in vitro assays with the TEV endopeptidase, recombinant TEV protease (R&D Systems, Cat. No. 4469-
TP-200) was incubated (25% v/v fraction) with engineered Ana GVs resuspended in PBS (final OD500nm in 
reaction mixture = 5-6) at 30°C for 14-16 h. This corresponds to a TEV concentration of 0.1~0.125 mg/mL 
(depending on the lot), within the range used in previous studies with this enzyme53,54. Engineered GVs 
with wild-type GvpC and TEV protease heat-inactivated at 80°C for 20-30 mins were used as the controls. 
For in vitro assays with calpain, calpain-1 from porcine erythrocytes (Millipore Sigma, Cat. No. 
208712) was incubated in a 10% v/v fraction with engineered Ana GVs in a reaction mixture containing 50 
mM Tris-HCl, 50 mM NaCl, 5 mM 2-mercaptoethanol, 1 mM EDTA and 1 mM EGTA and 5 mM Ca2+ 
(pH: 7.5) This corresponds to a calpain concentration of ≥  0.168 units per µl, with 1 unit defined by the 
manufacturer as sufficient to cleave 1 pmol of a control fluorogenic substrate in 1 min at 25˚C.. The final 






out at 25°C for 14-16h.  Negative controls included the same reaction mixture without calpain, without 
calcium, or without calpain and calcium. Engineered GVs with WT-GvpC were used as additional negative 
controls. 
For in vitro assays with ClpXP, a reconstituted cell-free transcription-translation (TX-TL) system 
adapted for ClpXP degradation assays55 (gift from Zachary Sun and Richard Murray) was used. Briefly, 
cell-free extract was prepared by lysis of ExpressIQ E.coli cells (New England Biolabs), and mixed in a 
44% v/v ratio with an energy source buffer, resulting in a master mix of extract and buffer comprising: 9.9 
mg/mL protein, 1.5 mM each amino acid except leucine, 1.25 mM leucine, 9.5 mM Mg-glutamate, 95 mM 
K-glutamate, 0.33 mM DTT, 50 mM HEPES, 1.5 mM ATP and GTP, 0.9 mM CTP and UTP, 0.2 mg/mL 
tRNA, 0.26 mM CoA, 0.33 mM NAD, 0.75 mM cAMP, 0.068 mM folinic acid, 1 mM spermidine, 30 mM 
3-PGA and 2% PEG-8000. For purified ClpX protein, a monomeric N-terminal deletion variant Flag-
ClpXdeltaNLinkedHexamer-His656 (Addgene ID: 22143) was used. Post Ni-NTA purification, active 
fractions of ClpX hexamers with sizes above 250 kDa were isolated using a Supradex 2010/300 column, 
flash frozen at a concentration of 1.95 µM and stored at -80°C in a storage buffer consisting of: 50 mM 
Tris-Cl (pH 7.5), 100 mM NaCl, 1mM DTT, 1 mM EDTA and 2% DMSO.  The final reaction mixture was 
prepared as follows: 75% v/v fraction of the master mix, 10% v/v of purified ClpX, 1nm of the purified 
pBEST-ClpP plasmid and engineered Ana GVs (concentration of OD500nm = 2.5-2.7 in the reaction mixture). 
The mixture was made up to the final volume using ultrapure H2O. The reaction was allowed to proceed at 
30°C for 14-16 h. As a negative control, a protease inhibitor cocktail mixture (SIGMAFASTTM, Millipore 
Sigma) was added to the reaction mixture at 1.65x the manufacturer-recommended concentration and pre-
incubated at room temperature for 30 mins.  
 
3.5.11 Dynamic sensing of ClpXP activity in DclpXP E.Coli Nissle 1917 cells 
ClpXP E. Coli Nissle 1917 cells were made electrocompetent and co-transformed with the pET expression 
plasmid (Lac-driven) containing the ASG for ClpXP and a modified pTARA plasmid (pBAD-driven) 
containing the clpX and clpP genes. Electroporated cells were rescued in SOC media supplemented with 
2% glucose for 2h at 37°C. Transformed cells were grown overnight at 37ºC in 5 mL LB medium 
supplemented with 50 µg/mL kanamycin, 25 µg/mL chloramphenicol and 2% glucose. Starter cultures were 
diluted 1:100 in LB medium with 50 µg/mL kanamycin, 25 µg/mL chloramphenicol and 0.2% glucose and 
allowed to grow at 37 °C to reach an OD600nm of 0.2-0.3. ASG expression was induced with 3µM IPTG and 
the bacterial culture was transferred to the 30 °C incubator with 250 rpm shaking for 30 minutes. The culture 
was then split into two halves of equal volume, and one half was induced with 0.5% (weight fraction) L-
arabinose for expression of ClpXP protease. Cultures with and without L-arabinose induction were allowed 






at 4 °C for 3-4 h in 50 mL conical tubes to isolate buoyant cells expressing GVs from the rest of the culture. 
The liquid column height was maintained at less than 10 cm to prevent GV collapse by hydrostatic pressure.   
 
3.5.12 Dynamic sensing of circuit-driven gene expression in E.Coli Nissle 1917 cells 
Electrocompetent E. coli Nissle cells were co-transformed with the pET expression plasmid (Lac-driven) 
containing the ASG for ClpXP and a modified pTARA plasmid57 (Tet-driven) containing the WT Ana GvpC 
gene. Electroporated cells were rescued in SOC media supplemented with 2% glucose for 2h at 37°C. 
Transformed cells were grown overnight at 37ºC in 5 mL LB medium supplemented with 50 µg/mL 
kanamycin, 50 µg/mL chloramphenicol and 2% glucose. Starter cultures were diluted 1:100 in LB medium 
with 50 µg/mL kanamycin, 50 µg/mL chloramphenicol and 0.2% glucose and allowed to grow at 37 °C to 
reach an OD600nm of 0.2-0.3. ASG expression was induced with 3 µM IPTG and the bacterial culture was 
transferred to 30 °C incubator with 250 rpm shaking for 1.5-2 h. The culture was then split into two halves 
of equal volume, and one half was induced with 50 ng/mL aTc for expression of WT GvpC. Cultures with 
and without aTc induction were allowed to grow for an additional 20 h at 30°C. Cultures were then spun 
down at 300 g in a refrigerated centrifuge at 4 °C for 3-4 h in 50 mL conical tubes to isolate buoyant cells 
expressing GVs from the rest of the culture. The liquid column height was maintained at less than 10 cm to 
prevent GV collapse by hydrostatic pressure.   
 
3.5.13 In vitro ultrasound imaging 
Imaging phantoms were prepared by melting 1% agarose (w/v) in PBS and casting wells using a custom 3-
D-printed template mold containing a 2-by-2 grid of cylindrical wells with 2 mm diameter and 1 mm 
spacing between the outer radii in the bulk material. Ana GV samples from in vitro assays or buoyant Nissle 
cells expressing GVs were mixed 1:1 with 1% molten agarose solution at 42°C and quickly loaded before 
solidification into the phantom wells. All samples and their controls were OD-matched using the Nanodrop 
prior to phantom loading, with the final concentration being OD500nm = 2.2 for Ana GVs and OD600nm= 1.0-
1.5 for buoyant Nissle cells. Wells not containing sample were filled with plain 1% agarose. Hydrostatic 
collapse at 1.4 MPa was used to determine that the contribution to light scattering from GVs inside the cells 
was similar for those expressing the acoustic sensor gene and its wild-type ARG counterpart. The phantom 
was placed in a custom holder on top of an acoustic absorber material and immersed in PBS to acoustically 
couple the phantom to the ultrasound imaging transducer.  
 Imaging was performed using a Verasonics Vantage programmable ultrasound scanning system 
and a L22-14v 128-element linear array Verasonics transducer, with a specified pitch of 0.1 mm, an 
elevation focus of 8 mm, an elevation aperture of 1.5mm and a center frequency of 18.5 MHz with 67% -6 






protocol. For each ray line, a single pulse was transmitted with an aperture of 40 elements. For nonlinear 
image acquisition, a custom cross-amplitude modulation (x-AM) sequence detailed in an earlier study15, 
with an x-AM angle (q) of 19.5° and an aperture of 65 elements, was used. Both B-mode and x-AM 
sequences were programmed to operate close to the center frequency of the transducer (15.625 MHz) and 
the center of the sample wells were aligned to the set transmit focus of 5 mm. Transmitted pressure at the 
focus was calibrated using a Precision Acoustics fiber-optic hydrophone system. Each image was an 
average of 50 accumulations. B-mode images were acquired at a transmit voltage of 1.6V (132 kPa), and 
an automated voltage ramp imaging script (programmed in MATLAB) was used to sequentially toggle 
between B-mode and x-AM acquisitions. The script acquired x-AM signals at each specified voltage step, 
immediately followed by a B-mode acquisition at 1.6V (132 kPa), before another x-AM acquisition at the 
next voltage step. For engineered Ana GVs subjected to in vitro protease assays, an x-AM voltage ramp 
sequence from 4V (230 kPa) to 10V (621 kPa) in 0.2V increments was used. For wild-type Nissle cells 
expressing GVs, an x-AM voltage ramp sequence from 7.5V (458 kPa) to 25V (1.6 MPa) in 0.5V 
increments was used. Samples were subjected to complete collapse at 25V with the B-mode sequence for 
10 seconds, and the subsequent B-mode image acquired at 1.6V and x-AM image acquired at the highest 
voltage of the voltage ramp sequence was used as the blank for data processing. There was no significant 
difference between the signals acquired at specific acoustic pressures during a voltage ramp or after directly 
stepping to the same pressure (Extended Data Fig. 3.9). 
 Extended Data Figure 3.9 | Absence of memory effect 
from imaging at sequentially increasing acoustic 
pressure. Ratio of sensor-specific signal (xAM/B-mode) 
acquired at the indicated acoustic pressures in the process of 
voltage ramping (comprising 36 points from 458 kPa to 1.6 
MPa) or stepping the transducer output directly to 
corresponding pressure in a single step, for WT Nissle cells 
expressing either ARGWT or ASGClpXP. N =3 biological 
replicates, with each N having 3 technical replicates. 
Individual dots represent each replicate, and the thick 
horizontal line indicates the mean. Error bars indicate SEM 
derived from biological replicates (see Online Methods). 
 
Due to transducer failure, a replacement Verasonics transducer (L22-14vX) with similar 
specifications was used in experiments with DclpXP cells. The transmitted pressure at the focus was 
calibrated in the same way as the L22-14v. B-mode images were acquired at a transmit voltage of 1.6V 
(309 kPa), and an x-AM voltage ramp sequence from 6V (502 kPa) to 25V (2.52 MPa) was used. The 
imaging protocol was otherwise unchanged.  
 
 
3.5.14 In vivo ultrasound imaging  

















All in vivo experiments were performed on C57BL/6J male mice, aged 14–34 weeks, under a protocol 
approved by the Institutional Animal Care and Use Committee of the California Institute of Technology. 
No randomization or blinding were necessary in this study. Mice were anesthetized with 1–2% isoflurane, 
maintained at 37 °C on a heating pad, depilated over the imaged region, and enema was performed by 
injecting PBS to expel gas and solid contents in mice colon. For imaging of E. coli in the gastrointestinal 
tract, mice were placed in a supine position, with the ultrasound transducer positioned on the lower 
abdomen, transverse to the colon such that the transmit focus of 5 mm was close to the center of the colon 
lumen. Prior to imaging, two variants of buoyancy-enriched E. coli Nissle 1917  were mixed in a 1:1 ratio 
with 4% agarose in PBS at 42 °C, for a final bacterial concentration of 1.5E9 cells ml−1. An 8-gauge gavage 
needle was filled with the mixture of agarose and bacteria of one cell population. Before it solidified, a 14-
gauge needle was placed inside the 8-gauge needle to form a hollow lumen within the gel. After the 
agarose–bacteria mixture solidified at room temperature for 10 min, the 14-gauge needle was removed. The 
hollow lumen was then filled with the agarose–bacteria of the other cell population. After it solidified, the 
complete cylindrical agarose gel was injected into the colon of the mouse with a PBS back-filled syringe. 
For the colon imaging, imaging planes were selected to avoid gas bubbles in the field of view. In all in vivo 
experiments, three transducers were used, including two L22-14v and one L22-14vX, due to transducer 
failures unrelated to this study. B-mode images were acquired at 1.9V (corresponding to 162 kPa in water) 
for L22-14v, and 1.6V (309 kPa in water) for L22-14vX. x-AM images were acquired at 20V (1.27 MPa in 
water) for L22-14v and 15V (1.56 MPa in water) for L22-14vX, with other parameters being the same as 
those used for in vitro imaging. B-mode anatomical imaging was performed at 7.4V using the ‘L22-14v 
WideBeamSC’ script provided by Verasonics.  
 
3.5.15 Image processing and data analysis  
All in vitro and in vivo ultrasound images were processed using MATLAB. Regions of interest (ROIs) were 
manually defined so as to adequately capture the signals from each sample well or region of the colon. The 
sample ROI dimensions (1.2 mm × 1.2 mm square) were the same for all in vitro phantom experiments. 
The noise ROI was manually selected from the background for each pair of sample wells. For the in vivo 
experiments, circular ROIs were manually defined to avoid edge effects from the skin or colon wall, and 
the tissue ROIs were defined as the rest of the region within the same depth range of the signal ROIs. For 
each ROI, the mean pixel intensity was calculated, and the pressure-sensitive ultrasound intensity (Δ𝐼 =
𝐼qrstls − 𝐼luvvtwxyz)  was calculated by subtracting the mean pixel intensity of the collapsed image from the 
mean pixel intensity of the intact image. The contrast-to-noise ratio (CNR) was calculated for each sample 











where ΔIh(V) is the pressure-sensitive nonlinear ultrasound intensity acquired by the x-AM sequence 
at a certain voltage V, and ΔIhuzy(V)	is the pressure-sensitive linear ultrasound intensity of the B-mode 
acquisitions at 1.6V (132 kPa) following the x-AM acquisitions at the voltage V. All images were pseudo-
colored (bone colormap for B-mode images, hot colormap for x-AM images), with the maximum and 
minimum levels indicated in the accompanying color bars.  
 
3.5.16 Statistical analysis 
Data is plotted as the mean ± standard error of the mean (SEM). Sample size is N=3 biological replicates 
in all in vitro experiments unless otherwise stated. For each biological replicate, there were technical 
replicates to accommodate for variability in experimental procedures such as sample loading and pipetting. 
SEM was calculated by taking the values for the biological replicates, each of which was the mean of its 
technical replicates. The numbers of biological and technical replicates were chosen based on preliminary 
experiments such that they would be sufficient to report significant differences in mean values. Individual 
data for each replicate is given in Extended Data Figures 1-9 in the form of scatter plots. P values, for 
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Supplementary Table 3.1: List and features of genetic constructs used in this study.  
pKD31 was a gift from Barry L. Wanner (Addgene plasmid # 45604 ; http://n2t.net/addgene:45604 ; 
RRID:Addgene_45604). pKD461 was obtained from the Coli Genetic Stock Center  
(CGSC, https://cgsc.biology.yale.edu/Site.php?ID=64672).  
pE-FLP2 was a gift from Drew Endy & Keith Shearwin 
(Addgene plasmid # 45978;http://n2t.net/addgene:45978 ; RRID:Addgene_45978). 
The pBEST_OR2-OR1-Pr-UTR1_ClpP-T500 was a gift from Zachary Sun and Richard Murray3. 
pACYC-FLAG-dN6-His4 was a gift from Robert Sauer (Addgene plasmid # 22143 ; 
http://n2t.net/addgene:22143 ; RRID:Addgene_22143) 
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The pTARA backbone was modified to make the araBAD-BCD20-ClpP-BCD17-ClpX and pTEtR-
BCD2-Ana GvpC constructs. pTARA5 was a gift from Kathleen Matthews (Addgene plasmid # 31491; 
http://n2t.net/addgene:31491 ; RRID:Addgene_31491). 
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C h a p t e r  4  
 
ULTRASENSITIVE ULTRASOUND IMAGING OF GENE EXPRESSION 
WITH SIGNAL UNMIXING 
 
This chapter is in large part a reformatted version of the manuscript entitled “Ultrasensitive Ultrasound 
Imaging of Gene Expression with Signal Unmixing” submitted by Sawyer, D. P., Bar-Zion, A., Farhadi, 
A., Lee-Gosselin, A., Shrivaei, S. and Shapiro, M. G. to Nature Methods and currently under peer review. 
Under the supervision of Mikhail Shapiro, my contributions to this work were to conceive, design, and 
conduct the experiments, design and optimize the ultrasound pulse sequence and reconstruction 
algorithm, analyzed the data, and write the manuscript. Thanks to Avinoam Bar-Zion for assisting with 
the preparation of engineered bacterial cells, Arash Farhadi for preparation of the engineered mammalian 
cells, Audrey Lee-Gosselin for assistance with the animal experiments, and Shirin Shrivaei for 
performing the flow cytometry experiments. 
 Additionally, section 4.3.6 includes previously-unpublished data demonstrating the ability of 




Acoustic reporter genes (ARGs) enable biomedical ultrasound to image gene expression in genetically 
modified cells, facilitating the study of cellular function in deep tissues inaccessible with conventional 
optical techniques. ARGs encode air-filled protein nanostructures known as gas vesicles, which scatter 
sound waves, enabling the bacterial or mammalian cells expressing them to be visualized with ultrasound. 
Despite the promise of this technology for biological research and potential clinical applications, the 
sensitivity with which ARG-expressing cells can be visualized is currently limited, with a published 
detection limit for bacteria on the order of 108 cells/ml. Overcoming this limit is critical to enabling the use 
of ARGs in the broadest range of potential applications. Here, we present BURST – an ARG imaging 
paradigm that improves cellular sensitivity by more than 1000-fold. BURST takes advantage of the unique 
temporal signal pattern produced by gas vesicles as they collapse under acoustic pressure above a 
genetically defined threshold. By extracting the unique pattern of this signal from total scattering using 






expressing cells, as demonstrated in vitro and in vivo in the mouse gastrointestinal tract. Furthermore, in 
dilute cell suspensions, BURST imaging enables the detection of gene expression in individual bacteria and 
mammalian cells. The resulting capabilities for ultrasensitive and single-cell imaging greatly expand the 
potential utility of ultrasound for non-invasive imaging of cellular function. 
 
4.2 Introduction 
The green fluorescent protein and its analogs allow biologists to visualize gene expression and other cellular 
processes under an optical microscope1. However, the scattering of light by tissue limits the use of such 
optical reporter genes in intact animals2. In contrast, ultrasound can propagate centimeters deep into 
biological tissues without losing coherence, enabling the noninvasive imaging of whole organs and 
organisms with excellent spatial and temporal resolution (~100 µm and ~1 ms, respectively)3,4. Recently 
the first acoustic reporter genes (ARGs) were developed for ultrasound imaging based on air-filled protein 
nanostructures called gas vesicles, or GVs5. When expressed in bacteria6 or mammalian cells7, ARGs allow 
the location and function of these cells to be visualized with ultrasound deep inside host organisms. 
 One of the main factors determining the utility of reporter genes is the sensitivity with which they 
can be detected. In previous work, ARG expression was detectable in bacteria using conventional 
ultrasound imaging at a concentration of 108 cells/ml6. While this density is relevant for certain in 
vivo scenarios, many applications would benefit from the ability to detect smaller numbers of cells. For 
example, many natural and engineered gastrointestinal (GI) microbes, which play critical roles in health 
and disease, must be studied within the context of the intact mammalian GI tract, which they populate at 
local concentrations spanning several orders of magnitude 8,9,10,11,12,13. Visualizing the spatial dynamics of 
such microbes in vivo requires extending the sensitivity of ARG-based cellular imaging by a factor of 100–
1000 while dealing with background scattering from anatomical structures. Furthermore, in some 
applications, it may be necessary to detect individual genetically labeled cells. Developing such capabilities 
requires large improvements in sensitivity and specificity compared to existing ARG imaging 
techniques14,15,6,7. 
To address this need, we introduce BURST (Burst Ultrasound Reconstructed with Signal Templates) – 
an ultrasensitive imaging paradigm tailored to ARGs, which improves cellular imaging sensitivity by more 
than 1000-fold. BURST imaging exploits the strong, transient signals generated during sudden GV collapse 
under acoustic pressure by unmixing the temporal dynamics of such signals from background scattering. 
Applied to imaging engineered commensal bacteria, BURST detects cells at concentrations below 105 
cells/ml in tissue-mimicking phantoms and visualizes cells during their passage through the mouse GI tract. 






quantitative single-cell imaging. Just as the broad application of fluorescent imaging required major 
advances in both fluorescent proteins and optical detection methods (such as multiphoton microscopy), the 
development of BURST imaging complements recent advances in ARGs to greatly broaden the potential 
applications of biomolecular ultrasound.  
 
4.3 Results 
4.3.1 The BURST paradigm for selective imaging of ARG-expressing cells 
BURST creates GV-specific ultrasound images by exploiting the phenomenon of GV collapse. GVs 
comprise a 2 nm-thick protein shell enclosing a hollow, air-filled compartment with dimensions on the 
order of 200 nm16,17 (Fig. 4.1a, top). GVs self-assemble inside cells from the constituent proteins encoded 
in ARGs6,7. When these nanostructures are exposed to pressures above their genetically defined collapse 
threshold, their shell breaks (Fig. 4.1a, bottom) and their air contents are rapidly dissolved into the 
surrounding media. The collapse of GVs under acoustic pressure generates a strong transient ultrasound 
signal7,18. In BURST imaging, we rapidly acquire a series of ultrasound images during which the transmit 
pressure undergoes a step-change from a value below the GV collapse threshold to above it (Fig. 4.1b). 
This step-change generates a transient collapse-based signal increase in voxels containing GVs, while the 
signal from non-GV linear scatterers steps up and persists with the higher applied pressure (Fig. 4.1b). The 
images acquired during this pulse train combine to form a time-series vector for each voxel in the field of 
view (Fig. 4.1, c-d). In BURST signal processing, we decompose these vectors into weighted sums of 
template vectors representing the expected signal patterns of GVs, linear scatterers and background 
noise/offset, allowing us to generate images specific to each source of signal (Fig. 4.1e). We hypothesized 
that by effectively isolating the strong signal impulse generated by GVs at the moment of their collapse, 
while subtracting background linear contrast, BURST imaging would significantly improve the detection 
sensitivity of GV-expressing cells. Importantly, GV collapse is well-tolerated by both bacterial and 







Figure 4.1 | BURST paradigm. (a) TEM images of intact (top) and collapsed (bottom) GVs from Anabaena flos-
aquae. Scale bars: 100 nm. (b) Illustration of the BURST pulse sequence, showing the step change in applied acoustic 
pressure (top), the resulting transient increase in GV signal (middle) and the persistent increase in linear scatterer 
signal (bottom). (c) Illustration of an image time series generated by the high-pressure segment of the BURST 
sequence applied to a hypothetical target, which consists of scattering tissue with ARG-expressing cells located at the 
center. (d) Illustration of intensity time course for a pixel location in the region containing GVs. (e) Illustration of the 
result of the signal template unmixing algorithm applied to the image timeseries, generating separate images 
representing the contribution of GV signal (left) and linear signal (right) to the recorded image timeseries. 
 
Temporal modulation of contrast agent signals has been used to enhance the detection of synthetic 
ultrasound contrast agents such as microbubbles19 and nanodroplets20, and has formed the basis for 
improved sensitivity and resolution in photoacoustic imaging21,22 and fluorescence microscopy23. However, 
each class of reporters requires a unique approach based on their physical properties. A method like 
BURST, tailored to ARGs, has not been established, and is uniquely enabled by the monodisperse, highly 
nonlinear pressure response of GVs.  
To test the BURST protocol, we prepared gel phantoms containing pairs of rectangular wells filled 
with either ARG-expressing E. coli Nissle cells or red fluorescent protein (RFP)-expressing controls (Fig. 
4.2a). The cells were embedded in an agarose-based tissue-mimicking material (TMM)24 with strong 
linear scatterers providing background contrast. For initial experiments, we used bacteria at a 
concentrations of 107 cells/ml, which is 10-fold lower than the previously published in vitro detection 
limit6. The phantoms were imaged at 6 MHz, using a single-cycle transmit waveform to maximize axial 






needed for GV collapse. Frames were acquired every 9 ms to minimize any impact from motion. In the 
initial low-pressure frame (0.27 MPa PPP), little signal was observed in either well (Fig. 4.2b). In the 
second frame, acquired at the stepped-up pressure of 4.3 MPa, both samples showed significant signal, 
with the ARG-expressing cells enhanced by 9 dB relative to RFP controls. By the next frame, this signal 
difference disappeared, as expected with GV collapse, leaving behind the linear scattering from the 
TMM. 
The temporal pattern of signal in the ARG-expressing well is clearly distinguishable from the RFP 
control (Fig. 4.2c). The former shows a spike in signal in the first high-pressure frame, followed by decay 
to a stable plateau, while the latter shows a simple step-function jump. Using the BURST algorithm, we 
decomposed the signal vector in each well into its contributions from GVs, linear scatterers and noise 
(Fig. 4.2d).  Performing this operation for each pixel in our field of view, we obtained images 
corresponding to each signal type (Fig. 4.2, e-f). The image corresponding to GV-specific signal shows 
very clear contrast between the well containing ARG-expressing cells and the control well, with a 
contrast-to-tissue ratio (CTR) of 32 dB (Fig. 4.2e). Meanwhile, the image corresponding to the linear 
scattering component showed a similar level of signal in each well, consistent with both wells having the 
same cell density and TMM composition (Fig. 4.2f).  
 
Figure 4.2 | BURST imaging of ARG-expressing cells. (a) Illustration of the agarose gel phantom containing cells 
engineered to express RFP or ARG, mixed with tissue-mimicking material (TMM). (b) Representative images from 
frames 1-5 of a BURST sequence applied to a 1% agarose phantom with wells containing TMM mixed with 107 
cells/ml RFP-expressing (left) or ARG-expressing E. coli Nissle cells (right). The acoustic pressure is ramped from 






Scale bars: 2 mm. (c) Mean pixel intensity vs. frame number in ROIs containing RFP or ARG1-expressing cells, 
outlined in (b). (d) Decomposition of the time traces in (c) using the template unmixing algorithm. (e) Output of the 
template unmixing algorithm applied pixel-wise to the full field of view, showing the estimated contribution of GV 
signal to every pixel. (f) Estimated contribution of linear tissue signal to every pixel. (g) Fiberoptic hydrophone 
measurement of the acoustic waveform used in the BURST high-pressure transmit, and the resulting BURST image 
of a phantom identical to the one described in (a). (h) Acoustic waveform for BURST+ and the corresponding image. 
All scale bars: 2 mm. 
 
In addition to our basic BURST paradigm, which uses a single-cycle transmit waveform (Fig. 4.2g), 
we hypothesized that we could further boost detection sensitivity by extending the transmit waveform to 
multiple cycles. This hypothesis is based on the fact that following GV collapse, the air contained inside 
GVs is liberated as free nanobubbles, which can be cavitated with extended pulses18. Such nanobubbles 
normally dissolve on the millisecond timescale, as evidenced by the disappearance of GV contrast by the 
second frame following acoustic collapse (Fig. 4.2b). However, a pulse containing multiple cycles can 
stably cavitate the released nanobubbles, producing additional signal. To test this possibility, we extended 
the transmitted waveform to 3 cycles, naming the resulting imaging mode BURST+ (Fig. 4.2h). The 
measured output of the transducer is slightly extended due to ringdown. The number of cycles was set to 
3 to enable nanobubble cavitation while preserving axial resolution. As hypothesized, ARG-expressing 
Nissle cells (at 107 cells/ml) imaged with BURST+ showed a signal enhancement of 6 dB relative to 
BURST. Detailed acoustic measurements confirmed that the BURST+ signal is predominantly generated 
by sustained stable cavitation of liberated nanobubbles, while BURST signal is generated by more 
transient dynamics (Supplementary Fig. 4.1). 
 
4.3.2 In vitro detection limit for BURST imaging 
To determine the cellular detection limits for BURST and BURST+, we used these techniques to image 
tissue-mimicking agarose phantoms containing ARG-expressing and RFP-expressing E. coli Nissle cells 
at concentrations ranging from 103 cells/ml to 108 cells/ml. In conventional B-mode images, it was 
challenging to make out clear GV contrast at any cell concentration (Fig. 4.3a). However, BURST images 
showed clear GV contrast down to 105 cells/ml (Fig. 4.3b), while BURST+ images showed clear GV 
contrast down to 104 cells/ml (Fig. 4.3c). This represents improvements of 1000-fold and 10,000-fold, 
respectively, over the previously reported detection limit6. Quantification across multiple replicates (Fig. 
4.3d) confirms these detection thresholds with a mean CTR greater than 6 dB.  
BURST and BURST+ signals increased with cell concentration up to approximately 106 cells/ml and 
thereafter plateaued. This plateauing is most likely due to acoustic shielding, in which collapsing GVs 
absorb energy from the acoustic waveform, preventing downstream GV collapse. Due to this effect, 
which increases with cell concentration, full collapse does not occur in the first high-pressure frame at 






weights in template unmixing (Supplementary Fig. 4.2). On the lower end of the concentration range, 
we noted that BURST+ images at 104 cells/ml appeared to show punctate clusters (Fig. 4.3c, second-to-
bottom row). Since, at this dilution, we expect the imaged field of view to contain on the order of 100 
cells, this suggested that BURST+ imaging may be capable of detecting signal from individual cells – a 
possibility examined further below. 
While these experiments used TMM phantoms to identify detection limits relevant for in vivo 
imaging, in certain locations such as major blood vessels or other fluid compartments, the cells may be 
surrounded by a low-scattering medium. In agarose phantoms mimicking such conditions, the unmixed 
signals from ARG-expressing cells were reliably detectable at cell concentrations down to 103 cells/ml 
(Supplementary Fig. 4.3). 
 
Figure 4.3 | Detection sensitivity of BURST imaging. (a-c) Ultrasound images of rectangular wells containing E. 
coli Nissle cells embedded with tissue-mimicking material (TMM) in an agarose phantom. The left well contains cells 
expressing RFP, and the right well contains cells expressing ARG. Rows correspond to cell concentrations ranging 
over six orders of magnitude. (a) B-mode images. (b) BURST images. (c) BURST+ images. The top edge of each 
image corresponds to a depth of 17.5 mm, the bottom to a depth of 23 mm. Scalebars: 2 mm. (d) Mean contrast-to-
tissue ratio (CTR) vs log cell concentration for BURST and BURST+ on TMM-embedded cells. N = 12 wells (4 from 
each of 3 biological replicates). CTR represents the mean intensity of the ARG well relative to the mean intensity of 
the RFP well. Error bars represent SEM. 
 
4.3.3 In vivo BURST imaging of bacterial passage through the small intestine 
Having demonstrated the ability of BURST imaging to provide sensitive imaging of bacterial gene 
expression in vitro, we set out to test the ability of this method to visualize cells in a living animal. Bacteria 
play major roles in the mammalian microbiome, influencing everything from metabolism and immunity to 
neurological function8,9,10,11,12,13. In addition, many synthetic biology efforts are focused on engineering 
bacterial cells to act as diagnostic or therapeutic agents in the GI tract after oral administration13. Previously, 
ARG-expressing E. coli were imaged in the mouse colon after direct rectal injection in clean agarose 






of the small intestine during their passage through this GI segment following oral administration was 
impossible. 
To evaluate the ability of BURST to image cells in vivo following oral administration, we gavaged 
wild-type mice with an attenuated strain of Salmonella typhimurium engineered to express ARGs, or with 
control cells expressing the luminescent LUX operon6 (Fig. 4.4a). No fasting, bicarbonate administration, 
or other pretreatments were used. Two hours later, we acquired BURST images at multiple transverse 
planes covering the abdominal cavity of each mouse. Display images were generated by overlaying 
grayscale B-mode images with heatmaps representing the GV-specific BURST signal (Fig. 4.4, b-e). 
In all but one mouse gavaged with ARG-expressing cells, we observed contiguous patches of supra-
threshold BURST signal with dimensions of approximately 2 mm × 1 mm, located 1 mm below the 
abdominal wall and spanning several contiguous frames in the abdomen (Fig. 4.4b). The anatomical region 
containing this signal corresponds to the expected location of the small intestine25. No significant BURST 
signal was observed in the abdominal cavities of control mice gavaged with LUX-expressing cells (Fig. 
4.4c). Aggregating the mean BURST CTR in the upper abdominal cavity in each image plane across mice 
shows a consistent signal in the ARG-expressing group for all image planes spanning 16 mm to 22 mm 
below the rib cage (Fig. 4.4f). These results validate the ability of BURST imaging to reliably visualize 
ARG expression in live cells passing through the mouse GI tract. 
 
Figure 4.4 | BURST imaging of orally gavaged cells. (a) Illustration of the oral gavage experiment and the expected 
distribution of ARG-expressing cells as viewed in a cross section of the mouse abdomen. (b-c) Coronal BURST 






acquired 2 hours after oral gavage of 2 x 108 ARG-expressing (b) or LUX-expressing (c) S. typhimurium cells. The 
four images correspond to coronal planes 18 mm to 21 mm caudal to the rib cage. (d-e) Magnified images of coronal 
planes directly preceding those in (b-c) (17 mm). (f) BURST CTR as a function of image plane location in mice 
gavaged with ARG-expressing or LUX-expressing cells. The CTR is calculated based the mean intensity of ROIs 
manually drawn to encompass the ventral half of the abdominal cavity. Tissue ROIs encompassed a rectangular region 
in the dorsal half of the abdominal cavity. Error bars represent SEM. N = 4 mice. Asterisks indicate 𝑝 < 0.05. Exact 
permutation test. 
 
4.3.4 BURST+ imaging enables single-cell detection 
The observation of punctate signals in BURST+ images at cell densities of 103 – 104 cells/ml (Fig. 4.3d 
and Supplementary Fig. 4.1) suggested that this imaging method may be capable of detecting signals from 
individual ARG-expressing cells. To test this hypothesis, we used BURST+ to image dilute samples of 
ARG-expressing and RFP-expressing Nissle cells, suspending them in degassed phosphate-buffered saline 
(PBS) at concentrations below 500 cells/ml (Fig. 4.5a). Suspending the cells in liquid buffer allowed us to 
thoroughly degas the medium to eliminate most microscopic air bubbles, which could otherwise act as 
confounding sources of signal. Based on hydrophone measurements of the beam profile of BURST+ 
transmit pulses, we estimated that cells in a 1 mm × 19.5 mm × 2 mm field of view (FOV) would experience 
sufficient pressure to generate collapse-dependent signal. Combining this volume with optical cell counts 
under fluorescence microscopy (for which cells were labeled with a synthetic dye), we could estimate the 
expected ground truth number of cells per image for each cell concentration.  
BURST+ images of ARG-expressing cells showed clear punctate signals, the number of which 
increased with the cell concentration (Fig. 4.5b). In contrast, RFP-expressing controls rarely showed any 
such signals (Fig. 4.5c). To quantify the number of signal sources in our field of view, we counted all 
contiguous signals distinct from background noise, regardless of their size. In suspensions of ARG-
expressing cells, the number of distinct sources increased linearly with cell concentration (R=0.86) and 
closely matched the number of cells expected from optical counting (Fig. 4.5d). In contrast, RFP-expressing 
controls had few signals and no significant dependence on cell concentration (R=0.08). 
Following the successful single-cell imaging of bacterial cells, we tested the ability of BURST 
imaging to detect GV expression in individual mammalian cells, which are larger than bacteria but have 
lower GV expression levels7. We imaged suspensions of HEK cells genetically engineered to express 
either mammalian acoustic reporter genes (mARGs), or the control fluorophore mCherry. Cell 
concentrations were measured with optical cytometry. Punctate signal sources could clearly be seen in 
BURST+ images of suspended mARG-expressing cells, with the number of such sources increasing 
linearly with cell concentration (R=0.79) (Fig. 4.5e). Similar sources were rarely seen with mCherry 
control cells, and their number did not correlate with cell concentration (R=0.07) (Fig. 4.5f). The number 






expected based on optical counting. We suspect that this discrepancy arose due to the heterogeneity of 
gene expression in this cell line (in which, unlike the bacterial samples, we have no way to pre-select cells 
for imaging based on ascertained GV expression). Nevertheless, the fact that the number of punctate 
signals was of the expected order of magnitude and scaled linearly with concentration demonstrates that 
BURST+ detects single-cell signals from both ARG expressing bacteria and mammalian cells. 
 
Figure 4.5 | Single cell imaging using BURST. (a) Illustration of the experimental setup, in which bacterial or 
mammalian cells are suspended in liquid at dilute concentrations while being imaged in the focal zone of the 
transducer. (b) Representative BURST+ images showing single sources in liquid buffer suspension of ARG-
expressing E. coli Nissle cells at the indicated concentrations. (c) Representative BURST+ images of RFP-expressing 
E. coli Nissle cells. (d) Average number of single sources counted in images acquired with BURST+ vs. cell 
concentration for ARG- and RFP-expressing E. coli Nissle cells. Error bars represent SEM. N = 3 biological replicates. 
Mean counts from 5 frames were used for each biological replicate. A independent estimate of the expected number 
of cells in the transducer’s field of view, based on cell counting by fluorescence microscopy, is also plotted for 
comparison. (e) Representative BURST+ images of suspended mARG-expressing HEK cells at the indicated 
concentrations. (f) Representative BURST+ images of mCherry-expressing HEK cells. (g) Average number of single 
sources counted in images acquired with BURST+ vs. cell concentration for mARG and mCherry-expressing HEK 
cells. Error bars represent SEM for N = 4 biological replicates. Mean counts from 5 frames were used for each 
biological replicate. 
  
4.3.5 BURST imaging preserves cell viability 
For BURST imaging of ARG-expressing cells to enable long-term studies with multiple imaging time 
points, it is important for this imaging mode to preserve the viability of imaged cells. To assess the 
cytocompatibility of BURST imaging, we quantified the viability of bacterial and mammalian cells after 






population growth and confirm ARG re-expression after imaging, we cultured ARG Nissle as colonies 
embedded in soft hydrogel media and applied BURST+ to half the sample (Fig. 4.6a). After 23 hours, 
colony growth was indistinguishable on the ultrasound-treated and untreated halves of the sample, as 
visualized with optical microscopy (Fig. 4.6, b-e). Moreover, strong GV-specific BURST+ signal was 
observed from the colonies with BURST+ imaging at this time point, confirming GV re-expression 
(Supplementary Fig. 4.4). Similar results were obtained with two additional plates. 
 
Figure 4.6 | Effects of BURST imaging on cell viability. (a) Darkfield optical image of ARG-expressing E. coli 
Nissle colonies on an agar plate 15 h after seeding. Width of 1 square is 12.7 mm. (b) Image of the same plate 23 h 
after application of BURST+ to the bottom half. (c) Representative magnified images of colonies from the top half of 
the plate in (a) (left) and (b) (right). (d) Representative magnified images of colonies from the bottom half of the plate 
in (a) (left) and (b) (right). (e) Area of colonies exposed or not exposed to BURST+ at the 38 hour time point. (f) 
Illustration of the experimental setup for single-cell viability. An acoustic cuvette with mylar windows is filled with 
1% agarose and submerged in a water tank. A 2 mm diameter cylindrical inclusion in the agarose is filled with a 
suspension of GV-expressing cells (1×105 ARG Nissle cells/ml or 2.5×105 mARG HEK cells/ml) and imaged with 
BURST, BURST+, or 0.3 MPa B-mode as a control. (g) Representative BURST and BURST+ images of ARG Nissle 
samples overlaid on a grayscale B-mode image. The edges of the cylindrical inclusion are indicated with dashed white 
lines. Scale bars: 2 mm. (h) Colony forming units of ARG-expressing E. coli Nissle cells for the samples exposed to 
BURST and BURST+ relative to B-mode controls. Error bars represent SEM. N = 12 samples from 6 biological 
replicates. Approximate permutation test with 107 permutations. (i) Viable mARG-expressing HEK cells, as measured 
by flow cytometry, after exposure to BURST and BURST+, relative to B-mode controls. Error bars: SEM. N = 3 
biological replicates. Exact permutation test. 
 
 To assess the impact of BURST and BURST+ imaging on bacterial cells in liquid suspension, we 
loaded ARG-expressing Nissle cells into a 2 mm cylindrical well within an agarose phantom (Fig. 4.6f) 






bacteria on selective solid media and counting the number of colonies formed after 20 hours. Both BURST 
and BURST+ produced a measurable decrease in the number of bacterial colonies relative to low-pressure 
controls, with an average reduction of 21% for BURST and 44% for BURST+ (Fig. 4.6h). This reduction 
may be indicative of the different acoustic or mechanical conditions experienced by individual cells in 
liquid compared to solid bacterial colonies, where no viability effects were observed. The colony results 
are arguably more relevant to most envisioned applications involving BURST imaging of bacteria inside 
mammalian hosts, where these cells typically inhabit crowded solid or gel-like environments40,4212. In 
addition, even in the liquid scenario, the exponential proliferation and saturating growth of bacteria would 
quickly make up for a modest reduction in the number of viable cells upon imaging. 
 To test the effects of BURST and BURST+ on the viability of mARG-expressing mammalian cells, 
we exposed liquid suspensions of mARG-expressing HEK cells to these imaging modes in the same 
apparatus as described above for bacteria. Following ultrasound exposure, we counted the number of live 
(metabolically active) and dead cells using flow cytometry. We observed no significant difference in the 
viability of cells exposed to either BURST or BURST+ relative to the low-pressure controls (Fig. 4.6i). 
The robustness of mammalian cells to these imaging modes may be due to the relatively small fraction of 
their cytosol being occupied by GVs7 (<0.003%, compared to up to 10% for bacteria). Altogether, these 
results demonstrate that BURST and BURST+ preserve cellular viability to a level acceptable for most 
biological imaging applications. 
4.3.6 BURST+ imaging enables detection of single gas vesicles 
The successful detection of single ARG-expressing cells in BURST+ images (Fig. 4.5) demonstrated that 
this imaging method is capable of detecting signals from small numbers of GVs closely packed inside 
cells, but did not establish the minimum number of GVs per voxel required to generate detectable signal. 
To investigate this question, we used an experimental setup similar to that described in Section 4.3.4 to 
acquire BURST+ images of GVs purified from Anabaena flos-aquae cyanobacteria (Ana GVs)26 at 
varying concentrations in the range of 102-103 GVs/ml, using pre-collapsed Ana GVs as controls. Because 
the gas inside free Ana GVs is known to equilibrate with the gas concentration in the surrounding 
medium in as little as 46 µs16, exposing the GVs to degassed buffer would result in the pressure inside the 
GVs dropping below atmospheric pressure, potentially causing pre-mature collapse or loss of some 
acoustic properties. Based on these considerations, we chose not to degas the liquid buffer used in this 
experiment. To estimate the expected number of gas vesicles in the FOV for each concentration, we 
measured the optical density (OD) of our sample and used a previously-published conversion factor 






BURST+ images of intact GVs showed clear punctate signals, the number of which increased with the 
GV concentration (Fig. 4.7a). In contrast, collapsed GV controls showed a consistently small number of 
such signals that did not increase with GV concentration (Fig. 4.7b). The larger number of punctate signals 
observed in the control condition of this experiment (1.3 ± 1.2 signals/frame) compared with the single-cell 
detection experiment (0.3 ± 0.6) signals/frame) is expected based on our use of non-degassed buffer. In 
suspensions of intact Ana GVs, the number of distinct sources increased linearly with cell concentration (R 
= 0.83) and closely matched the number of GVs expected from electron microscopy counting (Fig. 4.7c). 
In contrast, collapsed controls had few signals and no significant dependence on cell concentration (R = -
0.16). These results demonstrate that BURST+ detects signals from single Ana GVs. 
 
 Figure 4.7 | Single gas vesicle 
imaging using BURST. (a) 
Representative BURST+ images 
showing single sources in liquid 
buffer suspension of intact gas 
vesicles purified from Anabaena 
flos-aquae cyanobacteria (Ana 
GVs) at the indicated 
concentrations. (b) 
Representative BURST+ images 
of pre-collapsed Ana GVs. (c) 
Average number of single 
sources counted in images 
acquired with BURST+ vs. GV 
concentration for intact and 
collapsed Ana GVs. Error bars 
represent SEM. N = 5 replicates. 
An independent estimate of the 
expected number of GVs in the 
transducer’s field of view, based 
on GV counting under electron 






Taken together, the results of this study demonstrate the ability of the BURST imaging paradigm to provide 
ultrasensitive ultrasound imaging of gene expression with an improvement of more than 1000-fold 
compared to the state of the art. BURST achieves this unprecedented sensitivity by taking advantage of the 






surrounding and co-localized scatterers using a simple linear algorithm. This advance complements rapidly 
progressing efforts to develop and apply ARGs and GVs to a broad range of biological applications4,6,7,18, 
27,28,29 and will immediately enable the imaging of these acoustic biomolecules with dramatically increased 
sensitivity and specificity without changes to their composition. Moreover, we expect the sensitivity of 
BURST to lower the barrier for initial applications of ARG-based imaging in challenging settings by 
facilitating the detection of low ARG expression levels or small ARG-labeled cell densities.  
Several future improvements would help BURST imaging achieve widespread use. First, to enable 
rapid BURST imaging over a large field of view, it would be useful to develop ultrasound imaging 
transducers capable of higher transmit pressures. In the present study, transmitted beams had to be focused 
to a relatively small section of the available field of view to achieve the pressure needed to generate BURST 
signals. With stronger transducers, less focusing would be required, allowing more efficient scanning. At 
the same time, the pressure requirement could be reduced by engineering ARGs to encode GVs with lower 
critical collapse pressures. For example, the acoustic collapse mid-point of the ARGs used in this study is 
2.7 MPa6, whereas certain engineered GVs collapse at pressures below 0.6 MPa27. Lower pressure would 
also be expected to mitigate the already-minor effects of BURST imaging on cell viability, which itself 
should be extended to investigate other potential cellular side-effects in specific application scenarios. 
More broadly, the BURST paradigm presented in this work demonstrates the potential of novel imaging 
techniques, developed in parallel with biological reagents, to expand the scope of GV and ARG capabilities. 
The engineering of fluorescent proteins with improved and novel properties, such as selective 
photoactivation1,30, went hand-in-hand with complementary innovations in microscopy and image 
processing, such as PALM31, STORM32, and light sheet microscopy33, resulting in ever-improving 
resolution, scale, and information content. We envision a similar synergy in the evolution of acoustic 
proteins and ultrasound imaging techniques. 
 
4.5 Methods 
4.5.1 Bacterial expression 
Plasmids encoding ARGs were transformed into chemically competent E. coli Nissle 1917 (Ardeypharm 
GmbH) and grown in 5 ml starter cultures in LB medium with 50 µg/ml kanamycin, 2% glucose for 16 h 
at 37 °C. Large-scale cultures in LB medium containing 50 µg/ml kanamycin and 0.2% glucose were 
inoculated at a ratio of 1:100 with the starter culture. Cells were grown at 37 °C to OD600nm = 0.3, then 
induced with 3 µM IPTG. Cells were cultured for 22 h at 30 °C, then centrifugated for 4 hours at 150 x g 






agarose phantoms. Neutrally buoyant cells in the supernatant below the buoyant fraction were used for all 
other experiments involving ARG-expressing Nissle cells. The same expression protocol was followed to 
produce mRFP-expressing Nissle cells, except that cells were resuspended from the pellet in PBS following 
centrifugation. 
GV-expressing Salmonella typhimurium of the attenuated, tumor-homing strain ELH130134 were 
produced by transforming cells with a plasmid encoding an engineered genetic construct comprising either 
a GV operon or, as a control, a NanoLuc luciferase. Constructs were assembled using Gibson cloning. The 
genetic constructs were cloned into the pTD103 plasmid (gift from J. Hasty), with expression driven by a 
luxI promoter upon induction with 3nM N-(β-ketocaproyl)-l- homoserine lactone (AHL). The cells were 
cultured for 24 hours at 30 °C after induction, then centrifugated for 4 hours at 150 x g and 4 °C to enrich 
for buoyant cells. Cells in the buoyant fraction were used for in vivo experiments. 
In experiments employing multiple bacterial biological replicates, replicates correspond to cells 
cultured from separate colonies from the same transformation. 
4.5.2 Mammalian cell expression 
mARG-expressing and mCherry-expressing HEK cells were previously described7. Briefly, HEK293tetON 
cells were genetically engineered with mARG gene cassettes (Addgene 134343, 134344 and 134345) using 
the piggyBac transposase system and a monoclonal culture was created by flow cytometry (BD FACSAria 
III). Similarly, mCherry-expressing cells were created by genetically engineering HEK293tetON cells with 
mCherry using the piggyBac transposase system. Cell cultures were maintained in DMEM supplemented 
with 10% tetracycline-free FBS (Clontech) and penicillin/streptomycin. For BURST imaging, both cells 
were seeded in 10 cm plates, and once they reached 70-80% confluency treated with 1 µg/mL doxycycline 
and 5 mM sodium butyrate for 72 hours. Cells were then trypsinized and resuspended in media before being 
stained 1:1 with Trypan blue dye and counted using a disposable hemocytometer (C-chip DHC S02, Incyto) 
under a brightfield microscope.  
4.5.3 Ultrasound pulse sequence and data acquisition 
Ultrasound imaging for all experiments was performed using a Verasonics Vantage programmable 
ultrasound scanning system. In vitro experiments were done using an L10-4v 128-element linear array 
transducer (Verasonics). Image acquisition was performed using a custom imaging script with a 64-ray-
lines protocol with a synthetic aperture of 65 elements to form a focused excitation beam. The 
programmable transmit focus was set to 20 mm to be aligned with the fixed elevation focus of the 
transducer. The transmit waveform was set to a frequency of 6 MHz, 67% intra-pulse duty cycle resulting 






= 1.6 V, peak positive pressure = 0.27 MPa) followed by five high-pressure frames (transducer voltage = 
50 V, peak positive pressure = 4.3 MPa). The frame rate was 111 Hz. A similar imaging sequence was used 
for the in vivo experiments, with some modifications detailed below in the relevant section.  
4.5.4 BURST processing algorithm 
BURST images are generated by applying a temporal template unmixing algorithm across individual 
pixel locations in the frame stack. The input to the algorithm at the single pixel level consists of a 6-
element vector, corresponding to pixel values in each frame. The parameters of the algorithm are the 
following template vectors for GVs (𝒖𝒈 = [0	1	0	0	0	0]O), linear scatterers (𝒖𝒔 = [0	1	1	1	1	1]O) and 
offset (𝒖𝒐 = [1	1	1	1	1	1]O).  
The template unmixing model is represented by the linear equation 𝑼𝒘 = 𝒑, where the template 
vectors are concatenated into the template matrix 𝑼 = [𝒖𝒔	𝒖𝒐	𝒖𝒈], and 𝒘 contains the weights for each 
template. For each pixel vector 𝒑, least squares solution for the template weights is obtained by the 
pseudoinverse: 
𝒘 = (𝑼O𝑼)h𝟏𝑼O𝒑 
 The 𝑤 component of 𝒘 = 𝑤	𝑤	𝑤 was selected as the output of the algorithm. More generally, 
𝑼 can be an 𝑛 ×𝑚 matrix, where 𝑛 is the length of 𝒑 and the number of image frames and 𝑚 is the length 
of 𝒘 and the number of signal templates. 
In theory, because negative weights have no meaning in this model, a proper estimation of the template 
weights would require the appropriate constrained linear least squares solution, which is typically two 
orders of magnitude slower to compute. However, it was found empirically that setting all negative values 
of the unconstrained solution to zero results in a final image that is not appreciably different from that 
obtained using the constrained solution. The template unmixing algorithm was applied offline to acquired 
BURST data. All image processing was implemented in MATLAB. 
4.5.5 In vitro phantom imaging 
Phantoms for imaging were prepared by melting 1% (w/v) agarose in PBS and casting wells using a custom 
3D-printed template with 48 wells with dimensions of 6 mm × 5 mm × 2 mm. ARG- and RFP-expressing 
Nissle cells (at 2× the final concentration and at 25 °C) were mixed in a 1:1 ratio with molten agarose or 
molten TMM (at 2× the final concentration and at 56 °C) and immediately loaded into the phantom. The 
concentration of cells was determined before diluting and loading by measuring their OD600nm. TMM 
consisted of 1% (w/v) agarose, 0.53% (w/v) 37 µm silicon carbide, 0.94% (w/v) 3 µm aluminum oxide, 






et al. (2001)24 but with lower agarose content and no glycerol or antibiotic. Special care was taken to 
thoroughly degas the molten agarose to reduce the number of microbubbles present in the gel. 
4.5.6 In vivo imaging 
All in vivo experiments were performed on female BALB/cJ mice under a protocol approved by the 
Institutional Animal Care and Use Committee of the California Institute of Technology. No randomization 
or blinding were necessary in this study. Mice were anesthetized with 1–2% isoflurane, maintained at 37 °C 
on a heating pad, depilated over the imaged region, and imaged using an L11-4v transducer attached to a 
manipulator. For imaging of gavaged Salmonella typhimurium in the gastrointestinal tract, mice were 
placed in a supine position, with the ultrasound transducer positioned over the upper abdomen such that the 
transmit focus of 12 mm was close to the top of the abdominal wall. Two hours prior to imaging, mice were 
gavaged with 200 µl of buoyancy-enriched Salmonella typhimurium at a concentration of 109 cells/ml. 
To mitigate tissue motion during in vivo imaging, a rapid BURST script was implemented that transmits 
and acquires three 32-element aperture focused beams at a time, improving the frame rate by a factor of 3 
to 333 Hz. To maximize spatial resolution, the transmit waveform was set to a frequency of 11.4 MHz. The 
transmit focus was set at 12 mm to match the expected location of the small intestine relative to the 
transducer, which had to be positioned in relatively close proximity to maintain acoustic coupling. 
Prior to processing with template unmixing, a 2 × 2 median filter followed by a gaussian blur filter with 
σ = 1 was applied to each 2D image frame of each image plane of each mouse. The images output from 
template unmixing were then concatenated into a 3D array to which a 1 × 1 × 3 median filter was applied 
to remove isolated motion artifacts. The resulting 2D BURST images were then dB-scaled and overlaid on 
the square-root-scaled B-mode image representing frame 1 in the corresponding timeseries. The BURST 
images were overlaid in locations where the BURST image pixel values exceeded a threshold of 105 dB, 
which was chosen as the minimum threshold at which no residual motion artifacts were visible in the dorsal 
half of the abdominal cavity, where no BURST signal was expected. BURST images were pseudo-colored 
with the hot colormap and B-mode images with the gray colormap. Quantification was performed by 
manually drawing an ROI covering the ventral half of the abdominal cavity in each image plane for each 
mouse. 
4.5.7 Single-source counting 
Hydrophone measurements of the ultrasound transducer’s acoustic field were used to estimate the out-of-
plane dimension of the 3D field-of-view (FOV) in which ARG-expressing cells are expected to experience 
collapse dependent signal (2 mm). The out-of-plane FOV boundaries were defined as the displacement at 






ARGs used in this study6. These measurements were performed using a fiber-optic hydrophone system with 
a tapered sensor tip (Precision Acoustics) immersed in a tank filled with water that had been conditioned 
overnight using an AQUAS-10 water conditioner (Onda). The lateral dimension of the FOV (19.5 mm) was 
determined by the number of ray lines used to form the ultrasound image. The axial dimension (1 mm) was 
set by restricting the axial region of the BURST images displayed for counting to this size, which was 
chosen to cover the region around the transducer focus over which the mean BURST signal intensity was 
relatively constant. 
Prior to counting, cells were diluted to an estimated 106 cells/ml and were then incubated at 25 °C for 
30 min with BacLight Green fluorescent dye (Invitrogen). 10 µl of the cell suspension was loaded onto a 
C-Chip hemocytometer (SKC, Inc.) and cells were counted at 10x magnification with an Observer.A1 
microscope (Zeiss). 
For validation of single-cell detection, the L10-4v transducer was mounted on a BiSlide computer-
controlled 3D translatable stage (Velmex) above a 4 L container containing 3.8 L water that had been 
circulated through the water conditioner for 1 hour. 200 ml of 20x PBS was then gently added to the water, 
with the mouth of the PBS-containing bottle at the level of the surface of the water to avoid creating bubbles. 
A piece of acoustic absorber material was placed at the bottom of the bucket to reduce reflections. A 
MATLAB script was written to control the Verasonics system in tandem with the BiSlide stage, which was 
programmed to move 1 cm after each BURST+ acquisition. After each set of BURST+ acquisitions (starting 
with plain PBS), 30 µl of 106 cells/ml ARG-expressing Nissle cell suspension was added to the bucket, 
which was gently stirred with a glass rod. A separate bucket with freshly conditioned water and buffer was 
used for the RFP control cells. 
 We wrote a MATLAB script to display a 1 mm × 19.5 mm segment, centered at the point of highest 
average intensity, of all BURST images (all replicates, all concentrations, and RFP vs. ARG cells) in a 
random order, blinding the experimenter to the condition when performing source counting. 
4.5.8 Collapse signal characterization 
Collapse signal characterization experiments were performed with the same liquid buffer suspension setup 
and protocol used for single-source validation, apart from the variations in sequence parameters described 
in Supplementary Fig. 4.1. 
To capture the sub-millisecond dissolution times of the nanobubbles, an ultrafast version of the 
BURST+ pulse sequence was implemented in which the full timeseries of low- and high-pressure 






between frames for any given location in the image at the expense of significantly longer delays between 
separate ray lines.  
4.5.9 Bacterial colony growth assay 
ARG Nissle cells were transformed as described above. The transformation mix after recovery was plated 
on a 4-layer LB-Agar plate. In addition to LB and 50 µg/ml kanamycin, the first (bottom) layer contained 
1% agarose and 7.5 µM IPTG; the second layer 1% agarose and 1% glucose; and the third layer 0.25% 
agarose, 1% glucose, and 10 cells/ml of the transformed Nissle. The fourth (top) layer contained 0.25% 
agarose in PBS with 1% glucose and 50 µg/ml kanamycin. The first and second layers were 4 mm thick 
and the third and fourth layers were 1 mm thick. 
 After culturing for 15 h at 30 °C, a darkfield optical image of the plate was acquired using a gel 
imager (BioRad). The plate was then immersed in PBS to allow acoustic coupling to the L10-4v transducer. 
The transducer was connected to the BiSlide motor stage and aligned perpendicular to the plane of the plate 
at a distance of 20 mm from the LB-Agar layer containing the ARG-expressing colonies. One half of the 
plate was exposed to BURST+ by applying the sequence to planes spaced by 1 mm across the plate. The 
plate was incubated for an additional 23 h at 30 °C. 
 A second darkfield optical image of the plate was acquired following the second round of 
incubation. The BURST+ plate scan was then repeated to obtain images confirming GV re-expression. 
4.5.10 Bacterial colony-forming assay 
Neutrally buoyant ARG Nissle cells were exposed to ultrasound inside cylindrical inclusions in agarose gel 
in 3D-printed acoustic cuvettes with windows covered by mylar. Each cuvette was filled with molten 1% 
agarose gel and a 3D-printed cylindrical plug was used to cast a cylindrical inclusion with 40 mm length 
and 2 mm diameter. Each ARG Nissle sample was diluted to 105 cells/ml in PBS. 50 µL of the resulting 
suspension was loaded into the inclusion in the acoustic cuvette, which was placed in a water tank. The 
L10-4v transducer was attached to an XSlide translatable motor stage (Velmex), submerged in a water tank, 
and aligned such that the 20 mm transducer focus was positioned at the center of the inclusion. A single 
pulse sequence was applied to each sample, using either BURST+, BURST, or, in the control case, B-mode 
with 3 cycles and a PPP of 0.3 MPa. 20 µL of sample was then extracted from the inclusion and diluted 
with PBS to 104 cells/ml. 100 µL of this dilution was plated on Lennox LB agar with 50 µg/ml kanamycin 
and 2% glucose. Plates were incubated for 20 hours at 30 °C. 
Cell viability was measured by counting the number of colonies formed from samples exposed to 
BURST or BURST+ and dividing by the number of colonies formed from the same biological replicate 






4.5.11 Mammalian cell viability assay 
HEK cells from an mARG-expressing cell line were trypsinized and pelleted by centrifugation at 400 
g for 4 min at 4 °C. The pelleted cells were then resuspended in PBS and diluted to a concentration of 
2.5×105 cells/ml. These samples were then exposed to ultrasound and collected with the same protocol used 
for ARG-expressing bacteria described above. 
After ultrasound exposure, cells were stained with Zombie NIR viability dye (BioLegend Inc.) 
following the manufacturer’s protocol. Relative cell death was measured using the Beckman Coutler 
Cytoflex Flow Cytometer (Beckman Coutler Inc.) based on Zombie NIR fluorescence. This assay was 
validated with a positive control condition in which HEK cells were incubated at 80 °C for 1 minute, 
resulting in 100% measured cell death. 
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4.6 Supplementary Material 
 
 
Supplementary Figure 4.1 | Collapse signal generation mechanism. The imaging target for all panels is ARG E. 
coli Nissle at 103 cells/ml in suspension. All images are displayed in dB scale with the same colormap shown in the 
bottom right of panel (g) (min: 0 dB, max: 80 dB). All scalebars are 2 mm. (a) Distribution of BURST ray line peak 
intensities (i.e. maxima over columns of pixels) for PPP = 4.3 MPa. N = 650. (b) Distribution of BURST+ ray line 
peak intensities for PPP = 4.3 MPa. N = 650. (c) BURST pressure ramp images with PPP ranging from 3.4 MPa to 
4.3 MPa. (d) BURST+ pressure ramp with the same pressures as in (c). (e) Peak image intensity vs PPP for BURST 
and BURST+. Error bars: SEM. N = 10 BURST acquisitions. (f) Image time series acquired with an ultrafast 
implementation of BURST+, with 1 frame/100 µsec, at 4.3 MPa. (g) Cycle ramp images with the number of transmit 
waveform cycles ranging from 0.5 cycles to 10.5 cycles and PPP held constant at 4.0 MPa. (h) Mean intensity of cycle 
ramp images vs. depth. Traces are averaged over 10 replicates. Error bars not shown for clarity. (i) Proposed 
mechanism to account for the presence of dim signals, but not bright signals, in BURST. (j)  Proposed mechanism to 








Supplementary Figure 4.2 | Acoustic shielding in BURST sequence at high ARG-expressing cell concentration. 
(a) Images from the high-pressure frames (frames 2-5) of a BURST+ sequence applied to a 1% agarose phantom with 
wells containing tissue-mimicking scatterers mixed with 108 cells/ml RFP-expressing E. coli Nissle (left) and ARG-
expressing E. coli Nissle (right). Scale bars: 2 mm. (b) Mean pixel intensity vs. frame number for the ARG well, 




Supplementary Figure 4.3 | In vitro BURST imaging of ARG-expressing bacteria in plain agarose gel. (a-c) 
Array of ultrasound images of a cross section of rectangular wells containing Nissle E. coli embedded in 1% agarose 
wells within an agarose phantom. Each image contains a pair of wells, the left well containing RFP-expressing Nissle, 
the right well containing ARG-expressing Nissle. Rows correspond to cell concentrations, which range over six orders 
of magnitude. (a) B-mode images. (b) BURST images. (c) BURST+ images. The top edge of each image corresponds 
to a depth of 17.5 mm, the bottom to a depth of 23 mm. The left edge of each image corresponds to a lateral coordinate 
of -7 mm, the right to +7 mm. Scalebars: 2 mm. (d) Mean CTR vs log cell concentration for BURST and BURST+ 
on agarose-embedded cells. N = 12 wells, 4 from each of 3 biological replicates. CTR values represent the mean 







Supplementary Figure 4.4 | ARG Nissle colonies continue to grow and re-express GVs after exposure to 
BURST+. (a) Darkfield optical images of the half of the plate exposed to BURST+ after incubation at 30 °C for a 
total of 15 h (top) and 38 h (bottom). (b) BURST+ composite ultrasound images of the plate after 15 h (top) and 38 h 
(bottom), with the first collapse frame removed prior to template unmixing to reduce BURST signal area and allow 
easy comparison of signal spatial distribution with the optical image. The composite image was formed by taking the 
maximum of each BURST image plane along the axial dimension and concatenating the resulting rows of pixels to 
form 2D composite image. Prior to dB scaling, a 3×3 median filter was applied to the composite image, followed by 
a Gaussian filter with σ = 1. (c) The same BURST+ ultrasound images with all frames included in template unmixing. 
Due to the extremely high concentration of GV-expressing cells in the colonies, the BURST signal generated in the 
first collapse frame has an area significantly larger than the colony itself. This spatial broadening could be caused by 
the increased probability of a sufficient number of GVs stochastically collapsing at a lower pressure, thereby 








Supplementary Figure 4.5 | Gating strategy for quantifying cell death in mArg-HEK cells. (a) SSC-FSC gating 
for cell populations exposed to BURST+, BURST, and low-pressure control. (b) The corresponding Zombie NIR 
fluorescence histograms for each population. Cell death was quantified by gating the fraction of cells that emitted 
Zombie NIR fluorescence. The cutoff was the same for all samples. 
 
Supplementary Note 1: Collapse signal generation mechanism  
In performing the single cell detection experiments, we observed that the BURST signals from single cells 
tended to fall into two distinct categories: small, point-like “dim” signals of moderate intensity between 20 
dB and 60 dB, and larger, elongated “bright” signals with intensities of 60 dB to 80 dB (Fig 4.5, b, e). 
Analysis of the signal intensity distributions for BURST and BURST+ applied to cells in liquid suspension 
revealed that BURST generated predominantly dim signals (Supplementary Fig. 4.1a) and that BURST+ 
generated predominantly bright signals, though dim signals were also present (Supplementary Fig. 4.1b). 
An understanding of the mechanisms behind these acoustic phenomena would allow us to better predict the 
performance of BURST and BURST+ in novel settings.  
As a starting point for investigation, we hypothesized three mechanisms by which acoustic collapse of 
GVs might result in strong, transient ultrasound signal: 1) the same linear scattering that creates contrast 
when imaging below the collapse threshold of the GV, 2) an acoustic wave generated by the rapid volume 






collapse. In the case of (1), the signal strength is due to an increase in scattering amplitude in proportion to 
the higher pressures applied, while the signal transience is explained by collapse of the GVs after the initial 
scattering event. For (3), signal transience would result from the sub-millisecond dissolution times of the 
nanobubbles. 
 To test these hypotheses, we imaged ARG Nissle in liquid buffer suspension at 103 cells/ml with a 
range of pulse sequences differing in pressure level, number of waveform cycles, and frame rate. We used 
the same setup and sample preparation protocol used for the single cell detection experiments. We first 
applied a pressure ramp with BURST and BURST+ to determine the pressure threshold at which different 
signal intensities are generated for each pulse sequence. Dim signals appeared in the BURST images at 3.7 
MPa, but remained very sparse up to 3.9 MPa (Supplementary Fig. 4.1c). Bright signals did not appear in 
any BURST images. Both dim signals and bright signals appeared in BURST+ images at 3.4 MPa, although 
bright signals were very sparse, with less than one per frame at this pressure. Bright signals appeared 
consistently in BURST+ frames at 3.9 MPa and gradually increased in number at higher pressures 
(Supplementary Fig. 4.1d). Since BURST and BURST+ have identical pressure maxima and minima, 
these results suggest the larger number of cycles in BURST+ is necessary for the generation of bright signals 
and increases the generation of dim signals. Interestingly, although the 50% acoustic collapse pressure 
threshold of GVs expressed in ARG Nissle is 2.5 MPa, neither pulse sequence generated observable signal 
at 2.8 MPa. One explanation for this is that GV collapse is a stochastic event that occurs with probability 
proportional to both PPP and duration of insonation. However, both bright and dim signals are only 
observed in the first collapse frame for all pressure levels, which suggests that all GVs in the field of view 
collapse after the first pulse but, depending on the pulse parameters and GV characteristics, may not 
generate signal. This suggests that mechanism (2) is unlikely for bright or dim signals since it predicts that 
GV collapse is a sufficient condition for signal generation. 
Although both bright and dim signals increased in number at higher pressures (Supplementary Fig. 
4.1c-d), the peak intensity of the bright signals increased in direct proportion to the increase in pressure 
(Supplementary Fig. 4.1e). The number of dim signals, in contrast, increased with pressure while their 
intensity remained relatively constant up to 4.1 MPa. If the dim signals were generated by mechanism (1), 
we would expect to observe the opposite: there should be scattering from all cells in the field of view at an 
intensity that increases proportionally with incident pressure. Instead, our observations are consistent with 
a stochastic collapse model in which GVs in a given cell generate collapse signal with a probability 
proportional to the peak positive acoustic pressure. The stochasticity may be intrinsic to the physical process 
of collapse or may result from variability in shape, size, and number of expressed GVs. In either case, we 






bright and dim signals are generated from mechanism (3): the interaction of liberated nanobubbles with the 
high-pressure acoustic waveform. However, this does not explain their markedly different characteristics.   
 To investigate the temporal properties of the bright and dim signals, we designed an ultrafast 
implementation of BURST+ with an inter-frame delay of 100 µsec. Although both bright and dim signals 
appear transient in the standard BURST+ pulse sequence with an inter-frame delay on the order of 10 msec, 
the ultrafast sequence showed that many bright signals persist after several high-pressure transmits 
(Supplementary Fig. 4.1f). In contrast, the band of dim signals always vanishes after the first high-pressure 
frame. Because mechanisms (1) and (2) depend on an irreversible collapse of the GV shell, this provides 
further evidence against their involvement in generation of the bright signals. 
To obtain a tighter upper bound on the persistence time of the dim signals, we applied a cycle ramp 
with numbers of cycles ranging from 1 to 12. We held PPP constant at 4.0 MPa for each pulse sequence 
since this pressure level maximized visibility of individual bright and dim sources in the same frame. Both 
the intensity and size of the bright signals increased in proportion to the number of cycles (Supplementary 
Fig. 4.1g-h) Interestingly, after 2 cycles, more cycles did not obviously increase the number of either bright 
or dim signals (Supplementary Fig. 4.1g), suggesting a regime change in the signal generation mechanism 
caused by the presence of more than one cycle. The size of the dim signals, in contrast, did not change with 
the number of cycles, remaining at approximately the size of 1 wavelength (250 µm in this case). This 
implies that if the dim sources are generated by microbubbles, their dissolution times must be less than 500 
nsec.  
Physical modeling of GV collapse and nanobubble nucleation, dissolution, and cavitation will likely be 
required to elucidate the differences between the bright and dim signal generation mechanisms. While such 
modeling is beyond the scope of this work, we propose here a qualitative model that may account for our 
observations. It has been shown that, when insonated at 5 MHz with PPP > 4 MPa, microbubbles below a 
threshold radius of 800 nm decay as 1/𝑅  while larger bubbles undergo resonance enhancement35, 
increasing in size through rectified diffusion. Under this proposed mechanism, all nanobubbles liberated by 
the first positive half-cycle initially have radii below the 800 nm decay threshold, as predicted by typical 
GV volume26. During the first negative half-cycle, rarefaction of these nanobubbles generates the dim 
signals and also generates bubbles with radii above the decay threshold due to rectified diffusion or 
coalescence of the nanobubbles. In the case of multi-cycle waveforms, subsequent cycles result in cavitation 
of the larger bubbles, which generates the bright signals (Supplementary Fig. 4.1i). In contrast, single-
cycle waveforms do not generate bright signals because there are no subsequent cycles to cavitate the larger 
bubbles that form following the first negative half-cycle (Supplementary Fig. 4.1j). In this case, the dim 
signals generated by multi-cycle waveforms would be due to nanobubbles that remain below the decay 
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C h a p t e r  5  
ULTRASOUND IMAGING OF GENE EXPRESSION IN MAMMALIAN 
CELLS 
This chapter is in large part a reformatted version of the manuscript entitled “Ultrasound Imaging of Gene 
Expression in Mammalian Cells” published by Farhadi, A., Ho, G. H., Sawyer, D. P., Bourdeau, R. W. and 
Shapiro, M. G. in Science. Under the supervision of Mikhail Shapiro, my contributions to the work were to 
help design and optimize the ultrasound pulse sequence and assist with writing the manuscript. 
 Working as a collaborator on this project taught me valuable lessons about the impact of imaging 
capabilities on the development of novel tools in synthetic biology. The expression of gas vesicles (GVs) in 
mammalian cells was a tremendous achievement, but it was made especially difficult by the low expression 
levels. This challenge necessitated the development of an early destructive imaging protocol that extracted 
more signal from the GVs during collapse. However, it was only after developing this protocol further and 
experimenting with different pulse sequence parameters and reconstruction methods that I was able to 
develop this protocol into BURST and improve its specificity and sensitivity by multiple orders of 
magnitude. And yet, without the unmet need of improved imaging sensitivity, BURST likely would never 
have been developed. This is in contrast to how, in the case of xAM, the imaging technique created an 
opportunity for novel acoustic biosensors. In this way, I now appreciate how the innovation feedback loop 
works from both directions. 
 
5.1 Abstract 
The study of cellular processes occurring inside intact organisms requires methods to visualize cellular 
functions such as gene expression in deep tissues. Ultrasound is a widely used biomedical technology 
enabling non-invasive imaging with high spatial and temporal resolution. However, no genetically encoded 
molecular reporters are available to connect ultrasound contrast to gene expression in mammalian cells. To 
address this limitation, we introduce mammalian acoustic reporter genes. Starting with a gene cluster 
derived from bacteria, we engineered a eukaryotic genetic program whose introduction into mammalian 
cells results in the expression of intracellular air-filled protein nanostructures called gas vesicles, which 
produce ultrasound contrast. Mammalian acoustic reporter genes allow cells to be visualized at volumetric 








The study of cellular function within the context of intact living organisms is a grand challenge in biological 
research and synthetic biology1. Addressing this challenge requires imaging tools to visualize specific cells 
in tissues ranging from the developing brain to tumors, and to monitor gene- and cell-based therapeutic 
agents in vivo2. However, most common methods for imaging cellular processes such as gene expression 
rely on fluorescent or luminescent proteins, which have limited performance in intact animals due to the 
poor penetration of light in biological tissue3,4. On the other hand, ultrasound easily penetrates most tissues, 
enabling deep non-invasive imaging with excellent spatial and temporal resolution (~100 µm and ~1 ms, 
respectively)2,5. These capabilities, along with its safety, portability and low cost, have made ultrasound a 
widely used technology in biomedicine. Despite these advantages, to date ultrasound has played a relatively 
small role in cellular imaging due to the lack of appropriate genetically encoded reporters.  
Recently, biomolecular contrast agents for ultrasound were introduced based on gas vesicles, air-
filled protein nanostructures which evolved in certain waterborne bacteria and archaea to provide cellular 
buoyancy6,7. Gas vesicles comprise a 2 nm-thick protein shell enclosing a gas compartment with dimensions 
on the order of 100 nm. The acoustic impedance mismatch between their gas interior and surrounding 
aqueous media allows gas vesicles to strongly scatter sound waves and thereby serve as ultrasound contrast 
agents8–12. In their native organisms, gas vesicles are encoded by clusters of 8-14 genes, including one or 
two primary structural proteins, and several other essential genes encoding putative assembly factors or 
minor shell constituents.  
The use of gas vesicles as reporter genes requires the heterologous expression of their cognate 
multi-gene operon in a new cellular host, ensuring proper transcription and translation of each gene, 
functional folding of each corresponding protein and appropriate stoichiometry and co-localization of the 
constituents for gas vesicle assembly. Recently, a genetic engineering effort succeeded in expressing gas 
vesicles as acoustic reporter genes (ARGs) in commensal bacteria, allowing their imaging in the mouse 
gastrointestinal tract13. If ARGs could be developed for mammalian cells, this would enable the study of 
how such cells develop, function and malfunction within the context of model organisms and enable the in 
vivo imaging of mammalian cells engineered to perform diagnostic or therapeutic functions14–16. However, 
developing ARGs for mammalian cells represents an even greater synthetic biology challenge due to the 
differences in transcription, translation, co-localization and protein folding between prokaryotes and 
eukaryotes17–19. To our knowledge, no genetic operon larger than 6 genes has been moved between these 
domains of life20.  
 
5.3 Results 
Here, we describe the expression of ARGs in mammalian cells to enable ultrasound imaging of mammalian 






we synthesized individual gas vesicle genes from three different microbial species using codons optimized 
for human expression, cloned each gene into a separate monocistronic plasmid and transiently co-
transfected mixtures of the genes from each species into HEK293T cells (Fig. 5.1A). After allowing 72 
hours for protein expression, we gently lysed the cells (~2x106 cells per sample), and centrifugated the 
lysate to enrich for buoyant particles, which would include any gas vesicles. The top fraction of the 
centrifugated lysate was then screened for gas vesicles using transmission electron microscopy (TEM). 
These experiments took advantage of the intrinsic stochasticity of transient co-transfection, in terms of the 
ratios of genes and the overall DNA quantity delivered to each cell, to simultaneously sample a broad range 
of gene stoichiometries and expression levels without prior knowledge of parameters leading to gas vesicle 
formation.  
 
Figure 5.1 | Engineering of mammalian acoustic reporter genes. (A) Schematic of the transient co-transfection 
assay used to identify combinations of genes capable of producing gas vesicles in mammalian cells. (B) Schematic of 
nine genes from B. megaterium capable of encoding gas vesicle expression in mammalian cells. Thin arrow denotes 
CMV promoter. polyA denotes SV40 polyadenylation element. (C) Representative TEM image of purified gas 
vesicles expressed in HEK293T cells. (D) Gene cassettes comprising the mammalian acoustic reporter gene construct, 
mARG. (E) Representative TEM image of gas vesicles purified from HEK293T cells transiently transfected with 
mARGs for 72 hours. All scale bars represent 500 nm. 
The co-transfection of the gas vesicle genes from Halobacterium salinarum and Anabaena flos-






forming genes from Bacillus megaterium (Fig. 5.1B) resulted in the production of unmistakable gas vesicles 
as evidenced by their appearance in TEM images (Fig. 5.1C). The 9 genes originate from an eleven-gene 
B. megaterium gene cluster previously used to express gas vesicles in E. coli13,21, with the exception of 
GvpR and GvpT, which were found to be unnecessary for gas vesicle formation (Supplementary Fig. 5.1). 
 Using the 9 genes identified in our stochastic screen, we set out to construct a polycistronic 
mammalian operon for consistent gas vesicle expression by joining these genes using the viral co-
translational self-cleavage peptide P2A22. Having determined that all genes except GvpB could tolerate P2A 
peptide additions (Supplementary Fig. 5.2 and Supplementary Table 5.1), we constructed a polycistronic 
plasmid containing the 8 P2A-tolerant gas vesicle genes connected by P2A sequences, and co-transfected 
it into HEK293T cells together with a plasmid encoding GvpB. Unfortunately, this did not result in the 
production of gas vesicles. We hypothesized that one or more of the genes in our polycistronic plasmid was 
expressed at an insufficient level, and used a complementation assay to identify GvpJ, GvpF, GvpG, GvpL 
and GvpK as bottleneck genes (Supplementary Fig. 5.3). This led us to construct a polycistronic “booster” 
plasmid containing these five genes, ordered to minimize P2A modifications to GvpJ and GvpK, which 
were found to be most limiting. The co-transfection of the booster plasmid together with the two plasmids 
above (Fig. 5.1D) enabled robust expression of gas vesicles in cells (Fig. 5.1E). We named this set of three 
genetic constructs mammalian acoustic reporter genes, or mARGs. 
After establishing polycistronic constructs for mammalian gas vesicle assembly, we used an 
integrase23,24 to incorporate them into the cellular genome for stable expression under a doxycycline-
inducible TRE3G promoter, with fluorescent proteins added to each construct as transfection indicators 
(Fig. 5.2A). We transfected these plasmids into HEK293-tetON cells and used flow cytometry to sort cells 
according to their expression level of each fluorescent reporter. We found that the cell population 
combining the strongest expression of each construct produced the largest quantity of gas vesicles (Fig. 
5.2B, Supplementary Fig. 5.4, A-D). To ensure that mARG expression was not limited to HEK293 cells, 
we also transfected Chinese hamster ovary cells (CHO-K1), and obtained similar results (Supplementary 







Figure 5.2 | Formation, properties and non-toxicity of gas vesicles in cells with genome-integrated mammalian 
acoustic reporter genes. (A) Schematic of mARG constructs used for genomic integration into cells with the 
piggyBac transposase system. ITR, inverted terminal repeat; ChbGI, Chicken beta-globin insulator; GFP, Emerald 
green fluorescent protein; BFP, enhanced blue fluorescent protein 2. (B) Representative TEM image of buoyancy-
enriched lysate from HEK293-tetON cells transfected with the constructs in (A) and sorted for high expression of all 
three operons. (C) Fluorescence-activated cell sorting of HEK293-tetON cells transfected with the constructs in (A). 






monoclonal cell lines, including assays for viability, fluorescence intensity and gas vesicle yield. (E) Number of gas 
vesicles expressed by monoclonal HEK293-tetON cells after 72 hours of induced expression, as counted in lysates 
using TEM. Bar represents the mean and the shaded area represents SEM (n=3, each from two technical replicates). 
(F) Representative TEM image of a 60-nm section through an mARG-HEK cell showing an angled slice through two 
bundles of gas vesicles in the cytosol. (G) Representative TEM image of gas vesicles purified from mARG-HEK cells. 
(H) Size distribution of gas vesicles expressed in mARG-HEK cells. The mean and standard deviation of both 
distributions is illustrated as a circle and with error bars. (n=1828) (I) Phase contrast images of mARG-HEK and 
mCherry-HEK cells 72 hours after induction with 1 µg/mL doxycycline and 5 mM sodium butyrate. (J) Cell viability 
of mARG-HEK cells relative to mCherry-HEK cells after 72 hours of gene expression. Error bars indicate SEM. (K) 
Fraction of mARG-HEK cells in co-culture with mARG-mCherry cells seeded in equal numbers over 6 days of gene 
expression (n=3 biological replicates, each from 4 technical replicates, with darker symbols showing the mean). Scale 
bars in B, F, G represent 500 nm. Scale bar in I represents 20 µm.  
To generate a stable monoclonal cell line expressing mARGs for detailed analysis, we sorted 
individual high-expression HEK293-tetON cells for monoclonal growth (Fig. 5.2C), producing 30 cell 
lines, which we screened for viability, fluorescence and gas vesicle formation (Fig. 5.2D, Supplementary 
Table 5.2). The number of gas vesicles per cell was then estimated from TEM images, and a cell line 
yielding the largest quantity of gas vesicles was selected and named mARG-HEK. When induced for 72 
hours with 1 µg/mL of doxycycline and 5 mM sodium butyrate (to reduce epigenetic silencing), this cell 
line produced on average 45 gas vesicles per cell (Fig. 5.2E). Using thin-section TEM, gas vesicles could 
clearly be seen in the cytosol of individual mARG-HEK cells (Fig. 5.2F). From TEM images of cell lysates, 
we measured the average dimensions of gas vesicles produced in this cell line to be 64 ± 12 nm wide 
(standard deviation, n=1828) and 274 ± 212 nm long (standard deviation, n=1828), with some reaching 
lengths greater than 1 micron (aspect ratios greater than 30) (Fig. 5.2, G-H). This corresponds to an average 
gas vesicle volume of 0.605 attoliters. Together, the 45 gas vesicles expressed in an average mARG-HEK 
cell are expected to occupy just 0.0027% of the cell’s cytosolic volume.  
The expression of gas vesicles did not change the gross morphology of mARG-HEK cells (Fig. 
5.2I), and was non-toxic as determined by three different assays (Fig. 5.2J), as compared to a similarly 
prepared control cell line (mCherry-HEK) (Supplementary Fig. 5.5 A-B). During a 6-day co-culture, 
mARG-HEK cells showed only a minor growth disadvantage compared to mCherry-HEK cells (Fig. 5.2K). 
As expected, both engineered cell lines grew more slowly than wild-type HEK293T cells (Supplementary 
Fig. 5.6). 
Having engineered mARG-HEK cells, we sought to image their expression of acoustic reporters 
with ultrasound. Gas vesicles encoded by the B. megaterium gene cluster are expected to produce linear 
ultrasound scattering21. However, since mammalian cells themselves also produce significant linear 
contrast, detecting gas vesicles expressed in such cells using linear methods is challenging. To enable more 
selective imaging of mARG-expression, we took advantage of the ability of gas vesicles to collapse 
irreversibly above specific ultrasound pressure thresholds8,9,13,21. A switch in the incident ultrasound 






which decays to a lower level in the next ultrasound frame due to immediate dissolution of their gas contents 
and the elimination of ultrasound scattering (Fig. 5.3, A-B). Meanwhile, background tissue scattering rises 
with the increase in incident pressure and remains constant at the new level. Thus, images formed by taking 
the difference in signal between the collapsing and post-collapse frames reveal specifically the presence of 
gas vesicles.  
 
We implemented this collapse-based imaging approach using an amplitude modulation pulse 
sequence10, which we found to provide the best cancellation of non-gas vesicle signals. When hydrogels 
containing mARG-HEK cells were imaged using this technique at 18 MHz, they were easily distinguishable 
from mCherry-HEK controls based on their contrast dynamics (Fig. 5.3C). Critically, while this imaging 
paradigm requires the collapse of gas vesicles inside cells, this does not affect cell viability (Fig. 5.3D). 
To test if mARGs can faithfully monitor circuit-driven gene expression25,26, we measured the 
dynamic ultrasound response of mARG-HEK cells under the control of a doxycycline-inducible promoter 
(Fig. 5.3E). After induction with 1 µg/mL doxycycline, the cells showed a gradual buildup of ultrasound 
signal, with clear contrast appearing on day two and increasing over the next 4 days (Fig. 5.3F). These 
kinetics are similar to those observed with fluorescent indicators (Supplementary Fig. 5.7A).  When the 
gene circuit was driven using a range of inducer concentrations, the ultrasound contrast followed the 
expected transfer function of the promoter (Fig. 5.3G, Supplementary Fig. 5.7B).  
To determine how sensitively mARG-expressing cells could be detected in a mixed cell population, 
we combined mARG-HEK cells with mCherry-HEK cells at varying ratios. We were able to detect the 
presence of mARG-expressing cells in these mixtures down to 2.5% of total cells (Fig. 5.3H), 
corresponding to less than 0.5% volumetric density, or approximately 3 cells or 135 gas vesicles per voxel 
with dimensions of 100 µm. A similar voxel-averaged concentration of gas vesicles was detectable in a 
monoculture of mARG-HEK cells induced to express 1.4 ± 0.6 gas vesicles per cell (Supplementary Fig. 
5.8).  
In many imaging experiments, the output of a gene circuit is read out only once. However, in some 
cases it may be desirable to track gene expression over time. We therefore tested whether mARG-
expressing cells in which the gas vesicles have been collapsed during imaging could re-express these 
reporters to allow additional imaging. mARG-HEK cells cultured a nutrient-supported hydrogel produced 
clear ultrasound contrast 3 days after induction, and were able to re-express their acoustic reporters over 3 
additional days (Fig. 5.3, I-J).  
Having engineered mammalian cells to stably express gas vesicles and characterized their ability 
to produce ultrasound contrast in vitro, we next tested the ability of mARG expression to be visualized in 






inoculating mARG-HEK cells in Matrigel subcutaneously in their left flanks (Fig. 5.4A). In the same mice, 
the right flanks were inoculated with mCherry-HEK control cells. We induced reporter gene expression in 
both tumors for 4 days through systemic injections of doxycycline and sodium butyrate (Fig. 5.4B). We 
expected these nascent tumors to be mostly vascularized at their perimeter, resulting in the strongest 
inducible gene expression at the tumor periphery (Fig. 5.4A). Ultrasound, with its sub-100-µm spatial 
resolution (at 18 MHz), should be able to discern this gene expression pattern, whereas attaining such 







Figure 5.3 | Ultrasound imaging of mammalian gene expression in vitro. (A) Illustration of the collapse-based 
ultrasound imaging paradigm used to generate gas vesicle-specific ultrasound contrast from mARG-expressing cells. 
(B) Representative non-linear signal recorded during a step change in the incident acoustic pressure, from 0.27 MPa 
in the white-shaded region to 1.57 MPa in the grey-shaded region. (C) Representative collapse and post-collapse 
ultrasound images of mARG-HEK and mCherry-HEK cells acquired during this ultrasound imaging paradigm and 
their difference, indicating gas vesicle-specific contrast. (D) Cellular viability after being insonated under 3.2 MPa 
acoustic pressures, as measured using the MTT assay. (E) Schematic of a chemically inducible gene circuit with 
mARG expression as its output. All three mARG cassettes in mARG-HEK cells are under the control of the 
doxycycline-inducible TRE3G promoter (TRE), with expression triggered by incubation with doxycycline. (F) 
Representative ultrasound images and contrast measurements in mARG-HEK cells as a function of time following 






Representative ultrasound images and contrast measurements in mARG-HEK cells as a function of doxycycline 
induction concentrations. Cells were allowed to express gas vesicles for 72 hours in the presence of 5 mM sodium 
butyrate. (n=6, with the darker dots showing the mean). A sigmoidal function is fitted as a visual guide. (H) 
Representative ultrasound images and contrast measurements in mARG-HEK cells mixed with mCherry-HEK cells 
in varying proportions. Cells were induced with 1 µg/mL of doxycycline and 5 mM sodium butyrate for 72 hours prior 
to imaging. (n=4, with the darker dots showing the mean) (I) Schematic and representative ultrasound images from 
mARG-HEK cells in Matrigel re-expressing gas vesicles after acoustic collapse. Cells were induced with 1 µg/mL of 
doxycycline and 5 mM sodium butyrate for 72 hours before and after 3.2 MPa acoustic insonation. Ultrasound images 
were acquired after an additional 72 hours in culture following collapse. (J) Ultrasound contrast in mARG-HEK and 
mCherry-HEK cells after initial expression, after collapse, after re-expression and after second collapse. (n=7, with 
the darker dots showing the mean). GV, gas vesicles. All scale bars represent 1 mm. 
After 4 days of induction, we observed clear ultrasound contrast in the flank inoculated with 
mARG-HEK cells, which was absent from the contralateral side (Fig. 5.4, C-D). As expected, the pattern 
observed with ultrasound revealed mARG expression at the perimeter of the tumor, while the core remained 
dark, and the imaging of adjacent ultrasound planes revealed this pattern of gene expression to persist across 
the tumor mass (Fig. 5.4E, Supplementary Fig. 5.9). 
The ultrasound-observed spatial distribution of gene expression was consistent with the low 
vascularity in the tumor core, as observed with Doppler ultrasound (Supplementary Fig. 5.10). The 
peripheral gene expression pattern was confirmed with subsequent histological examination of the tissue 
(Fig. 5.4F, Supplementary Fig. 5.11). In comparison, our in vivo fluorescence images just showed the 
presence of signal somewhere in the tissue and not its precise distribution (Fig. 5.4G). These results, which 
were consistent across 5 animals (Supplementary Fig. 5.12A), demonstrate that mARGs enable gene 
expression imaging in vivo and highlight the ability of ultrasound to visualize intricate patterns of gene 
expression non-invasively. We imaged 3 of the animals again after an additional 4 days to look for re-
expression of the collapsed gas vesicles, and observed ultrasound contrast in each case (Supplementary 







Figure 5.4 | Ultrasound imaging 
of mammalian gene expression 
in vivo. (A) Diagram of a mouse 
implanted with a subcutaneous 
tumor model, and the expected 
spatial pattern of vascularization 
and doxycycline-induced reporter 
gene expression. (B) Experimental 
timeline. (C) Representative 
ultrasound image of tumors 
containing mARG-HEK cells after 
4 days of doxycycline 
administration. mARG-specific 
contrast shown in the hot colormap 
is overlaid on an anatomical B-
mode image showing the 
background anatomy. (D) 
Representative ultrasound image 
of tumors containing mCherry-
HEK cells after 4 days of 
doxycycline administration. (E) 
Ultrasound images of adjacent 
planes in the mARG-HEK tumor 
acquired at 1 mm intervals. The 
minimum and maximum values of 
color bars in C-E are 4000 and 
40000 au, respectively. (F) 
Representative fluorescence image 
of a histological tissue section of 
an mARG-HEK tumor. Blue color 
shows the TO-PRO3 nucleus stain, 
green color shows GFP 
fluorescence and red color shows 
mCherry fluorescence. (G) 
Fluorescence image of a mouse 
implanted with mARG-HEK and 
mCherry-HEK tumors on the left 
and right flanks, respectively, after 
4 days of expression. Scale bars for 
are 1 mm for C-F and 1 cm for G.  
 
5.4 Discussion 
Our results establish the ability of an engineered genetic construct encoding prokaryote-derived gas vesicles 
to serve as a mammalian reporter gene for ultrasound, providing the ability to monitor cellular location and 
function inside living organisms. mARGs provide many of the capabilities associated with established 
genetically encoded optical reporters, including imaging cellular dynamics via promoter-driven expression 






capabilities in culture and surgically accessed tissues, mARGs enable gene expression to be resolved non-
invasively in vivo. 
While the genetic constructs described in this work should be immediately useful in a variety of 
contexts, significant scope exists for further optimization to make acoustic reporter genes as widely useful 
as GFP5,11. For example, accelerating mARG expression beyond the day-scale kinetics shown in this study 
and developing sensitive imaging paradigms that do not require gas vesicle collapse would enable the 
imaging of more dynamic cellular processes. In addition, while this study demonstrated essential mARG 
functionality with clonally selected cell lines, the expression of mARGs in primary cells, their delivery to 
endogenous cells via viral vectors, and their expression in transgenic animals would greatly expand the 
utility of this technology. To facilitate such uses, it would be helpful to further condense the mARG 
constructs. For example, genes could be consolidated into fewer clusters, and preliminary experiments show 
that gvpB can be combined with the 8-gene polycistron encoding gvpN-gvpU via an internal ribosome entry 
sequence (IRES) (Supplementary Fig. 5.13). In addition, the total length of the coding sequence contained 
in mARG could be reduced from 7.6 kb to 4.8 kb by eliminating the need for redundant booster genes, 
relying instead on non-coding elements such as different-strength promoters to tune expression 
stoichiometry. Further optimization of mARG genetic constructs is also needed to reduce epigenetic 
silencing and metabolic burden27–29. Just as the engineering of GFP over many years yielded brighter and 
more colorful reporters enabling new uses of fluorescence microscopy, further engineering of the genetic 
constructs comprising mARGs would help cellular ultrasound penetrate and enable new areas of 
mammalian biology and biomedicine. 
 
5.5 Methods 
5.5.1 Chemicals, cell lines and synthesized DNA 
All chemicals were purchased from Sigma Aldrich unless otherwise noted. HEK293T and CHO-K1 
cell lines were ordered from American Type Culture Collection (ATCC) and HEK293-tetON cells and 




Monocistronic plasmids used for transient transfection of HEK293T cells of gas vesicle genes used 
the pCMVSport backbone. Codon optimized gas vesicle genes were assembled in each plasmid using 
Gibson assembly. To test the effect of N- and C-terminal P2A modification each B. megaterium gas vesicle 






techniques. To test the N-terminal modification, the CCT codon was inserted following the start codon. To 
test the C-terminal modification, a linker-P2A sequence (GGAGCGCCAGGTTCCGGG-
GCTACTAACTTCAGCCTCCTTAAACAGGCCGGCGA CGTGGAAGAGAATCCTGGC) was 
inserted upstream of the stop codon for each gene.  
The polycistronic plasmid containing GvpN, GvpF, GvpG, GvpL, GvpS, GvpK, GvpJ, GvpU and 
Emerald GFP (EmGFP) were codon optimized, and synthesized in three fragments. The three fragments 
were Gibson assembled in the pCMVSport plasmid. The booster plasmid was assembled by multi-fragment 
Gibson assembly from PCR amplified fragments of the above plasmid.  
The piggyBac transposon system (System Biosciences) was used to genomically integrate the mARG 
cassettes. To clone the mARG cassettes to the piggyBac transposon backbone, the plasmid was first 
digested using the SpeI and HpaI restriction enzymes and the mARG cassettes were Gibson assembled in 
the backbone. For doxycycline-inducible expression, the CMV promoter upstream of the gas vesicle genes 
was replaced with the TRE3G promoter. Internal ribosome entry site (IRES) and mCherry were cloned 
downstream GvpB as a marker for genomic integration. For the booster plasmid, CMVmin followed by 
enhanced BFP2 (eBFP2) and a polyadenylation element were cloned in the reverse direction upstream of 
the TRE3G promoter (creating a bi-directional doxycycline-inducible promoter) and used as a marker for 
genomic integration. A piggyBac transposon plasmid containing TRE3G and mCherry was Gibson 
assembled similarly to above.  
 
5.5.3 Cell culture, transient transfection and TEM analysis 
HEK293T and CHO-K1 cells were cultured in DMEM with 10% FBS and penicillin/streptomycin 
and seeded in a 6-well plate for transfection experiments. When the cells reached 70-80% confluency, 2 µg 
of total DNA (comprising the indicated mixtures of plasmids) was complexed with 2.58 µg 
polyethyleneimine (PEI-MAX; Polysciences Inc.) per µg of DNA, added to the cell culture, and incubated 
for 12-18 hours. The transfection of monocistronic plasmids encoding Halobacterium salinarum, Anabaena 
flos-aquae and Bacillus megaterium were all at equal molar ratios. Thereafter, the media containing the 
PEI-DNA complex was changed with fresh media. Cells were allowed to express the recombinant proteins 
for 72 hours.  
To look for gas vesicles, fully confluent cells cultured in 6-well plates were lysed with 400 µL of 
Solulyse-M (Genlantis Inc) per well for one hour at 4 °C. The lysate was then transferred to 2 mL tubes, 
diluted with 800 µL of 10 mM HEPES buffer at pH 8.0 and centrifugated overnight at 300 g and 8 °C. 
Then, 60 µL of the supernatant was transferred to a fresh tube to be analyzed using transmission electron 






From this top fraction, 2 µL of sample was added to Formvar/carbon 200 mesh grids (Ted Pella) that 
were rendered hydrophilic by glow discharging (Emitek K100X). The samples were then stained with 2% 
uranyl acetate. The samples were imaged on a FEI Tecnai T12 transmission electron microscope equipped 
with a Gatan Ultrascan CCD. 
To estimate gas vesicle yield and analyze size distribution, the cells were seeded in 6-well plates and 
gas vesicle expression was induced with 1 µg/mL of doxycycline and 5 mM sodium butyrate for 72 hours. 
The cells were lysed using Solulyse-M and buoyancy enriched at 300 g at 8 ˚C overnight. The top fraction 
of the supernatant was mixed with 2M urea and spotted on Formvar/carbon grids. The TEM grids were 
washed with water before staining with 2% uranyl acetate. To calculate gas vesicle yield per cell, the total 
number of gas vesicles per sub-grid on the TEM grid was manually counted and related via lysate volume 
to the number of source cells. Gas vesicle size distribution was quantified using FIJI30.   
To visualize gas vesicles inside cells, mARG-HEK cells were seeded in 6-well plates and allowed to 
express gas vesicles for 72 hours. The cells were fixed in 1.25% glutaraldehyde in PBS, post-fixed in 1% 
aqueous osmium tetroxide, reduced with ferrocyanide and block-stained in 1% uranyl acetate (all reagents 
from Electron Microscopy Sciences). The material was then dehydrated through a graded ethanol series 
and embedded in Eponate12 (Ted Pella). Sections were cut 60 nm thin onto formvar-filmed copper grids, 
stained with 2% uranyl acetate and Reynolds lead citrate, and imaged at 80 kV in a Zeiss EM10C 
(Oberkochen) equipped with an ES1000W Erlangshen CCD camera (Gatan). 
 
5.5.4 Genomic integration and FACS  
 HEK293-tetON and CHO-tetON cells were used for genomic integration of the mARGs. The cells 
were cultured in a 6-well plate containing 2 mL DMEM with 10% tetracycline-free FBS (Clontech) and 
penicillin/streptomycin. Cells were transfected with the piggyBac transposon backbone containing the 
mARGs and the piggyBac transposase plasmid at a transposon:transposase molar ration of 2.5:1. 
Transfection was conducted using parameters mentioned above and the cells were allowed to incubate for 
72 hours. Cells were induced with 1 µg/mL of doxycycline 24 hours prior to FACS (BD FACSAria III). 
Polyclonal subpopulations of mARG-expressing HEK293-tetON cells were sorted into the following four 
bins: (subtype 1) cells with eBFP2 fluorescence greater than 104 and EmGFP fluorescence greater than 104 
and mCherry fluorescence greater than 2x104 au, (subtype 2) cells with eBFP2 fluorescence between 3x103 
and 2x104 and EmGFP fluorescence between 2x103 and 2x104 and mCherry fluorescence between 2x103 
and 2x104 au, (subtype 3) cells with eBFP2 fluorescence between 103 and 6x103 and EmGFP fluorescence 
between 2x102 and 103 and mCherry fluorescence greater than 2x104 au, (subtype 4) cells with eBFP2 
fluorescence greater than 104 and EmGFP fluorescence greater than 2x104 and mCherry fluorescence 






plasmid similar to above. mARG-expressing CHO-tetON cells with eBFP2 fluorescence greater than 104, 
EmGFP fluorescence greater than 104 and mCherry fluorescence greater than 2x104 au were sorted.  
For monoclonal cell lines, naïve HEK293-tetON cells were transfected with mARGs and the piggyBac 
transposase similar to above. mARG-expressing cells with eBFP2 fluorescence greater than 104, EmGFP 
fluorescence greater than 104 and mCherry fluorescence greater than 2x104 au were sorted. 576 cells were 
sorted in individual wells of 96-well plate and the surviving 30 cells were analyzed for gas vesicle 
expression as described above.  
To generate mCherry-HEK cells, HEK293-tetON cells were transfected with piggyBac transposon 
plasmid containing TRE3G promoter driving mCherry and the transposase plasmid similar to above. 
mCherry-HEK cells were sorted from cells with mCherry fluorescence between 1.5x104 and 105 au.   
Monoclonal cell lines (mARG-HEK and mCherry-HEK cells) were maintained in tetracycline-free 
media without butyrate and all imaging and toxicity experiments were conducted with cells that were less 
than 16 generations.  
 
5.5.5 In vitro toxicity assays  
The viability of the mARG-expressing cells was determined using three different assays involving 
cellular metabolic activity (resazurin reduction, MTT assay), quantification of cellular ATP content 
(CellTiter-Glo, Promega Corp.), and dye exclusion (Trypan Blue, Caisson Labs). The measurements were 
all quantified as percent viability compared to control cells that expressed mCherry only (mCherry-HEK). 
For the MTT and CellTiter-Glo assays, cells were grown in 96-well plates and induced with 1 µg/mL 
doxycycline and 5 mM sodium butyrate for 72 hours. They were then treated with reagents according the 
manufacturers’ protocols. Luminescence (CellTiter-Glo) and absorbance at 540 nm (MTT) was measured 
using a SpectraMax M5 spectrophotometer (Molecular Devices). For the Trypan Blue assay, the cells were 
first grown in 6-well plates and treated with 1 µg/mL doxycycline and 5 mM sodium butyrate for 72 hours. 
They were then trypsinized and resuspended in media before being stained 1:1 with Trypan Blue dye. Ten 
µL of the solution was loaded in a disposable hemocytometer (C-chip DHC S02, Incyto) and total cell count 
and blue-stained dead cells were quantified by bright field microscopy. Cellular morphology was imaged 
from mARG-HEK and mCherry-HEK cells after 3 days of expression with 1 µg/mL doxycycline and 5 
mM sodium butyrate. Phase images were acquired using a Zeiss Axio Observer with a 20x objective. For 
the co-culture cell competition assay, cells were counted and 2x105 cells from each type were mixed 
together and seeded in 6-well plates. One day after seeding, cells were induced with 1 µg/mL doxycycline 
and 5 mM sodium butyrate and the media was exchanged daily. At each time point, cells were trypsinized 
and sorted using the MACSQuant VYB Flow Cytometer (Miltenyi Biotech) to quantify relative cell ratios. 







5.5.6 In vitro ultrasound imaging 
To create phantoms for in vitro ultrasound imaging, wells were casted with molten 1% w/v agarose in 
PBS using a custom 3D-printed template. mARG-HEK and mCherry-HEK cells were allowed to express 
their transgenes using the specified inducer concentrations and expression duration. They were then 
trypsinized and counted via disposable hemocytometers in bright field microscopy. Next, cells were mixed 
at a 1:1 ratio with 50 °C agarose and loaded into the wells before solidification. The volume of each well 
was 60 µl and contained 6x106 cells. The phantoms were submerged in PBS, and ultrasound images were 
acquired using a Verasonics Vantage programmable ultrasound scanning system and L22-14v 128-element 
linear array transducer with a 0.10-mm pitch, an 8-mm elevation focus, a 1.5-mm elevation aperture, and a 
center frequency of 18.5 MHz with 67% −6 dB bandwidth (Verasonics, Kirkland, WA). Each frame was 
formed from 89 focused beam ray lines, each with a 40-element aperture and 8 mm focus. A 3-half-cycle 
transmit waveform at 17.9 MHz was applied to each active array element. For each ray line, the amplitude 
modulation (AM) code was implemented using one transmit with all elements in the active aperture 
followed by 2 transmits in which first the odd- and then the even-numbered elements are silenced (10). 
Each image captured a circular cross-section of a well with a 4-mm diameter and center positioned at a 
depth of 8 mm. In AM mode, the signal was acquired at 0.27 MPa (2V) for 10 frames and the acoustic 
pressure was increased to 1.57 MPa (10V) to collect 46 additional frames. Ultrasound images were 
constructed by subtracting the collapsing frame by frame 4 post-collapse.  
For Fig. 5.3, F-H, the high gas vesicle content of some samples resulted in acoustic shielding and a 
residual amount of gas vesicles remained intact after 46 frames of insonation at 1.57 MPa.  To fully collapse 
all the gas vesicles and collect the background signal, the acoustic pressure was increased to 3.2 MPa (25V), 
then a second set of images was acquired with 10 frames at 0.27 MPa and 46 frames at 1.57 MPa. Gas 
vesicle-specific signal was determined by subtracting the total ultrasound signal from the 46 frames 
acquired before 3.2 MPa ultrasound by the total ultrasound signal from the 46 frames post collapse. 
 
5.5.7 Cytotoxicity assay on cells exposed to ultrasound 
mARG-HEK and mCherry-HEK cells were cultured on custom made Mylar-bottom 24-well plates. 
Cells were cultured on fibronectin-coated Mylar films until they reached 80% confluency and induced for 
gas vesicle expression (1 µg/mL doxycycline and 5 mM sodium butyrate) for 3 days. The cells were then 
insonated from the bottom using an L22-14v 128-element linear array transducer (Verasonics). The 
transducer was mounted on a computer-controlled 3D translatable stage (Velmex). The bottom of the plates 
was acoustically coupled to the transducer with water and positioned 8 mm away from the transducer face. 






plates were returned to the incubator for 24 hours. Cytotoxicity was then assayed using resazurin reduction 
(MTT) on cells exposed to ultrasound and compared to non-insonated control cells. 
 
5.5.8 3D cell culture and in vitro acoustic recovery after collapse  
mARG-HEK and mCherry-HEK cells were mixed in Matrigel (Corning) containing 1 µg/mL of 
doxycycline and 5 mM sodium butyrate. The cell-laden hydrogels were placed in a 1% w/v agarose base to 
prevent cell migration out of the hydrogel and to separate the cells away from the bottom of the plates 
during imaging. Cells were cultured for total of 6 days and imaged every 3 days from the top using an L22-
14v 128-element linear array transducer (Verasonics). The transducer was wiped with 70% ethanol, and 
imaging was conducted in a laminar flow biosafety cabinet to preserve sterility. After imaging, to ensure 
complete collapse of all gas vesicles in the cells, the entire hydrogel was exposed to 3.2 MPa ultrasound 
and the transducer was translated three times across the gel at a rate of 1-2 mm/s. The culture media was 
changed daily and contained 1 µg/mL of doxycycline and 5 mM sodium butyrate. 
 
5.5.9 In vivo expression of gas vesicles and ultrasound imaging 
All in vivo experiments were performed on NOD SCID mice (NOD.CD17 Prkdcscid/NCrCrl; Charles 
River), aged 10-15 weeks, under a protocol approved by the Institutional Animal Care and Use of 
Committee of the California Institute of Technology. mARG-HEK and mCherry-HEK cells were cultured 
in tetracycline-free media in T225 flasks. 1-1.2x107 cells were trypsinized and the 200 µl cell-pellet was 
mixed with 200 µl Matrigel (Corning) containing 5 mM sodium butyrate. The mixture of mARG-HEK cells 
and Matrigel was injected subcutaneously in the left flank of mice and the mixture of mCherry-HEK cells 
and Matrigel was injected subcutaneously in the right flank of mice. Starting from the day of tumor 
inoculation, mice we interperitoneally injected with 200 µl of saline containing 75 µg doxycycline and 25 
mg of sodium butyrate daily. The lower half of mice were depilated to allow for fluorescence imaging and 
ultrasound coupling. 
For ultrasound imaging, the mice were anesthetized with 2% isoflurane and maintained at 37˚C using 
a heating pad. Ultrasound imaging was carried out using the pulse sequence described above with an L22-
14v transducer attached to a custom-made manual translation stage. Using B-mode ultrasound imaging, the 
center of the tumor was positioned approximately 8 mm from the surface of the transducer, and gas vesicle-
specific ultrasound images were acquired. The transducer was translated laterally with 1 mm steps to collect 
ultrasound images of most of the tumor.  
High framerate ultrasound datasets for Doppler imaging were acquired with the same ultrasound 
transducer and scanner. The Doppler pulse sequence consisted of 11 tilted plane wave transmissions 






compounding. Plane wave transmissions lasted 0.5 s (or 250 frames). A power Doppler image representing 
blood flow was computed from each ensemble of 250 frames using a singular value decomposition filter 
that separates clutter from red blood cell echoes31. 
To obtain tissue samples after the mice were euthanized, tumors were resected and placed in 3.7% 
formaldehyde solution (4˚C) for 24 hours and transferred to sterile 30% sucrose for an additional 24 hours. 
Tumors were embedded in OCT compound (Tissue-Tek), flash frozen and sectioned to 60 µm slices using 
a Cryostat (Leica CM3050). Sections were stained with TO-PRO3 nucleus stain, mounted (Fluoromount 
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5.6 Supplementary Material 
 
Supplementary Figure 5.1 – GvpR and GvpT genes in the B. megaterium gene cluster are not necessary for gas 
vesicle formation. Schematic of bacterial gas vesicle gene clusters used for heterologous expression of gas vesicles 
in E. coli (top). Representative whole cell TEM images of E. coli Rosetta 2(DE3)pLysS cells after expression of gas 
vesicles genes for 22 hours (bottom). Scale bars represent 500 nm. Expression performed as in Farhadi et al. (21) and 
TEM imaging as in Bourdeau et al. (13). 








Supplementary Figure 5.2 – Assay for tolerability of P2A peptide additions. Illustration of gas vesicle gene cluster 










Supplementary Figure 5.3 – Identification of bottleneck genes on the polycistronic gas vesicle gene plasmid. (A) 
Schematic of the experiment. To test the efficiency with which gas vesicles could be formed when a given gene was 
supplied only on the polycistronic plasmid, and thereby identify “bottleneck” genes, cells were co-transfected with a 
monocistronic plasmid containing GvpB, 7 other monocistronic plasmids including all but the gene being assayed, 
and the polycistronic plasmid. (B) Qualitative estimate of the relative number of gas vesicles produced when each 
indicated gene was supplied solely by the polycistronic plasmid. (C) Representative TEM images of gas vesicles in 
the lysate of HEK293T cells for all 8 assays. Scale bars represent 500 nm. These results suggest that GvpN, GvpS and 
GvpU supplied in either monocistronic or polycistronic form supported abundant gas vesicle assembly. However, the 
production of gas vesicles was significantly reduced when GvpJ, GvpF, GvpG, GvpL or GvpK was supplied from the 










Supplementary Figure 5.4 – Fluorescence activated cell sorting of HEK293-tetON and CHO-tetON cells 
transfected with integrating mARG constructs. (A) Diagram of the integrating constructs used to generate 
polyclonal cell lines. (B) FACS of mARG-expressing HEK293-tetON cells. Colored data indicate cells sorted for each 
group and gray dots are unsorted population. (C) Illustration of the four polyclonal subtypes sorted to study the impact 
of polycistron stoichiometry on gas vesicle expression. Red bars indicate mCherry expression; cyan bars indicate 
EmGFP and eBFP2 expression. (D) Approximate gas vesicle yield from polyclonal cells in each subtype. (E) FACS 
of mARG-expressing CHO-tetON cells. Colored data indicate cells sorted in subtype 1 and gray dots are unsorted 
cells. (F) Representative TEM image of buoyancy-enriched lysate from CHO-tetON cells sorted as indicated in (E). 







Supplementary Figure 5.5 – Genetic construct and sorting of mCherry-HEK cell line. (A) Genetic construct for 
stable genomic integration of mCherry containing a TRE3G promoter upstream and SV40 polyadenylation element 







Supplementary Figure 5.6 – Co-culture of reporter gene expressing cells with HEK293T cells. Fraction of 
mARG-HEK cells in co-culture with HEK293T cells (blue) or mARG-mCherry cells in co-culture with HEK293T 
cells (red) seeded in equal numbers over 6 days of gene expression (n=3 biological replicates, each from 4 technical 









Supplementary Figure 5.7 – Fluorescence measurements of gene expression as a function of time and inducer 
concentration in mARG-HEK cells. (A) mCherry fluorescence of mARG-HEK cells induced with 1 µg/mL 
doxycycline and 5 mM sodium butyrate at the indicated times after induction (n=4, with the darker dots showing the 
mean). (B) mCherry fluorescence of mARG-HEK cells with the indicated inducer concentration and 5 mM sodium 









Supplementary Figure 5.8 – Dependence of ultrasound contrast on gas vesicle density. Relative ultrasound 
contrast produced by mARG-HEK cells in hydrogel as a function of the estimated average number of gas vesicles 
(GV) per nanoliter present after a monoculture of mARG-HEK cells was induced with different concentrations of 
doxycycline, or after  fully-induced mARG-HEK cells were mixed with mCherry-HEK cells at different ratios. Blue 
symbols represent results from mARG-HEK cells induced with 1 µg/mL doxycycline for 3 days (producing on average 
45 gas vesicles per cell) mixed with mCherry-HEK cells (expressing no gas vesicles) in varying proportions, as 
presented in Fig. 5.3H. Red symbols represent results from mARG-HEK cells induced with 0.01, 0.05, 0.1 and 1 
µg/mL doxycycline for 3 days; expressing on average 0.01 ± 0.004, 1.4 ± 0.4, 3.5 ± 0.3, 45 ± 5.1 (mean ± SEM) gas 
vesicles per cell, respectively, as quantified by TEM. All cells were cultured with 5 mM sodium butyrate during 
expression. The number of gas vesicles was quantified after 72 hours of induced expression, as counted in lysates 
using TEM. Ultrasound contrast was normalized to the maximum in each type of titration. Dark symbols show the 
mean of ultrasound contrast for 4 replicates. Error bars represent SEM of 4 biological replicates for 0.01, 0.05, 0.1 










Supplementary Figure 5.9 – Additional examples of in vivo ultrasound images of adjacent planes in mARG-
HEK tumors acquired at 1 mm intervals. For each imaging slice the difference heatmap of nonlinear signal between 
frame 1 and frame 4 is overlaid on grayscale anatomical scale. Minimum and maximum values of color bar are 4000 









Supplementary Figure 5.10 – Representative Doppler ultrasound images of tumors containing mARG-HEK 
cells. Doppler ultrasound images were acquired using 250 frames of ultrafast planewaves at 25V and used to 
reconstruct vascular maps plotted as normalized power doppler signal overlaid on anatomical images in grayscale. 








Supplementary Figure 5.11 – Representative histology sections of tumors containing mARG-HEK cells. For 
each mouse, two neighboring sections are presented. Blue color indicates cell nuclear staining using TO-PRO-3, green 









Supplementary Figure 5.12 – Biological replicates of in vivo ultrasound imaging of gene expression. (A) The left 
column shows ultrasound images of tumors containing mARG-HEK cells after 4 days of doxycycline administration. 
The right column shows ultrasound images of tumors containing mCherry-HEK cells after 4 days of doxycycline 
administration. After imaging the tumors were insonated with 3.2 MPa of ultrasound to collapse the expressed gas 
vesicles. (B) The left column shows ultrasound images of tumors containing mARG-HEK cells re-expressing gas 
vesicles after an additional 4 days of doxycycline administration. The right column shows ultrasound images of tumors 
containing mCherry-HEK cells after an additional 4 days of doxycycline administration. Difference heatmap of 
nonlinear signal between frame 1 and frame 4 is overlaid on a grayscale anatomical ultrasound image. Min and max 








Supplementary Figure 5.13 – Consolidated mARG construct comprising 2 gene cassettes enables mammalian 
gas vesicle expression. (A) Schematic of two gene cassettes integrated to the genome of HEK293-tetON cells. In the 
top construct GvpB is separated from GvpN by an internal ribosome entry sequence (shown in purple). (B) 
Representative TEM image of GVs in the lysate of HEK293-tetON cells transfected with the constructs in (A) and 







Gene GVs after N-term addition? GVs after C-term addition? 
GvpB -- No 
GvpR Yes Yes 
GvpN Yes Yes 
GvpF Yes Yes 
GvpG Yes Yes 
GvpL Yes Yes 
GvpS Yes Yes 
GvpK Yes Yes 
GvpJ Yes Yes 
GvpT Yes Yes 
GvpU Yes Yes 
 
Supplementary Table 5.1 – Tolerability of P2A peptide additions to B. megaterium gas vesicle genes. Each gene 
of the B. megaterium gene cluster was modified with an N-terminal proline after the start codon or with a linker and 
P2A peptide at the C-terminus, resulting in a total of 21 unique GV gene clusters as illustrated in Supplementary Fig. 
5.2. E. coli were transformed with each plasmid and gas vesicles were induced for expression for a total of 22 hours 
and assayed for the presence of gas vesicles using TEM. The table indicates whether gas vesicles were observed by 


















576 30 21 12 6 
 
Supplementary Table 5.2 – Selection funnel for monoclonal mARG-HEK cells. The numbers indicate the number 
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C h a p t e r  6  
CONCLUSIONS AND FUTURE DIRECTIONS 
This thesis describes some of the initial work on the design of pulse sequences and algorithms for enhancing 
the capabilities of noninvasive ultrasound imaging of gas vesicles and acoustic reporter genes. Chapter 2 
introduced xAM, a pulse sequence that achieves high specificity imaging of harmonic gas vesicles by using 
the transient interaction of axisymmetric, cross-propagating plane waves to eliminate artifacts caused by 
nonlinear wave propagation. Chapter 3 presented an application of xAM to the visualization of the dynamic 
biomolecular process of proteolytic enzyme activity deep inside living animals. Chapter 4 introduced 
BURST, an imaging paradigm that improves the sensitivity of gas vesicle imaging by a factor of at least 
1000 and enables the detection of single ARG-expressing cells as well as single gas vesicles in liquid 
suspension by inducing and capturing transient cavitation events following gas vesicle collapse and 
unmixing their temporal dynamics from background signal. Chapter 5 described the application of an early 
implementation of BURST to visualize the dynamics of expression of the first mammalian acoustic reporter 
genes and to image vascularization patterns in tumors expressing mammalian acoustic reporter genes. 
Currently, out of all known methods for ultrasound imaging of gas vesicles, xAM and BURST provide the 
best specificity and sensitivity, two metrics fundamental to the quality of all forms of measurement. As 
such, the number of applications of these methods can be expected to increase in proportion to the number 
of research directions utilizing gas vesicles and acoustic reporter genes. 
Nevertheless, a number of limitations remain for both xAM and BURST, some of which can be 
obviated with improvements in hardware, others of which may be overcome with advances in gas vesicle 
and acoustic reporter gene engineering, and still others that will require entirely novel imaging approaches 
to surpass. Several of these limitations, along with possible future directions for addressing them, are 
discussed below. 
 
6.1 Future Directions for xAM  
The most pressing limitation of xAM is the low framerate of live imaging in its current implementation, 
which is typically 1 to 5 Hz. While this framerate is sufficient for stationary targets, it makes in vivo imaging 
difficult in the presence of tissue motion. This limitation arises because xAM image lines are not formed 
along the propagation direction of the ultrasonic waves, but along the line at which the two cross-






software beamforming algorithm implemented on Verasonics ultrasound systems1 that normally enables 
reconstruction at high frame rates. Without the bottleneck of software beamforming, xAM could in 
principle be used to acquire a 10-mm-deep image with 64 ray lines at 400 Hz. Consequently, addressing 
this limitation is largely an engineering challenge, albeit one that requires some effort at algorithmic 
optimization in a compiled programming language and knowledge of parallel computing.  
Increasing the framerate of xAM by two orders of magnitude in this way would make in vivo 
imaging more robust and also create opportunities for experimenting with in-software compounding 
methods to improve CNR and artifact cancellation. One interesting idea would be to use non-axisymmetric 
plane waves that cross-propagate at different angles and combine the resulting echoes similar to 
compounding with tilted plane waves. Of course, this would necessitate a new beamforming strategy 
because the ray lines would no longer be perpendicular to the axis of the transducer array. 
Once the beamforming bottleneck is addressed, the framerate of xAM will be limited by the fact 
that it forms images on the basis of ray lines from separates sets of transmits. To match the frame rates used 
in ultrafast doppler2 and super-localization3 applications, the xAM framerate would need to be improved 
by a further two orders of magnitude. One way to do this would be to use a planar ultrasound array and 
transmit an X-wave on each row of the array simultaneously.  
Another limitation of xAM is its non-adjustable depth of field for a given aperture and cross-




where 𝐷 is the aperture size. At the empirically optimal angle of 19.5° and a 6.5 mm aperture, this translates 
to a maximum depth of 9.1 mm, though intensity of the beam begins to fade around 7 mm. This is 50% to 
90% of the maximum attenuation-limited depth for in vivo imaging with 18 MHz ultrasound, which is 
typically 10 to 15 mm. Because both probe element spacing and the attenuation-limited depth increase with 
ultrasound frequency, the portion of the potential depth of field compromised by this limitation should be 
roughly constant for different probes. The only way to increase the maximum depth for a given angle is to 
increase the programmed aperture, which reduces the lateral field of view. To circumvent this trade-off, a 
linear array with a larger number of elements could be used. 
 
6.3 Future Directions for BURST 
A notable limitation of BURST is its sensitivity to motion of the imaging target, which required a modified 
pulse sequence and additional post-processing steps to remove motion artifacts for in vivo experiments, as 






based template unmixing algorithm assumes that no tissue displacement larger than 300 µm occurs over 
the full series of frames, which requires a much higher framerate than simply matching the Nyquist 
frequency of tissue motion. One strategy to address this would be to apply tissue motion corrections 
methods developed for ultrasound super-localization, which also relies on a stack of frames and is 
susceptible to motion artifacts4,5. Another interesting approach would be to use multi-pixel signal templates 
capable of unmixing signals based on spatial characteristics, allowing templates to correspond to patterns 
of tissue motion as well other spurious signal sources such as bubbles. However, this would increase 
complexity and would likely require learning templates from in vivo data, which may not be available in 
sufficient quantities to prevent overfitting. Alternatively, the framerate could be increased by two orders of 
magnitude by applying the sequence of voltages to each ray line at a time, rather than transmitting every 
ray line at each voltage value. Of course, this would also increase the time between ray line acquisitions by 
two orders of magnitude, which could lead to visible discontinuities in BURST signal between ray lines, 
but the threshold for tolerable motion levels would be much higher for this effect, and it would likely be 
preferable to the false positive BURST signal caused by motion artifacts in the original sequence. However, 
this method could reduce total BURST signal by collapsing gas vesicles adjacent to the current ray line and 
allowing the liberated nanobubbles to dissolve before being insonified. 
 Another potential limitation of BURST could be specific frequency requirements, though more 
experiments are needed to determine the effects of frequency on BURST signal. Using our L10-4v probe, 
we found that BURST was significantly more effective at transmit waveform frequencies in the range of 5 
MHz to 7 MHz (unpublished data), but this may simply be due to the probe’s center frequency of 6 MHz 
as these experiments did not control for pressure. More research is needed to determine both the effect of 
transmitted waveform frequency on BURST signal intensity as well as the full frequency spectrum of 
received BURST signal. 
A third limitation of BURST is its narrow axial field of view, which is restricted to 2 mm, less than 
10% of the available field of view, due to the need for highly focused beams to achieve the required pressure 
levels. The axial field of view is also limited to half the width of the probe due to the need for a large 
aperture to produced sharply focused beams, though this is comparable to the lateral field of view of xAM. 
All three of these limitations could be overcome by developing a custom transducer capable of 
achieving peak positive pressures in the range of 3.4 MPa to 4.3 MPa throughout the image plane using 
only plane waves. This would allow each BURST frame to be acquired in a single transmit, obviating the 
need for focused beams and allowing for ultrafast frame rates. This could also allow the receive function to 
be performed with a separate probe, whose specifications would no longer be constrained by the frequency 
and peak pressure requirements of the transmit waveform. Moreover, 100% of the receiving probe’s axial 






Of course, the primary limitation of BURST is the irreversible collapse of gas vesicles required to 
generate the strong signal responsible for this method’s dramatically increased sensitivity. This limits the 
potential of BURST to image targets over time. Unfortunately, this is a fundamental limitation of BURST, 
which generates signal through the transient cavitation of nanobubbles liberated from collapsed gas 
vesicles. However, it may still be possible to apply BURST to enable high sensitivity in multiplexed gas 
vesicle imaging6 and in the acoustic biosensor imaging described in Chapter 3 through the development of 
gas vesicles with higher collapse pressure. As shown in Supplementary Figure 4.1, BURST+ requires a 
peak positive pressure of at least 3.4 MPa to generate detectable collapse signal. Because the gas vesicles 
used in that experiment have an acoustic collapse midpoint of 2.6 MPa7, this result suggests that, at least at 
a frequency of 6 MHz, a peak positive pressure greater than 3.4 MPa may be required to initiate the transient 
cavitation events responsible for strong BURST+ signal and that the gas vesicle collapse threshold may not 
be the limiting factor.  
If this is the case, new gas vesicle variants with acoustic collapse thresholds above 3.4 MPa could 
enable BURST to be used for ultrasensitive multiplexed collapse imaging. Though no gas vesicle variants 
with acoustic collapse thresholds in this range are currently known, the wide spread of collapse thresholds 
for currently-characterized gas vesicles over an order of magnitude8 suggests that such variants could be 
produced through directed evolution. Noting that a given reporter gene variant typically produces gas 
vesicles with a distribution of sizes and collapse pressures, variants with narrow distributions would be 
advantageous for multiplexed imaging. 
A more ambitious direction would be to engineer or evolve gas vesicles whose high collapse 
threshold is conditional on the binding of GvpC. In Ana gas vesicles, removal of GvpC reduces the acoustic 
collapse midpoint by 300 kPa, which, considering the distribution of collapse thresholds for Ana gas 
vesicles with intact GvpC, is a shift of two standard deviations6. The prospects for developing a high-
threshold variant with this property are less certain because the gas vesicles with the highest known collapse 
thresholds are small in size and do not bind with GvpC, but there is no reason to believe evolving such a 
variant would not be possible. If such a high-threshold, GvpC-strengthened gas vesicle were developed and 
engineered to have biomolecular sensing capabilities similar to those described in Chapter 3, it could enable 
ultrasensitive imaging of not only gene expression, but other biomolecular processes as well. 
Finally, while BURST will always be a destructive imaging method, it may be possible to design a 
novel, non-destructive pulse sequence that still improves sensitivity by multiple orders of magnitude, as 
will be explored in the final section below. 
 






As described above, there are several opportunities for extending the capabilities of xAM and BURST, but 
some limitations will require novel imaging methods to overcome. The destructive nature of BURST is one 
such limitation, making the development of a non-destructive method with similar sensitivity a high-impact 
objective. BURST is capable of detecting single gas vesicles, a surprising capability made possible by 
transient cavitation of nanobubbles liberated from collapsed gas vesicles. In contrast, echoes from the 
scattering of a sub-collapse-threshold acoustic wave on a single gas vesicle would be below the noise floor 
of an ultrasound probe.  
One method often used to detect very weak signals buried in noise is lock-in detection9, in which 
the amplitude of a sinusoidal signal confounded by noise is measured by comparison to a reference signal 
with the same phase and frequency. This process efficiently cancels noise by integrating only those 
components of the input signal with the same phase as the reference signal, such that the measurement SNR 
increases in direct proportion to the integration time. For comparison, SNR increases in proportion to the 
square root of the integration time for detection methods that are not phase-sensitive. However, lock-in 
detection is rarely used in contrast-enhanced ultrasound imaging because clutter signal from tissue, which 
does have the same phase as contrast agent signal, is a much stronger source of confounding than noise, 
even in AM and other contrast imaging modes. 
Dual-frequency transducers have recently been used to generate echoes from contrast agents at low 
frequencies while recording their nonlinear echoes at frequencies several times higher10. Nonlinear contrast 
agent signal remains detectable while tissue signal is strongly attenuated at the higher-order harmonics. In 
a study with microbubbles, a CTR of 25.5 was achieved by transmitting at 1.5 MHz center frequency with 
a peak acoustic pressure of 1600 kPa and receiving at 10 MHz center frequency11. Because tissue 
nonlinearity increases with pressure, we could expect to achieve significantly higher CTR by using 350 kPa 
to induce buckling in stripped Ana gas vesicles. Because dual-frequency imaging experiments have only 
been performed with receive-to-transmit center frequency ratios at which contrast agent signal remains 
above the noise floor, it may be possible to reduce tissue signal further relative to contrast agent signal by 
using even higher center frequency ratios. Combining dual-frequency transducers with gas vesicles and 
lock-in detection could therefore be a promising direction for achieving non-destructive ultrasensitive 
imaging, especially in areas of the body with low scattering, such as the brain and blood vessels. 
Ultimately, as innovations in imaging methods are iteratively developed alongside innovations in 
gas vesicle and acoustic reporter gene engineering, I anticipate that many of the remaining barriers to robust 
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